Sentence,class,file
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Ksiazek I, Burkhardt C, Lin S, et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/58/annrheumdis-2015-207316.PMC4760904.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/40273_2015_Article_378.PMC4760993.pdf
http://www.sciencedirect.com/science/article/pii/ B9780124045767099809 .,Non-OADS,/arxiv_data1/oa_pdf/e8/3e/40273_2015_Article_378.PMC4760993.pdf
http://blogs.gartner.com/doug- laney/ﬁles/2012/01/ad949-3D-Data-Management-Controlling- Data-Volume-Velocity-and-Variety.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e8/3e/40273_2015_Article_378.PMC4760993.pdf
http://www.emc.com/collateral/analyst-reports/ idc-extracting-value-from-chaos-ar.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e8/3e/40273_2015_Article_378.PMC4760993.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
ISPOR Connect 2013;19:9–11.Available at: http://www.ispor.org/news/articles/march-april13/ real-world-data.asp .,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
Available at: http://www.hscic.gov.,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
Available at: https://www.nice.org.uk/ guidance/cg61 .,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
Avail-able at: https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ﬁle/213150/PbR-Simple-Guide-FINAL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
Available at: https://www.rct.,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
Availableat:http://www.york.ac.uk/media/economics/documents/herc/wp/ 08_20.pdf .,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/40273_2015_Article_339.PMC4760998.pdf
"Open Access This article is distributed under the terms of the Crea- tive Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium,provided you give appropriate credit to the original author(s) and thesource, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3b/75/10620_2015_Article_3917.PMC4761007.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/49/3a/40262_2015_Article_317.PMC4761011.pdf
2012. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM292362.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/3a/40262_2015_Article_317.PMC4761011.pdf
2012. http://www.ema.europa.eu/docs/en_ GB/document_library/Scientiﬁc_guideline/2012/07/WC500129 606.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/3a/40262_2015_Article_317.PMC4761011.pdf
2008 [cited 2014 November 20]; Available from: http://www.gsk- clinicalstudyregister.com/study/FNM10004#rs .,Non-OADS,/arxiv_data1/oa_pdf/49/3a/40262_2015_Article_317.PMC4761011.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2c/f6/40261_2015_Article_372.PMC4761013.pdf
32.http://www.equalis.se/media/41723/u040_kvalitetsma ˚l_equalis_1.2.,Non-OADS,/arxiv_data1/oa_pdf/2c/f6/40261_2015_Article_372.PMC4761013.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ed/a4/40261_2015_Article_361.PMC4761015.pdf
http://www.who.int/vmnis/indica tors/haemoglobin/en .,Non-OADS,/arxiv_data1/oa_pdf/ed/a4/40261_2015_Article_361.PMC4761015.pdf
14.http://www.products.sanoﬁ-aven tis.us/ferrlecit/ferrlecit.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ed/a4/40261_2015_Article_361.PMC4761015.pdf
"Table 1 Physicochemical and in vitro pharmacokinetic parameters of darunavir Parameter Value References Physicochemical Molecular weight 548 g mol-1Pubchem [ 52] Log Po:w 1.8 http://www.antimicrobe.org/d94.asp (February 2015) [ 53] http://www.drugbank.ca/drugs/db01264 (February 2015) [ 54] Compound type Weak basepKa http://www.drugbank.ca/drugs/db01264 (February 2015) [ 54]Strongest basic 2.39 Strongest acidic 13.59 Physiological charge 0Blood:plasma ratio 0.64 EMA scientiﬁc discussion [ 19,55] Fraction unbound in plasma 0.06 EMA scientiﬁc discussion [ 19,55] Main plasma binding protein AAG EMA scientiﬁc discussion [ 19,55] Absorption Absorption model ADAMPermeability predicted via Caco-2Apical pH:basolateral pH ratio 6.5:7.4Activity Passive and activeP appCaco-2 (10E -06 cm s-1) 7 (in the absence of ritonavir) Holmstock et al.",Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
"Updating the Simcyp model with the indicated parameters did not signiﬁcantly alter the simulation outcomes (data notshown).Table 3 Physicochemical and in vitro pharmacokinetic parameters of ritonavir Parameter Value References Physicochemical Molecular weight 720.95 g mol-1Pubchem [ 57] Log Po:w 4.3 Simcyp compound libraryCompound type Monoprotic basepKa 2 Simcyp compound libraryBlood:plasma ratio 0.587 Simcyp compound libraryFraction unbound in plasma 0.02 http://www.drugbank.ca/drugs/DB00503 [58] Main plasma binding protein AGP Absorption Absorption model First-order absorptionFraction absorbed 1 Simcyp compound library k a(1 h-1) 0.24 Simcyp compound library Distribution Distribution model Minimal PBPK modelV ss(L kg-1) 0.41 Simcyp compound library Metabolism/elimination Clearance type In vivo clearanceCL po(L h-1) 16 non-pregnant; 20 pregnant Product characteristics Norvir [ 21], Colbers et al.",Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/ 000127/WC500028728.pdf .,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/ human/000707/WC500041756.pdf .,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
2013.Available at: http://impaactnetwork.org/DocFiles/P1026s/ P1026SF8_17Jan13.pdf .,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://pubchem.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://www.antimicrobe.org/d94.asp .,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://www.drugbank.,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Scientiﬁc_Discussion/human/000707/WC500041754.pdf .,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://pubchem.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
Available at: http://www.drugbank.,Non-OADS,/arxiv_data1/oa_pdf/00/e9/40262_2015_Article_325.PMC4761019.pdf
"The C-terminally truncated and fully bioactive proGIP product, peptide GIP(1 –30)NH 2, has been shown to beTables of Links TARGETS GPCRs GIP receptorLIGANDS GIP, glucose-dependent insulinotropic polypeptide GIP(6–30)NH 2 GIP(7–30)NH 2 GIP(1-30)NH 2 GIP(3-42) GIP(3-30)GIP(5-30) These Tables list key protein targets and ligands in this article which are h yperlinked to corresponding entries in http://www.guidetopharmacolog y. org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Pawson et al.",Non-OADS,/arxiv_data1/oa_pdf/93/b2/BPH-173-826.PMC4761099.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://dx.doi.org/10.1111/bph.13384 Figure S1 The functionality of the N- and C-terminal trun- cated ligands re ﬂects the binding properties.,Non-OADS,/arxiv_data1/oa_pdf/93/b2/BPH-173-826.PMC4761099.pdf
<http://www.cochrane-handbook.org >(2011).,OADS,/arxiv_data1/oa_pdf/09/41/PSP4-5-54.PMC4761229.pdf
<http://www.R-project.org/ >(2013).,Non-OADS,/arxiv_data1/oa_pdf/09/41/PSP4-5-54.PMC4761229.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)The Many Flavors of Model-Based Meta-Analysis: Part 1—Introduction and Landmark Data Boucher and Bennetts 64 CPT: Pharmacometrics & Systems Pharmacology,Non-OADS,/arxiv_data1/oa_pdf/09/41/PSP4-5-54.PMC4761229.pdf
"See Table 1 for parameters used in the model and Supplementary Method S1 for model equations and detailed description.RESULTS Clinical data To train and validate our model, we used the publicly avail- able dataset (release P20 at http://www.ntis.gov/) of the Multicenter AIDS Cohort Study, which includes longitudinal semiannual clinical measurements of patients from 1984–2007.",Non-OADS,/arxiv_data1/oa_pdf/91/f7/PSP4-5-82.PMC4761230.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Predicting Efficacy of CCR5 D32 Stem Cell Therapy Hosseini and Mac Gabhann 90 CPT: Pharmacometrics & Systems Pharmacology,Non-OADS,/arxiv_data1/oa_pdf/91/f7/PSP4-5-82.PMC4761230.pdf
<http://www.fda.gov/ AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/default.htm > (2009).,OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.fda.gov/ScienceRe- search/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/default.htm>(2004).,OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"ACoP .<http://www.vantage- research.net/wp-content/uploads/2015/10/diabetes-acop-rk.pdf >Las Vegas, NV (2014).A Model Qualification Method for QSP Models Friedrich 52 CPT: Pharmacometrics & Systems Pharmacology",Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"ASCPT Atlanta, GA.<http://www.rosaandco.com/posters/rosaASCPT2014AbstrMedImm.pdf >(2014).",Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.rosaandco.com/webinarBansal.html >(2014).,Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.acop5.org/program >(2014).,Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.acop5.org/ program >(2014).,Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"Atlanta, GA. <http://www.rosaandco.com/posters/bms_rosa_ImmunoOncolo- gyposter_ASCPT2015.pdf >(2014).",Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"Atlanta, GA. <http://www.rosaandco.com/webinarSinghI.html >(2014).",Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.acop5.org/program >(2014).,Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.acop5.org/ program > (2014).65.,Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
<http://www.vantage-research.net/images/anemia-acop-kmoore.pdf >(2011).,Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"San Diego, CA.<http://www.rosaandco.com/posters/rosaACoP2011Methodabstract.pdf >(2011).",Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"Holford, N. The visual predictive check – superiority to standard diagnostic (Rorschach) plots.<http://www.page-meeting.org/page/page2005/PAGE2005P105.pdf >(2005).",Non-OADS,/arxiv_data1/oa_pdf/48/96/PSP4-5-43.PMC4761232.pdf
"Sandow, N. RxList: The Internet Drug Index .<http://www.rxlist.com >(1995).",OADS,/arxiv_data1/oa_pdf/d5/2f/PSP4-5-74.PMC4761233.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Application of a Physiologically Based Pharmacokinetic Navid et al.,Non-OADS,/arxiv_data1/oa_pdf/d5/2f/PSP4-5-74.PMC4761233.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Modeling Ribavirin-Induced Anemia in HCV Patients Wu et al.,Non-OADS,/arxiv_data1/oa_pdf/e1/2e/PSP4-5-65.PMC4761234.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/80/iev160.PMC4761261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/0e/ehv627.PMC4761401.pdf
"Accepted for publication: 23 December 2015 To cite this article: Strindberg JE, Hol C, Torgersen G, Møystad A, Nilsson M, Näsström K, Hellén-Halme K. Comparison of Swedish and Norwegian Use of Cone-Beam Computed Tomography: a Questionnaire Study J Oral Maxillofac Res 2015;6(4):e2 URL: http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2.pdf doi: 10.5037/jomr.2015.6402 http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
[URL: http://www.sedentexct.eu ] 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
[URL: https://www.gov.uk ] 3.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
Stockholm; 2015 Jan. [URL: http://www.tandlakarforbundet.se ] 5.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
[URL: http://www.julkari.fi ] 6.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
"[Medline: 21196094 ] [doi: 10.1016/j.ejrad.2012.05.028 ] To cite this article: Strindberg JE, Hol C, Torgersen G, Møystad A, Nilsson M, Näsström K, Hellén-Halme K. Comparison of Swedish and Norwegian Use of Cone-Beam Computed Tomography: a Questionnaire Study J Oral Maxillofac Res 2015;6(4):e2 URL: http://www.ejomr.org/JOMR/archives/2015/4/e2/v6n4e2.pdf doi: 10.5037/jomr.2015.6402 Copyright ©  Strindberg JE, Hol C, Torgersen G, Møystad A, Nilsson M, Näsström K, Hellén-Halme K. Published in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 31 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/jomr-06-e2.PMC4761432.pdf
Mechanobiological Assessment of TMJ Disc Surfaces: Nanoindentation and Transmission Electron Microscopy J Oral Maxillofac Res 2015;6(4):e3 URL: http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3.pdf doi: 10.5037/jomr.2015.6403 http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
"Mechanobiological Assessment of TMJ Disc Surfaces: Nanoindentation and Transmission Electron Microscopy J Oral Maxillofac Res 2015;6(4):e3 URL: http://www.ejomr.org/JOMR/archives/2015/4/e3/v6n4e3.pdf doi: 10.5037/jomr.2015.6403 Copyright ©  Juran CM, Dolwick MF, McFetridge PS.",Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 31 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/b0/c2/jomr-06-e3.PMC4761433.pdf
"Accepted for publication: 22 December 2015 To cite this article: Rykman A, Smailiene D. Application of Pont‘s Index to Lithuanian Individuals: a Pilot Study J Oral Maxillofac Res 2015;6(4):e4 URL: http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4.pdf doi: 10.5037/jomr.2015.6404 http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.",Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4ht.htm J Oral Maxillofac Res 2015 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
"[Medline: 22605945 ]  [PMC free article: 3349411 ] To cite this article: Rykman A, Smailiene D. Application of Pont‘s Index to Lithuanian Individuals: a Pilot Study J Oral Maxillofac Res 2015;6(4):e4 URL: http://www.ejomr.org/JOMR/archives/2015/4/e4/v6n4e4.pdf doi: 10.5037/jomr.2015.6404 Copyright ©  Rykman A, Smailiene D. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 31 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/5d/f2/jomr-06-e4.PMC4761434.pdf
"Is it possible to verify the EDITORIAL Young-Kyun Kim Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul  National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 13620, Korea TEL: +82-31-787-7541   FAX: +82-31-787-4068 E-mail: kyk0505@snubh.org ORCID: http://orcid.org/0000-0002-7268-3870    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Editor-in-Chief should not neglect case reports Young-Kyun Kim, D.D.S., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/d8/8f/jkaoms-42-1.PMC4761566.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.1 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/d8/8f/jkaoms-42-1.PMC4761566.pdf
"Bears have attracted the  attention of scientists due to their unique adaptation of re-ORIGINAL ARTICLE Indu Bhusan Kar Department of Oral and Maxillofacial Surgery, Sriram Chandra Bhanja Dental  College and Hospital, Dock Road, Manglabag, Cuttack, Odisha 753007, India TEL: +91-9437020349 E-mail: indubkar@yahoo.co.in ORCID: http://orcid.org/0000-0002-6524-9240    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Management of maxillofacial injuries in bear mauling cases:   a review of 20 cases Indu Bhusan Kar, Prashant Dilip Chopda, Niranjan Mishra, Alok Kumar Sethi, Bikas Ranjan Mahavoi Department of Oral and Maxillofacial Surgery, Sriram Chandra Bhanja Dental College and Hospital, Cuttack, India Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:13-19) Objectives:  As the craniofacial and neck regions are prime areas of injury in bear attacks, the careful management of soft and hard tissue injuries  and selection of reconstructive options is of the utmost importance.",Non-OADS,/arxiv_data1/oa_pdf/12/08/jkaoms-42-13.PMC4761567.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.13 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/12/08/jkaoms-42-13.PMC4761567.pdf
"ORCID Indu Bhusan Kar, http://orcid.org/0000-0002-6524-9240 Prashant Dilip Chopda, http://orcid.org/0000-0002-9792-8862 Niranjan Mishra, http://orcid.org/0000-0003-0783-5302 Alok Kumar Sethi, http://orcid.org/0000-0003-1303-8369 Bikas Ranjan Mahavoi, http://orcid.org/0000-0001-5106-5662 References 1.",Non-OADS,/arxiv_data1/oa_pdf/12/08/jkaoms-42-13.PMC4761567.pdf
Injury 2008;39:249-55.able from: http://print.ispub.com/api/0/ispub-article/6174.,Non-OADS,/arxiv_data1/oa_pdf/12/08/jkaoms-42-13.PMC4761567.pdf
"Good bone remodeling, favorable bone quality for den-ORIGINAL ARTICLE Yong-Deok Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan  National University, 49 Busandaehak-ro, Mulgeum-eup, Yangsan 50612, Korea TEL: +82-55-360-5100   FAX: +82-55-360-5104 E-mail: ydkimdds@pusan.ac.kr ORCID: http://orcid.org/0000-0002-5807-7487    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Low-level laser therapy affects osseointegration in titanium implants:  resonance frequency, removal torque, and histomorphometric analysis   in rabbits Jong-Ryoul Kim1, Sung-Hee Kim2, In-Ryoung Kim3, Bong-Soo Park3, Yong-Deok Kim2,4 1Department of Oral and Maxillofacial Surgery, On General Hospital, Busan,   Departments of 2Oral and Maxillofacial Surgery and 3Oral Anatomy, School of Dentistry, Pusan National University, Yangsan,   4Institute of Translational Dental Sciences and Dental Research Institute, Pusan National University Dental Hospital, Yangsan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:2-8) Objectives:  The purpose of this study was to investigate the effects of low-level laser therapy (LLLT) with a diode gallium-aluminum-arsenide (Ga- Al-As) low-level laser device on the healing and attachment of titanium implants in bone.",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jkaoms-42-2.PMC4761568.pdf
"http://dx.doi.org/10.5125/jkaoms.2016.42.1.2 pISSN 2234-7550 ·eISSN 2234-5930 This study was supported by the (Bio)Medical Research Institute Grant (2000-9), Pusan National University Hospital, and by the Basic Science  Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011–0026921).",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jkaoms-42-2.PMC4761568.pdf
"ORCID Jong-Ryoul Kim, http://orcid.org/0000-0002-7737-7127 Sung-Hee Kim, http://orcid.org/0000-0001-5086-1237 In-Ryoung Kim, http://orcid.org/0000-0003-0232-0385 Bong-Soo Park, http://orcid.org/0000-0002-9799-5627 Yong-Deok Kim, http://orcid.org/0000-0002-5807-7487 References 1.",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jkaoms-42-2.PMC4761568.pdf
"Furthermore, in recent  conflicts in the Middle East, craniofacial injuries account for  more than one-quarter of all injuries sustained by US sol-ORIGINAL ARTICLE Teja Guda Department of Biomedical Engineering, The University of Texas at San Antonio,  One UTSA Circle, AET 1.356, San Antonio, TX 78249, USA TEL: +1-210-458-8529   FAX: +1-210-458-7007 E-mail: teja.guda@utsa.edu ORCID: http://orcid.org/0000-0002-3218-2916    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Investigation of a pre-clinical mandibular bone notch defect model   in miniature pigs: clinical computed tomography,   micro-computed tomography, and histological evaluation Patricia L. Carlisle1, Teja Guda1,2, David T. Silliman1, Wen Lien1, Robert G. Hale1, Pamela R. Brown Baer1 1Department of Craniomaxillofacial Regenerative Medicine, The United States Army Dental and Trauma Research Detachment, Fort  Sam Houston, 2Department of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:20-30) Objectives:  To validate a critical-size mandibular bone defect model in miniature pigs.",Non-OADS,/arxiv_data1/oa_pdf/1a/64/jkaoms-42-20.PMC4761569.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.20 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/1a/64/jkaoms-42-20.PMC4761569.pdf
"ORCID Patricia L. Carlisle, http://orcid.org/0000-0001-6781-017X Teja Guda, http://orcid.org/0000-0002-3218-2916 David T. Silliman, http://orcid.org/0000-0001-6440-4694 Wen Lien, http://orcid.org/0000-0001-5657-4765 Robert G. Hale, http://orcid.org/0000-0002-9699-3224 Pamela R. Brown Baer, http://orcid.org/0000-0001-6964-1955 References 1.",Non-OADS,/arxiv_data1/oa_pdf/1a/64/jkaoms-42-20.PMC4761569.pdf
"The first ORIGINAL ARTICLE Jin-Wook Kim Department of Oral and Maxillofacial Surgery, Kyungpook National University  School of Dentistry, 2177 Dalgubeol-daero, Jung-gu, Daegu 41940, Korea TEL: +82-53-600-7575   FAX: +82-53-426-5365 E-mail: vocaleo@knu.ac.kr ORCID: http://orcid.org/0000-0003-4074-877X    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Changes in the management and survival rates of patients   with oral cancer: a 30-year single-institution study Bo-Yun Seo1, Chung-O Lee2, Jin-Wook Kim2 1Department of Dentistry, The Graduate School of Kyungpook National University,   2Department of Oral and Maxillofacial Surgery, Kyungpook National University School of Dentistry, Daegu, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:31-37) Objectives:  The aim of the present study was to evaluate changes in the management and 5-year survival rates of patients with oral cancer in our de- partment over a 30-year period.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jkaoms-42-31.PMC4761570.pdf
"http://dx.doi.org/10.5125/jkaoms.2016.42.1.31 pISSN 2234-7550 ·eISSN 2234-5930 This research was supported by Kyungpook National University Research Fund, 2011.",OADS,/arxiv_data1/oa_pdf/8a/55/jkaoms-42-31.PMC4761570.pdf
Available from: http://seer.cancer.gov/data/.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/jkaoms-42-31.PMC4761570.pdf
Available from: http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-252716.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/jkaoms-42-31.PMC4761570.pdf
"ORCID Bo-Yun Seo, http://orcid.org/0000-0001-8506-8968 Chung-O Lee, http://orcid.org/0000-0003-1428-5660 Jin-Wook Kim, http://orcid.org/0000-0003-4074-877X References 1.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jkaoms-42-31.PMC4761570.pdf
"Most of the studies to date that have been conducted on  implant surface treatments are based on cell or animal experi-CASE REPORT Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 303 Pilmun-daero, Dong-gu, Gwangju 61452, Korea TEL: +82-62-220-3819   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr ORCID: http://orcid.org/0000-0002-0424-9984    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Histologic analysis of resorbable blasting media surface implants  retrieved from humans: a report of two cases Kyung-In Jeong1, Young-Kyun Kim2, Sang-Woon Moon2, Su-Gwan Kim3, Sung-Chul Lim4, Pil-Young Yun2 1Department of Oral and Maxillofacial Surgery, Section of Dentistry, Konyang University Hospital, Daejeon,   2Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam,   3Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju,   4Department of Pathology, School of Medicine, Chosun University, Gwangju, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:38-42) The purpose of this study is to evaluate the degree of osseointegration of resorbable blasting media (RBM) surface implants retrieved from humans.",Non-OADS,/arxiv_data1/oa_pdf/84/e2/jkaoms-42-38.PMC4761571.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.38 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/84/e2/jkaoms-42-38.PMC4761571.pdf
"ORCID Kyung-In Jeong, http://orcid.org/0000-0001-8588-6696 Young-Kyun Kim, http://orcid.org/0000-0002-7268-3870 Sang-Woon Moon, http://orcid.org/0000-0002-1136-7591 Su-Gwan Kim, http://orcid.org/0000-0002-0424-9984 Sung-Chul Lim, http://orcid.org/0000-0003-3912-2809 Pil-Young Yun, http://orcid.org/0000-0001-6097-1229 References 1.",Non-OADS,/arxiv_data1/oa_pdf/84/e2/jkaoms-42-38.PMC4761571.pdf
"Box  3772, Zaria, Kaduna, Nigeria TEL: +234-8034515494 E-mail: benfometey@hotmail.com ORCID: http://orcid.org/0000-0003-4690-0496    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Ameloblastic carcinoma of the maxilla:   a report of two cases and a review of the literature Benjamin Fomete1, Ezekiel Taiwo Adebayo2, Godwin Iko Ayuba3, Uche Albert Okeke1 1Maxillofacial Unit, Ahmadu Bello University Teaching Hospital, Zaria, 2Army Dental Centre, Military Hospital, Lagos,   3Department of Medical Laboratory, 44 Nigerian Army Reference Hospital, Kaduna, Nigeria Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:43-46) Ameloblastic carcinoma is a malignant form of ameloblastoma defined by histological evidence of malignancy in primary, recurrent, or metastatic  tumor.",Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkaoms-42-43.PMC4761572.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.43 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/e4/bc/jkaoms-42-43.PMC4761572.pdf
"This procedure opens the oropharyngeal airway space as the  tongue base is pulled forward.CASE REPORT Anand Sivadasan Department of Plastic and Reconstructive Surgery, Baby Memorial Hospital,  Indira Gandhi Road, Calicut 673004, Kerala, India TEL: +91-4952777777   FAX: +91-9497048387 E-mail: anand6527@gmail.com ORCID: http://orcid.org/0000-0003-3162-0037    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Tongue-lip adhesion in Pierre Robin sequence K. S. Krishna Kumar1, Suresh Vylopilli2, Anand Sivadasan1, Ajit Kumar Pati1,  Saju Narayanan1, Santhy Mohanachandran Nair1 Departments of 1Plastic and Reconstructive Surgery and 2Maxillofacial Surgery, Baby Memorial Hospital, Calicut, India Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:47-50) Patients with Pierre Robin sequence exhibit varying degrees of airway obstruction and feeding difficulty.",Non-OADS,/arxiv_data1/oa_pdf/c8/9e/jkaoms-42-47.PMC4761573.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.47 pISSN 2234-7550 ·eISSN 2234-5930 Fig.,OADS,/arxiv_data1/oa_pdf/c8/9e/jkaoms-42-47.PMC4761573.pdf
"J Korean Assoc Oral Maxillofac Surg 2016;42:47-50 50Ajit Kumar Pati, http://orcid.org/0000-0002-4533-7534 Saju Narayanan, http://orcid.org/0000-0002-4937-8456 Santhy Mohanachandran Nair, http://orcid.org/0000-0002- 3409-6923 References 1.",Non-OADS,/arxiv_data1/oa_pdf/c8/9e/jkaoms-42-47.PMC4761573.pdf
"ORCID K. S. Krishna Kumar, http://orcid.org/0000-0002-0526-8685 Suresh Vylopilli, http://orcid.org/0000-0002-9423-3774 Anand Sivadasan, http://orcid.org/0000-0003-3162-0037",Non-OADS,/arxiv_data1/oa_pdf/c8/9e/jkaoms-42-47.PMC4761573.pdf
"The patient had a medical history of hypertension, diabetes, CASE REPORT Sang-Hoon Kang Department of Oral and Maxillofacial Surgery, National Health Insurance  Service Ilsan Hospital, 100 Ilsan-ro, Ilsan-donggu, Goyang 10444, Korea TEL: +82-31-900-0267   FAX: +82-303-3448-7138 E-mail: omfs1ksh@hanmail.net ORCID: http://orcid.org/0000-0003-3335-3040    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Anterior tympanic plate fracture following extraction of the lower molar Yeon-Ho Kim, Moon-Key Kim, Sang-Hoon Kang Department of Oral and Maxillofacial Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:51-54) The present case report describes an external auditory canal injury following extraction of the lower molar.",Non-OADS,/arxiv_data1/oa_pdf/36/84/jkaoms-42-51.PMC4761574.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.51 pISSN 2234-7550 ·eISSN 2234-5930 Fig.,OADS,/arxiv_data1/oa_pdf/36/84/jkaoms-42-51.PMC4761574.pdf
"ORCID Yeon-Ho Kim, http://orcid.org/0000-0001-9488-7041 Moon-Key Kim, http://orcid.org/0000-0002-3634-3705 Sang-Hoon Kang, http://orcid.org/0000-0003-3335-3040 References 1.",Non-OADS,/arxiv_data1/oa_pdf/36/84/jkaoms-42-51.PMC4761574.pdf
"MO progressi-CASE REPORT Ezekiel Taiwo Adebayo Army Dental Centre, Military Hospital, 18 Awolowo Road, Ikoyi, Lagos  100001, Nigeria TEL: +234-803-330-9149 E-mail: taiwo_adebayo@yahoo.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Myositis ossificans of the platysma mimicking a malignancy:   a case report with review of the literature Ezekiel Taiwo Adebayo1, Godwin Iko Ayuba2, Sunday Olusegun Ajike3, Benjamin Fomete3 1Army Dental Centre, Military Hospital, Lagos, 2Department of Pathology, 44 Nigeria Army Reference Hospital, Kaduna,   3Department of Dental Surgery, Ahmadu Bello University, Shika-Zaria, Nigeria Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:55-59) The two main forms of myositis ossificans are congenital and acquired.",Non-OADS,/arxiv_data1/oa_pdf/34/85/jkaoms-42-55.PMC4761575.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.55 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/34/85/jkaoms-42-55.PMC4761575.pdf
"Case Report A 30-year-old female presented with swelling of the right CASE REPORT Hoon Myoung Department of Oral and Maxillofacial Surgery, Dental Research Institute,  School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea TEL: +82-2-2072-3059   FAX: +82-2-766-4948 E-mail: myoungh@snu.ac.kr ORCID: http://orcid.org/0000-0002-9984-8479    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Neurilemmoma in the floor of the mouth: a case report Seung-Kee Shim, Hoon Myoung Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:60-64) Neurilemmomas are well-encapsulated, benign, slow-growing tumors originating from Schwann cells of the nerve sheath surrounding cranial, periph- eral, or autonomic nerves.",Non-OADS,/arxiv_data1/oa_pdf/89/a2/jkaoms-42-60.PMC4761576.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.60 pISSN 2234-7550 ·eISSN 2234-5930 Fig.,OADS,/arxiv_data1/oa_pdf/89/a2/jkaoms-42-60.PMC4761576.pdf
"ORCID Seung-Kee Shim, http://orcid.org/0000-0002-9434-8424 Hoon Myoung, http://orcid.org/0000-0002-9984-8479 References 1.",Non-OADS,/arxiv_data1/oa_pdf/89/a2/jkaoms-42-60.PMC4761576.pdf
"Consequently, osteotomy can be better ORIGINAL ARTICLE Byung-Ho Choi Department of Dentistry, Yonsei University Wonju College of Medicine, 20  Ilsan-ro, Wonju 26426, Korea TEL: +82-33-741-0672   FAX: +82-33-741-1442 E-mail: choibh@yonsei.ac.kr ORCID: http://orcid.org/0000-0002-6105-6118    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC The effect of low-speed drilling without irrigation on heat generation:   an experimental study Ji-Hyeon Oh, Yiqin Fang, Seung-Mi Jeong, Byung-Ho Choi Department of Dentistry, Yonsei University Wonju College of Medicine, Wonju, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2016;42:9-12) Objectives:  In this study we evaluated heat generation during the low-speed drilling procedure without irrigation.",Non-OADS,/arxiv_data1/oa_pdf/3a/3a/jkaoms-42-9.PMC4761577.pdf
http://dx.doi.org/10.5125/jkaoms.2016.42.1.9 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/3a/3a/jkaoms-42-9.PMC4761577.pdf
"ORCID Ji-Hyeon Oh, http://orcid.org/0000-0002-6050-7175 Yiqin Fang, http://orcid.org/0000-0003-0077-8261 Seung-Mi Jeong, http://orcid.org/0000-0002-1543-7227 Byung-Ho Choi, http://orcid.org/0000-0002-6105-6118",Non-OADS,/arxiv_data1/oa_pdf/3a/3a/jkaoms-42-9.PMC4761577.pdf
"We undertook a systematic review of the medical literature to examine the progress in cell therapy during the last 30 years for the treatment of early stage osteonecrosis.Keywords: Hip, Osteonecrosis, Cell therapy, Mesenchymal stromal cells, Tissue engineering Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/dd/cios-8-1.PMC4761591.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 5, 2016; Accepted January 9, 2016 Correspondence to: Philippe Hernigou, MD  Department of Orthopaedic Surgery, University Paris East (UPEC), Hôpital  Henri Mondor, Creteil 94010, FranceTel: +33-1-49-81-26-01, Fax: +33-1-49-81-26-08 E-mail: philippe.hernigou@wanadoo.frReview Article    Clinics in Orthopedic Surgery 2016;8:1-8   •  http://dx.doi.org/10.4055/cios.2016.8.1.1",Non-OADS,/arxiv_data1/oa_pdf/ff/dd/cios-8-1.PMC4761591.pdf
"Keywords: Tuberculosis, Bursitis, Trochanter Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/cios-8-106.PMC4761592.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 19, 2014; Accepted February 12, 2015 Correspondence to: Luis R. Ramos-Pascua, PhD  Department of Orthopedics, Hospital Universitario de León, Altos de  Nava, s/n 24071 Leon, SpainTel: +34-987-23-4900, Fax: +34-987-23-3222 E-mail: luisramospascua@gmail.comCase Report    Clinics in Orthopedic Surgery 2016;8:106-109   •  http://dx.doi.org/10.4055/cios.2016.8.1.106",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/cios-8-106.PMC4761592.pdf
"Keywords: Anterior cruciate ligament, Anterior cruciate ligament reconstruction, Compartment syndromes, Arterial embolism,   Arterial injury Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/05/cios-8-110.PMC4761593.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 18, 2014; Accepted October 16, 2014 Correspondence to: Jeong Ku Ha, MD  Department of Orthopedic Surgery, Inje University Seoul Paik Hospital,  Inje University College of Medicine, 85 Jeo dong 2-ga, Jung-gu, Seoul 04551, Korea Tel: +82-2-2270-0025, Fax: +82-2-2270-0023 E-mail: revo94@hanmail.netCase Report    Clinics in Orthopedic Surgery 2016;8:110-114   •  http://dx.doi.org/10.4055/cios.2016.8.1.110",Non-OADS,/arxiv_data1/oa_pdf/b3/05/cios-8-110.PMC4761593.pdf
"Although the arthroscopic removal of intra-articular bullets following gunshot injuries seems to have low morbidity rates, it should always be considered that the articular capsule may have been ruptured and the fluids used during the operation may leak into surrounding tissues and result in compartment syndrome.Keywords: Bullet, Knee, Joint, Arthroscopy Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/f5/cios-8-115.PMC4761594.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received November 8, 2014; Accepted March 31, 2015 Correspondence to: Mert Keskinbora, MD  Department of Orthopaedics and Traumatology, İstanbul Medipol University  Hospital, Ba ğcılar, 34214, Istanbul, Turkey Tel: +90-5532-714-1805, Fax: +90-212-460-7070E-mail: mert.keskinbora@yahoo.comCase Report    Clinics in Orthopedic Surgery 2016;8:115-118   •  http://dx.doi.org/10.4055/cios.2016.8.1.115",Non-OADS,/arxiv_data1/oa_pdf/77/f5/cios-8-115.PMC4761594.pdf
"Antegrade transmalleolar drilling can be a possible option for the treatment of OLT if the lesion is not easily reachable; however, other viable treatment should be considered due to its possibility of distal tibial pathologic change.Keywords: Tibia, Talus, Cartilage, Osteochondritis dissecans, Cysts Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/d7/cios-8-119.PMC4761595.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received November 16, 2013; Accepted July 28, 2014 Correspondence to: Woo-Chun Lee, MD  Department of Orthopaedic Surgery, Seoul Paik Hospital, Inje University  College of Medicine, 9 Mareunnae-ro, Jung-gu, Seoul 04551, Korea Tel: +82-2-2270-0042, Fax: +82-2-2270-0023 E-mail: leewoochun@gmail.comCase Report    Clinics in Orthopedic Surgery 2016;8:119-122   •  http://dx.doi.org/10.4055/cios.2016.8.1.119",Non-OADS,/arxiv_data1/oa_pdf/9f/d7/cios-8-119.PMC4761595.pdf
"This rare case of snapping hip syndrome from the AIIS was treated surgically and the symptoms completely disappeared after excision of the tumor.Keywords: Osteochondromas, Ilium, Hip Joint/physiopathology, Tendons/physiopathology Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/74/cios-8-123.PMC4761596.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received March 27, 2014; Accepted December 16, 2014 Correspondence to: Young Soo Chun, MD  Department of Orthopaedic Surgery, Kyung Hee University Hospital at  Gangdong, College of Medicine, Kyung Hee University, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea  Tel: +82-2-440-6155, Fax: +82-2-440-7498  E-mail: mozart13@khu.ac.krCase Report    Clinics in Orthopedic Surgery 2016;8:123-126   •  http://dx.doi.org/10.4055/cios.2016.8.1.123",Non-OADS,/arxiv_data1/oa_pdf/7e/74/cios-8-123.PMC4761596.pdf
"Conclusions: The proposed care protocol is recommended to shorten hospital stay in elderly patients with hip fractures.Keywords: Hip fractures, Aged, Length of stay  Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/cios-8-19.PMC4761597.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 5, 2015; Accepted November 2, 2015 Correspondence to: Hamed Yazdanshenas, MD  Department of Family Medicine, Charles R. Drew University of Medicine  and Science & Departments of Family Medicine and Orthopaedic Surgery, University of California, Los Angles (UCLA), 1731 East 120th Street, Los  Angeles, CA 90059, USA Tel: +1-323-357-3452, Fax: +1-323-357-3660E-mail: Yazdanshenas@ucla.eduOriginal Article    Clinics in Orthopedic Surgery 2016;8:19-28   •  http://dx.doi.org/10.4055/cios.2016.8.1.19",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/cios-8-19.PMC4761597.pdf
"Keywords: Epidemiology, Hip, Arthroplasty, Cross-sectional studies Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/e2/cios-8-29.PMC4761598.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 27, 2015; Accepted December 12, 2015 Correspondence to: Jeong Joon Yoo, MD  Department of Orthopedic Surgery, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaTel: +82-2-2072-1994, Fax: +82-2-764-2718 E-mail: jjyos@snu.ac.krOriginal Article    Clinics in Orthopedic Surgery 2016;8:29-37   •  http://dx.doi.org/10.4055/cios.2016.8.1.29",Non-OADS,/arxiv_data1/oa_pdf/de/e2/cios-8-29.PMC4761598.pdf
Available from: https://aoanjrr.dmac.adelaide.edu.,Non-OADS,/arxiv_data1/oa_pdf/de/e2/cios-8-29.PMC4761598.pdf
"Keywords: Femur head necrosis, Decompression, Hip replacement arthroplasty, Complications Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/a5/cios-8-38.PMC4761599.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received November 10, 2015; Accepted December 23, 2015 Correspondence to: Kyung-Soon Park, MD  Department of Orthopedic Surgery, Center for Joint Disease, Chonnam  National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun 58128, Korea Tel: +82-61-379-7677, Fax: +82-61-379-7681 E-mail: chiasma@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2016;8:38-44   •  http://dx.doi.org/10.4055/cios.2016.8.1.38",Non-OADS,/arxiv_data1/oa_pdf/a1/a5/cios-8-38.PMC4761599.pdf
"In this study, the TT-TG distance in normal Korean peo-ple was approximately 10.24 mm without significant differences in TT-TG values between genders.Keywords: Tibial tubercle-trochlear groove, Rotational profile computed tomography Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/e9/cios-8-45.PMC4761600.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 5, 2015; Accepted August 27, 2015 Correspondence to: Eun Kyoo Song, MD  Department of Orthopedic Surgery, Center for Joint Disease, Chonnam  National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun 58128, Korea Tel: +82-62-379-7676, Fax: +82-62-379-7681 E-mail: eksong@jnu.ac.krOriginal Article    Clinics in Orthopedic Surgery 2016;8:45-48   •  http://dx.doi.org/10.4055/cios.2016.8.1.45",Non-OADS,/arxiv_data1/oa_pdf/ad/e9/cios-8-45.PMC4761600.pdf
"In simple linear regression, it was predictable that MPT resection at a thickness of 2.80 mm was required to increase the medial gap by 1.00 mm in knee extension.Conclusions: The method of bone resection of the MPT can be considered effective with a predictable result for achieving soft tissue balancing in terms of quantification during TKA.Keywords: Knee, Arthroplasty, Varus, Soft tissue balancing, Bone resection Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/cios-8-49.PMC4761601.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 13, 2015; Accepted October 20, 2015 Correspondence to: Ji Hyun Ahn, MD   Department of Orthopedic Surgery, Dongguk University Ilsan Hospital, 27  Dongguk-ro, Ilsandong-gu, Goyang 10326, KoreaTel: +82-31-961-7317, Fax: +82-31-961-7319 E-mail: drsky71@duih.orgOriginal Article    Clinics in Orthopedic Surgery 2016;8:49-56   •  http://dx.doi.org/10.4055/cios.2016.8.1.49",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/cios-8-49.PMC4761601.pdf
"Keywords: Knee, Osteochondritis dissecans, Bioabsorbable implant Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/e7/cios-8-57.PMC4761602.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received August 24, 2015; Accepted November 30, 2015 Correspondence to: Churl Hong Chun, MD  Department of Orthopaedic Surgery, Wonkwang University School of  Medicine, 460 Iksan-daero, Iksan 54538, KoreaTel: +82-63-859-1360, Fax: +82-63-852-9329  E-mail: cch@wonkwang.ac.krOriginal Article    Clinics in Orthopedic Surgery 2016;8:57-64   •  http://dx.doi.org/10.4055/cios.2016.8.1.57",Non-OADS,/arxiv_data1/oa_pdf/f7/e7/cios-8-57.PMC4761602.pdf
"An increase in lumbar lordosis on the OSI frame should be considered during posterior spinal fusion surgery, especially in spondylolisthesis patients.Keywords: Spondylolisthesis, Lordosis, Prone position Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/0a/cios-8-65.PMC4761603.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 12, 2015; Accepted May 1, 2015 Correspondence to: Seung-Hwan Lee, MD  Department of Orthopaedic Surgery, Gwangmyeong Sungae Hospital, 36  Digital-ro, Gwangmyeong 14241, KoreaTel: +82-2-2680-7699, Fax: +82-2-2680-7755 E-mail: java5885@gmail.com Original Article    Clinics in Orthopedic Surgery 2016;8:65-70   •  http://dx.doi.org/10.4055/cios.2016.8.1.65",Non-OADS,/arxiv_data1/oa_pdf/c8/0a/cios-8-65.PMC4761603.pdf
"Keywords: Thoracolumbar fracture, Two level posterior screw fixation, Three level posterior screw fixation, Spinal fractures Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/e9/cios-8-71.PMC4761604.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received August 13, 2015; Accepted October 27, 2015 Correspondence to: Hwa-Yeop Na, MD  Department of Orthopedic Surgery, Bundang Jesaeng General Hospital,  Daejin Medical Center, 20 Seohyeon-ro 180 beon-gil, Bundang-gu, Seongnam 13590, Korea Tel: +82-31-779-0175, Fax: +82-31-779-0179 E-mail: hynaspin@naver.comOriginal Article    Clinics in Orthopedic Surgery 2016;8:71-77   •  http://dx.doi.org/10.4055/cios.2016.8.1.71",Non-OADS,/arxiv_data1/oa_pdf/28/e9/cios-8-71.PMC4761604.pdf
"Therefore, postoperative spinal epidural hematoma would not be prevent-ed by LD.Keywords: Hematoma, Epidural, Spinal, Postoperative, Larger suction drain Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/ba/cios-8-78.PMC4761605.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 19, 2015; Accepted November 8, 2015 Correspondence to: Dong Ki Ahn, MD  Department of Orthopedic Surgery, Seoul Sacred Heart General Hospital,  259 Wangsan-ro, Dongdaemun-gu, Seoul 02488, KoreaTel: +82-2-966-1616, Fax: +82-2-968-2394 E-mail: adkajs@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2016;8:78-83   •  http://dx.doi.org/10.4055/cios.2016.8.1.78",Non-OADS,/arxiv_data1/oa_pdf/e0/ba/cios-8-78.PMC4761605.pdf
"Keywords: Shoulder, Instability, Bone loss, Dislocation Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/62/cios-8-84.PMC4761606.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 16, 2015; Accepted November 24, 2015 Correspondence to: Thay Q. Lee, PhD  Orthopaedic Biomechanics Laboratory, VA Long Beach Healthcare System,  5901 East 7th Street (09/151), Long Beach, CA 90822, USATel: +1-562-826-5344, Fax: +1-562-826-5675 E-mail: tqlee@med.va.gov Original Article    Clinics in Orthopedic Surgery 2016;8:84-91   •  http://dx.doi.org/10.4055/cios.2016.8.1.84",Non-OADS,/arxiv_data1/oa_pdf/65/62/cios-8-84.PMC4761606.pdf
"Keywords: Humeral fractures, Intra-articular fractures, Fracture fixation Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/69/cios-8-9.PMC4761607.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received February 26, 2015; Accepted July 13, 2015 Correspondence to: Sung-Weon Jung, MD  Department of Orthopedic Surgery, Samsung Changwon Hospital,  Sungkyunkwan University School of Medicine, 158 Paryong-ro, Masanhoewon-gu, Changwon 51353, Korea  Tel: +82-55-290-6030, Fax: +82-55-290-6888 E-mail: can1204@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2016;8:9-18   •  http://dx.doi.org/10.4055/cios.2016.8.1.9",Non-OADS,/arxiv_data1/oa_pdf/43/69/cios-8-9.PMC4761607.pdf
"For optimum results, surgery a few months earlier is rec-ommended, rather than at the calculated operation time.Keywords: Idiopathic adolescent genu varum, Percutaneous permanent hemiepiphysiodesis, Proximal tibia Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/57/cios-8-92.PMC4761608.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received September 14, 2015; Accepted December 26, 2015 Correspondence to: Jong Sup Shim, MD  Department of Orthopaedic Surgery, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-2991, Fax: +82-2-3410-0061 E-mail: jss3505@skku.eduOriginal Article    Clinics in Orthopedic Surgery 2016;8:92-98   •  http://dx.doi.org/10.4055/cios.2016.8.1.92",Non-OADS,/arxiv_data1/oa_pdf/68/57/cios-8-92.PMC4761608.pdf
"A more accurate and safer RAO can be performed using 3D preoperative planning and intraoperative assistance with a computed tomography-based navigation system.Keywords: Computer-assisted surgery, Hip, Periacetabular osteotomy Copyright © 2016 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/93/cios-8-99.PMC4761609.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received September 9, 2015; Accepted November 2, 2015 Correspondence to: Yutaka Inaba, MD  Department of Orthopaedic Surgery, Yokohama City University, 3-9  Fukuura, Kanazawa-ku, Yokohama 236-0004, JapanTel: +81-45-787-2655, Fax: +81-45-781-7922 E-mail: yute0131@med.yokohama-cu.ac.jpTechnical Note    Clinics in Orthopedic Surgery 2016;8:99-105   •  http://dx.doi.org/10.4055/cios.2016.8.1.99",Non-OADS,/arxiv_data1/oa_pdf/b3/93/cios-8-99.PMC4761609.pdf
Available from http://omim.org/entry/614327.,Non-OADS,/arxiv_data1/oa_pdf/d6/91/modpathol201587a.PMC4761613.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Modern Pathology (2015) 28, 1360 –1368BAP1 in mesothelioma 1368 J Andrici et al",Non-OADS,/arxiv_data1/oa_pdf/d6/91/modpathol201587a.PMC4761613.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/cd/main.PMC4761621.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.065 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/a3/cd/main.PMC4761621.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/ce/main.PMC4761626.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.01.090 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/10/ce/main.PMC4761626.pdf
This inventory was used under license from Mind Garden which was purchased via their website ( http://www.mindgarden.,Non-OADS,/arxiv_data1/oa_pdf/10/ce/main.PMC4761626.pdf
"Anxiety, 2013, 30(6), 515-527. http://dx.doi.org/10.1002/da.22063 [2] Dowlati, Y.; Herrmann, N.; Swardfager, W. A meta-analysis of cytokines in major depression.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rev., 2014, 42C, 93-115. http://dx.doi.org/10.1016/j.neubiorev.2014.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2013, 18(5), 595-606. http://dx.doi.org/10.1038/mp.2012.33 [5] Kreisel, T.; Frank, M.G.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2014, 19(6), 699-709. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"CNS Drugs, 2014, 28(1), 1-10. http://dx.doi.org/10.1007/s40263-013-0119-1 [7] Carvalho, A.F.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychosom., 2014, 83(2), 70-88. http://dx.doi.org/10.1159/000357500 [8] Hasselbalch, B.J.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Disord., 2011, 134(1-3), 20-31. http://dx.doi.org/ 10.1016/j.jad.2010.11.011 [9] Maes, M.; Leonard, B.E.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2011, 35(3), 702-721. http://dx.doi.org/10.1016/j.pnpbp.2010.12.017",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2014, 48, 261-267. http://dx.doi.org/10.1016/j.pnpbp.2013.10.018 [11] Maes, M.; Ringel, K.; Kubera, M.; Berk, M.; Rybakowski, J.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Disord., 2012, 136(3), 386-392. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Disord., 2012, 141(2-3), 308-314. http://dx.doi.org/ 10.1016/j.jad.2012.03.033 [13] Galecki, P.; Szemraj, J.; Bienkiewicz, M.; Zboralski, K.; Galecka, E. Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive p a t i e n t s .",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psycho- pharmacol., 2009, 24(4), 277-286. http://dx.doi.org/10.1002/hup.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Brain Res., 2012, 235(2), 302-317. http://dx.doi.org/10.1016/j.bbr.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2012, 37(2), 222-226. http://dx.doi.org/10.1016/j.pnpbp.2012.02.002 [16] Naismith, S.L.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"BMC Psychiatry, 2007, 7, 32. http://dx.doi.org/10.1186/1471-244X-7-32 [17] Eisenberger, N.I.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2010, 68(8), 748-754. http://dx.doi.org/10.1016/ j.biopsych.2010.06.010 [18] Kheirbek, M.A.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacology, 2011, 36(1), 373-374. http://dx.doi.org/10.1038/npp.2010.148 [19] Stahl, S.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2014, 48, 295-303. http://dx.doi.org/10.1016/j.pnpbp.2012.12.013 [21] Clark, I.A.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Ther., 2010, 128 (3), 519-48. http://dx.doi.org/10.1016/j.pharmthera.2010.08.007 [22] Kaster, M.P.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropharmacology, 2012, 62 ( 1 ) ,  419-426. http://dx.doi.org/10.1016/j.neuropharm.2011.08.018 [23] Souza, L.C.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Pharmacol., 2013, 24(2), 79-86. http://dx.doi.org/10.1097/FBP.0b013e32835efc2f [24] Belarbi, K.; Jopson, T.; Tweedie, D. TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuroinflamm., 2012, 9, 23. http://dx.doi.org/10.1186/1742-2094-9-23 [25] Eller, T.; Vasar, V.; Shlik, J.; Maron, E. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2008, 32(2), 445-450. http://dx.doi.org/10.1016/j.pnpbp.2007.09.015 [26] Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Ther., 2008, 117(2), 244-279. http://dx.doi.org/10.1016/j.pharmthera.2007.10.001 [28] Wong, M.; Ziring, D.; Korin, Y. TNFalpha blockade in human diseases: mechanisms and future directions.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immunol., 2008, 126(2), 121-136. http://dx.doi.org/10.1016/j.clim.2007.08.013 [29] Zhou, M.; Wang, C.M.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Brain Res., 2013, 1506, 105-14. http://dx.doi.org/ 10.1016/j.brainres.2013.02.010 [30] Sato, T.A.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immunol., 2003, 170(1), 158-66. http://dx.doi.org/ 10.4049/jimmunol.170.1.158 [31] Kollias, G. TNF pathophysiology in murine models of c h r o n i c  inflammation and autoimmunity.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Arthritis Rheum., 2005, 34 (5 Suppl1), 3-6. http://dx.doi.org/10.1016/j.semarthrit.2005.01.002 [32] Gommerman, J.L.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immunol., 2003, 3(8), 642-655. http://dx.doi.org/10.1038/nri1151 [33] Maes, M.; Yirmyia, R.; Noraberg, J.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Brain Dis., 2009, 24(1), 27-53. http://dx.doi.org/10.1007/s11011-008-9118-1 [34] Bernardino, L.; Agasse, F.; Silva, B.; Ferreira, R.; Grade, S.; Malva, J.O.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Stem Cells, 2008, 26(9), 2361-2371. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Glia, 2007, 55(5), 453-462. http://dx.doi.org/10.1002/glia.20467 [36] McCoy, M.K.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuroinflamm., 2008, 5, 45. http://dx.doi.org/10.1186/ 1742-2094-5-45 [37] Kerfoot, S.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Hepatology, 2006, 43(1), 154-162. http://dx.doi.org/10.1002/hep.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuroinflamm., 2013, 10, 43. http://dx.doi.org/10.1186/1742-2094-10-43 [39] Muller, N.; Schwarz, M.J.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2007, 12 ( 1 1 ) ,  9 8 8-1000. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"http://dx.doi.org/10.1038/tp.2012.34 [41] Blaylock, R.L.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Int., 2011, 2, 107. http://dx.doi.org/10.4103/2152-7806.83391 [42] Stellwagen, D.; Beattie, E.C.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
", 2005, 25 ( 1 2 ) ,  3 2 1 9-3228. http://dx.doi.org/10.1523/JNEUROSCI.4486-04.2005 [43] Fan, L.W.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immun., 2011, 25(2), 286-297. http://dx.doi.org/10.1016/j.bbi.2010.09.020 [44] Beattie, E.C.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Science, 2002, 295 (5563), 2282-2285. http://dx.doi.org/10.1126/science.1067859",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuroscience, 2004, 124 ( 2 ) ,  3 1 9-326. http://dx.doi.org/10.1016/j.neuroscience.2003.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Brain Res., 2014, 261, 305-314. http://dx.doi.org/10.1016/j.bbr.2013.12.037 [48] MacEwan, D.J.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Science, 1995, 270(5240), 1326-1331. http://dx.doi.org/10.1126/ science.270.5240.1326 [50] Imayoshi, I.; Sakamoto, M.; Ohtsuka, T. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neurosci., 2008, 11(10), 1153-1161. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"http://dx.doi.org/10.1371/journal.pone.0038170 [53] Dunn, A.J.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rev., 2005, 29(4-5), 891-909. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Brain Res., 2011, 225(1), 135-141. http://dx.doi.org/10.1016/j.bbr.2011.07.006 [55] van Heesch, F.; Prins, J.; Korte-Bouws, G.A.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Brain Res., 2013, 253, 191-195. http://dx.doi.org/10.1016/j.bbr.2013.07.038 [56] Zhu, C.B.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacology, 2006, 31(10), 2121-2131. http://dx.doi.org/10.1038/sj.npp.1301029 [57] Simen, B.B.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuroimmunol., 2000, 111(1-2), 131-138. http://dx.doi.org/10.1016/S0165-5728(00)00375-1 [59] McAfoose, J.; Baune, B.T.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rev., 2009, 33(3), 355-366. http://dx.doi.org/10.1016/j.neubiorev.2008.10.005 [60] Takei, Y.; Laskey, R. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Med., 2008, 14(9), 381-388. http://dx.doi.org/10.1016/j.molmed.2008.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Cortex, 2004, 14(1), 97-105. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Ge net., 200 8, 147B(7), 1056-1064. http://dx.doi.org/10.1002/ajmg.b.30712 [63] He, P.; Cheng, X.; Staufenbiel, M.; Li, R.; Shen, Y.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"http://dx.doi.org/10.1371/ journal.pone.0055091 [64] Kubera, M.; Obuchowicz, E.; Goehler, L.; Brzeszcz, J.; Maes, M. In animal models, psychosocial stress-induced (neuro) inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2011, 35(3), 744-759. http://dx.doi.org/10.1016/j.pnpbp.2010.08.026 [65] Brustolim, D.; Ribeiro-dos-Santos, R.; Kast, R.E.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immunopharmacol., 2006, 6(6), 903-907. http://dx.doi.org/10.1016/j.intimp.2005.12.007 [66] Song, C.; Killeen, A.A.; Leonard, B.E.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuro- psychobiology, 1994, 30 ( 1 ) ,  2 4-8. http://dx.doi.org/10.1159/ 000119131 [67] Grippo, A.J.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Behav., 2013, 103(4), 853-859. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immun., 2012, 26(3), 469-479. http://dx.doi.org/10.1016/j.bbi.2011.12.011 [70] Liu, D.; Wang, Z.; Liu, S.; Wang, F.; Zhao, S.; Hao, A. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropharmacology, 2011, 61(4), 592-599. http://dx.doi.org/10.1016/j.neuropharm.2011.04.033 [71] Dhami, K.S.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Chem., 2006, 281 (3 0), 21362-8. http://dx.doi.org/10.1074/jbc.M600504200 [73] Huang, Y.Y.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
",  2007, 104(1), 61-72. http://dx.doi.org/10.1254/jphs.FP0061255 [74] Krabbe, G.; Matyash, V.; Pannasch, U.; Mamer, L.; Boddeke, H. W.; Kettenmann, H. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immun., 2012, 26(3), 419-428. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychopharmacology, 2011, 216(1), 75-84. http://dx.doi.org/10.1007/s00213-011-2190-y [76] Czeh, B.; Di Benedetto, B. Antidepressants act directly on astrocytes: evidences and functional consequences.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacol., 2013, 23 ( 3 ) ,  1 7 1-185. http://dx.doi.org/10.1016/j.euroneuro.2012.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuron, 2012, 74(4), 691-705. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rev., 2010, 34 ( 1 ) ,  1 3 0-43. http://dx.doi.org/ 10.1016/j.neubiorev.2009.07.014 [79] Khandaker, G.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Med., 2013, 43(2), 239-257. http://dx.doi.org/10.1017/S0033291712000736 [80] Chapman, D.P.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Dermatol., 2014, 134(6), 1542-1551. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Lett., 2008, 430(3), 264-268. http://dx.doi.org/10.1016/j.neulet.2007.11.001 [84] Krueger, C.; Hawkins, K.; Wong, S.; Enns, M.W.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
http://dx.doi.org/10.1111/j.1365-2893.2010.,Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neurosci., 2009, 63(2), 202-208. http://dx.doi.org/10.1111/ j.1440-1819.2008.01918.x [86] Himmerich, H.; Fulda, S.; Linseisen, J. Depression, comorbidities and the TNF-alpha system.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2008, 23(6), 421-429. http://dx.doi.org/10.1016/j.eurpsy.2008.03.013 [87] Miller, A.H.; Haroon, E.; Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Anxiety, 2013, 30(4), 297-306. http://dx.doi.org/10.1002/ da.22084 [88] Yoon, H.K.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"J. Psychiatry, 2012, 66(3), 183-188. http://dx.doi.org/10.3109/08039488.2011.611894 [89] Karlovic, D.; Serretti, A.; Vrkic, N.; Martinac, M.; Marcinko, D., Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry Res., 2012, 198(1), 74-80. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2013, 18(6), 692-699. http://dx.doi.org/10.1038/mp.2012.144 [91] Bufalino, C.; Hepgul, N.; Aguglia, E.; Pariante, C.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immun., 2013, 31, 31-47. http://dx.doi.org/10.1016/j.bbi.2012.04.009 [92] Jun, T.Y.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Res., 2003, 61(1), 39-45. http://dx.doi.org/10.1016/S0920-9964(02) 00303-1 [93] Cerri, A.P.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2010, 25(3), 219-223. http://dx.doi.org/10.1002/gps.2323 [94] Kim, Y.K.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Disord., 2013, 150(2), 668-672. http://dx.doi.org/10.1016/j.jad.2013.03.019 [95] Dean, B.; Tawadros, N.; Scarr, E.; Gibbons, A. S. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Disord., 2010, 120(1-3), 245-8. http://dx.doi.org/10.1016/j.jad.2009.04.027 [96] Dean, B.; Gibbons, A.S.; Tawadros, N.; Brooks, L.; Everall, I.P.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry 2013, 18(7), 767-773. http://dx.doi.org/10.1038/mp.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"J. Psychiatry Res., 2012, 46(1), 57-63. http://dx.doi.org/10.1016/j.jpsychires.2011.08.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Depress Anxiety,  2013, 30(4), 307-314. http://dx.doi.org/10.1002/da.22087 [100] Lindqvist, D.; Janelidze, S.; Hagell, P.; Erhardt, S.; Samuelsson, M.; Minthon, L.; Hansson, O.; Björkqvist, M.; Träskman-Bendz, L.; Brundin, L..Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry 2009, 66(3), 287-292. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2008, 32(2), 356-361. http://dx.doi.org/10.1016/j.pnpbp.2007.08.041 [102] Danese, A.; Pariante, C.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Med., 2011, 73(8), 656-663. http://dx.doi.org/10.1097/PSY.0b013e31822fc277 [105] Hannestad, J.; DellaGioia, N.; Bloch, M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacology, 2011, 36(12), 2452-2459. http://dx.doi.org/10.1038/npp.2011.132 [106] Lanquillon, S.; Krieg, J.C.; Bening-Abu-Shach, U.; Vedder, H. Cytokine production and treatment response in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacology, 2000, 22(4), 370-379. http://dx.doi.org/10.1016/S0893-133X(99)00134-7 [107] Hestad, K.A.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"J. ECT, 2003, 19(4), 183-188. http://dx.doi.org/10.1097/00124509-200312000-00002 [108] Tuglu, C.; Kara, S.H.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychopharmacology (Berl), 2003, 170(4), 429-433. http://dx.doi.org/10.1007/s00213-003-1566-z [109] Li, Z.; Qi, D.; Chen, J. Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-alpha) in the Chinese patients with major depressive disorder: a prospective longitudinal study.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Psychiatry, 2003, 25(6), 495-496. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Pharmacopsychiatry, 2002, 35(6), 220-225. http://dx.doi.org/ 10.1055/s-2002-36390 [112] O'Brien, S.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Res., 2007, 41(3-4), 326-331. http://dx.doi.org/10.1016/j.jpsychires.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Pharmacol., 2010, 10(3), 308-315. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Behav., 2013, 119, 145-148. http://dx.doi.org/10.1016/j.physbeh.2013.06.010 [115] Krugel, U.; Fischer, J.; Radicke, S.; Sack, U.; Himmerich, H. Antidepressant effects of TNF-alpha blockade in an animal model of depression.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Res., 2013, 47(5), 611-616. http://dx.doi.org/10.1016/j.jpsychires.2013.01.007 [116] Karson, A.; Demirtas, T.; Bayramgurler, D.; Balci, F.; Utkan, T. Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat m o d e l  o f  chronic mild stress.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Toxicol., 2013, 112(5), 335-340. http://dx.doi.org/10.1111/bcpt.12037 [117] Grippo, A.J.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"http://dx.doi.org/10.1152/ajpregu.00430.2002 [118] O'Connor, J.C.; Andre, C.; Wang, Y. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neurosci., 2009, 29(13), 4200-4209. http://dx.doi.org/10.1523/JNEUROSCI.5032-08.2009 [119] Ertenli, I.; Ozer, S.; Kiraz, S. Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Int., 2012, 32(2), 323-330. http://dx.doi.org/10.1007/s00296-010-1616-x [120] Guloksuz, S.; Wichers, M.; Kenis, G. Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0060435 [121] Persoons, P.; Vermeire, S.; Demyttenaere, K. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Ther., 2005, 22(2), 101-110. http://dx.doi.org/10.1111/j.1365-2036.2005.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Dermatol., 2008, 49(4), 250-251. http://dx.doi.org/10.1111/j.1440-0960.2008.00487.x [125] Tookman, A.J.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Care Cancer, 2008, 16(10), 1131-1140. http://dx.doi.org/10.1007/s00520-008-0429-x [126] Mehta, D.; Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Immun., 2013, 31, 205-215. http://dx.doi.org/10.1016/j.bbi.2013.04.004 [127] Cattaneo, A.; Gennarelli, M.; Uher, R. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacology, 2013, 38(3), 377-385. http://dx.doi.org/10.1038/npp.2012.191 [128] Powell, T.R.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neuropsychopharmacol., 2013, 23(9), 1105-1114. http://dx.doi.org/10.1016/j.euroneuro.2012.09.009 [129] Kekow, J.; Moots, R.; Khandker, R.; Melin, J.; Freundlich, B.; Singh, A.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rheumatology (Oxford), 2011, 50(2), 401-409. http://dx.doi.org/10.1093/rheumatology/keq327 [130] Machado, D.A.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rheumatol., 2014, 20(1), 25-33. http://dx.doi.org/10.1097/ RHU.0000000000000055 [131] Gelfand, J.M.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Value Health, 2008, 11(3), 400-407. http://dx.doi.org/ 10.1111/j.1524-4733.2007.00251.x [132] Dauden, E.; Griffiths, C.E.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Venereol., 2009, 23 (12), 1374-1382. http://dx.doi.org/10.1111/j.1468-3083.2009.03321.x [133] Tyring, S.; Gottlieb, A.; Papp, K. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Lancet, 2006, 367(9504), 29-35. http://dx.doi.org/10.1016/S0140-6736(05)67763-X [134] Krishnan, R.; Cella, D.; Leonardi, C. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Dermatol., 2007, 157(6), 1275-1277. http://dx.doi.org/10.1111/ j.1365-2133.2007.08205.x [135] Gniadecki, R.; Robertson, D.; Molta, C.T.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Venereol., 2012, 26(11), 1436-1443. http://dx.doi.org/10.1111/ j.1468-3083.2011.04308.x [136] Papp, K.; Poulin, Y.; Vieira, A.; Shelton, J.; Poulin-Costello, M. Disease characteristics in patients with and without psoriatic arthritis treated with etanercept.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Venereol., 2014, 28(5), 581-589. http://dx.doi.org/10.1111/jdv.12138 [137] Loftus, E.V.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Dermatol., 2010, 62(5), 812-818. http://dx.doi.org/10.1016/j.jaad.2009.07.022 [139] Arisoy, O.; Bes, C.; Cifci, C.; Sercan, M.; Soy, M. The effect of TNF-alpha blockers on psychometric measures in ankylosing spondylitis patients: a preliminary observation.",OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Int., 2013, 33(7), 1855-1864. http://dx.doi.org/10.1007/s00296-013-2671-x [140] Tong, Q.; Zhao, L.; Qian, X.D.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"J, 2013, 14(14), 1691-1700. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rheumatol., 2010, 37(4), 740-746. http://dx.doi.org/10.3899/ jrheum.090707 [142] Morales-Lara, M.J.; Canete, J.D.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Joint Bone Spine, 2012, 79(6), 591-596. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"J., 2011, 12(11), 1571-1585. http://dx.doi.org/10.2217/pgs.11.114 [144] Uguz, F.; Akman, C.; Kucuksarac, S .",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Neurosci., 2009, 63(1), 50-55. http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rev., 2013, 37(10 Pt 1), 2438-2444. http://dx.doi.org/10.1016/j.neubiorev.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"http://dx.doi.org/10.1186/ar4108 [147] Elfferich, M.D.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Respiration, 2010, 80(3), 212-219. http://dx.doi.org/10.1159/ 000314225 [148] Tobinick, E.L.; Gross, H. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"BMC Neurol., 2008, 8, 27. http://dx.doi.org/10.1186/1471-2377-8-27 [149] Thalayasingam, N.; Isaacs, J.D.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Rheumatol., 2011, 25 ( 4 ) ,  5 4 9-567. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"J. Psychiatry, 2014, 171(4), 395-397. http://dx.doi.org/10.1176/appi.ajp.2014.14020138   Received: October 08, 2014 Revised: December 05, 2014 Accepted: December 08, 2014",Non-OADS,/arxiv_data1/oa_pdf/62/7e/CN-13-558.PMC4761629.pdf
"Gen. Psychiatry, 2007, 64(3), 305-315. http://dx.doi.org/10.1001/archpsyc.64.3.305 [3] Panza, F.; Frisardi, V.; Capurso, C.; D'Introno, A.; Colacicco, A.M.; Imbimbo, B.P.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2010, 18(2), 98-116. http://dx.doi.org/10.1097/ JGP.0b013e3181b0fa13 [4] Keller, M.B.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 1998, 44(5), 348-360. http://dx.doi.org/10.1016/S0006-3223(98)00110-3 [5] Mueller, T.I.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 2014, 152, 65-75. http://dx.doi.org/10.1093/fampra/cml071 [7] Licht-Strunk, E.; van der Windt, DAWM.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Pract., 2007, 24(2), 168-180. http://dx.doi.org/ 10.1093/fampra/cml071 [8] Riihimäki, K.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Med., 2014, 44(7), 1369-1379. http://dx.doi.org/ 10.1017/S0033291711002303 [9] Stegenga, B.T.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Epidemiol., 2012, 47(1), 87-95. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 1997, 54(11), 993-999. http://dx.doi.org/10.1001/archpsyc.1997.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 1993, 50(10), 759-766. http://dx.doi.org/10.1001/archpsyc.1993.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2011, 168(3), 257-64. http://dx.doi.org/10.1176/ appi.ajp.2010.10050695 [13] Dowrick, C.; Shiels, C.; Page, H. Predicting long-term recovery from depression in community settings in Western Europe: evidence from ODIN.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Epidemiol., 2011, 46(2), 119-126. http://dx.doi.org/10.1007/s00127-009-0179-1 [14] Eaton, W.W.; Shao, H.; Nestadt, G. Population-based study of first onset and chronicity in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 2008, 65(5), 513-520. http://dx.doi.org/10.1001/  archpsyc.65.5.513 [15] Colman, I.; Naicker, K.; Zeng, Y.; Ataullahjan, A.; Senthilselvan, A.; Patten, S.B.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 2003, 60(7), 664-672. http://dx.doi.org/10.1001/ archpsyc.60.7.664 [17] Nierenberg, A.A.; Amsterdam, J.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 1990, 51, 39-47. http://dx.doi.org/10.1176/appi.ajp.163.11.1905 [18] Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2006, 163(11), 1905-1917. http://dx.doi.org/10.1176/appi.ajp.163.11.1905 [19] Malhi, G.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Suppl., 2013, 443, 6-23. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry Neurol., 1998, 11(4), 186-193. http://dx.doi.org/10.1177/089198879901100404 [21] McIntyre, R.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 2014, 156, 1-7. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 1975, 32(3), 285-305. http://dx.doi.org/10.1001/archpsyc.1975.01760210019001 [23] Alexopoulos, G.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Lancet, 2005, 365(9475), 1961-1970. http://dx.doi.org/10.1016/S0140-6736(05) 66665-2 [24] Beck, A.T.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychol., 1994, 62(2), 297-305. http://dx.doi.org/10.1037/0022-006X.62.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Soc., 1987, 35(5), 383-386. http://dx.doi.org/10.1111/ j.1532-5415.1987.tb04658.x [30] Murphy, E.; Smith, R.; Lindesay, J.; Slattery, J.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 1988, 152, 347-353. http://dx.doi.org/10.1192/bjp.152.3.347 [31] Green, B.H.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Scand., 1992, 86(3), 213-217. http://dx.doi.org/10.1111/j.1600-0447.1992.tb03254.x [32] Harwood, D.G.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 1999, 14(5), 331-337. http://dx.doi.org/10.1002/(SICI)1099-1166(199905) 14:5<331::AID-GPS911>3.0.CO;2-8 [33] McKinney, B.C.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"G e r i a t r i c  P s y c h i a t r y , 2013, 21(5), 418-432. http://dx.doi.org/10.1016/j.jagp.2013.01.053 [34] Aan het Rot, M.; Mathew, S.J.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
",  2009, 180(3), 305-313. http://dx.doi.org/10.1503/cmaj.080697 [35] Maletic, V.; Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Landmark Ed., 2009, 14, 5291-5338. http://dx.doi.org/10.2741/3598 [36] Benjamin, S.; Steffens, D.C.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
Structural Neuroimaging of Geriatric http://dx.doi.org/10.1016/j.psc.2011.02.001 D e p r e s s i o n .,OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 1997, 54(10), 915-922. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"S o c., 2014, 62(1), 130-134. http://dx.doi.org/10.1111/jgs.12600 [39] Rapp, M.A.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2005, 162(4), 691-698. http://dx.doi.org/10.1176/appi.ajp.162.4.691 [40] Sheline, Y.I, Gado, M.H.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2003, 160(8), 1516-1518. http://dx.doi.org/10.1176/appi.ajp.160.8.1516 [41] McEwen, B.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"R es., 2012, 46(1), 135-139. http://dx.doi.org/10.1016/j.jpsychires.2011.09.007 [43] Diniz, B.S.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neurol., 2013, 26(6), 656-661. http://dx.doi.org/ 10.1097/WCO.0000000000000028 [45] Mettenburg, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neuroimage, 2012, 60(4), 2182-2190. http://dx.doi.org/10.1016/j.neuroimage.2012.02.044 [46] Oldehinkel, A.J.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 2003, 74(3), 237-246. http://dx.doi.org/10.1016/ S0165-0327(02)00014-9 [47] Anisman, H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2005, 58(4), 297-306. http://dx.doi.org/10.1016/ j.biopsych.2005.04.013 [49] Páv, M.; Kovárů, H.; Fiserová, A.; Havrdová, E.; Lisá, V. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 1987, 144(5), 641-5. http://dx.doi.org/10.1176/ajp.144.5.641 [51] Heuser, I.; Yassouridis, A., Holsboer, F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Res., 1994, 28(4), 341-356. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 1996, 153(1), 93-99. http://dx.doi.org/ 10.1176/ajp.153.1.93 [53] Hatzinger, M.; Hemmeter, U.M.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Res., 2002, 36(5), 287-297. http://dx.doi.org/10.1016/S0022-3956(02)00021-3 [54] Yamada, K.;, Nabeshima, T. Brain-derived neurotrophic factor/TrkB signaling in memory processes.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Sci., 2003, 91(4), 267-270. http://dx.doi.org/10.1254/jphs.91.267 [55] Molendijk, M.L.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2011, 16(11), 1088-1095. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 2011, 135(1-3), 332-335. http://dx.doi.org/ 10.1016/j.jad.2011.06.041 [57] Brunoni, A.R.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Res., 2014, 49, 96-101. http://dx.doi.org/10.1016/j.jpsychires.2013.11.004 [59] Diniz, B.S.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Res., 2012, 46(1), 135-139. http://dx.doi.org/10.1016/j.jpsychires.2011.09.007 [60] Mattson, M.P.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Trends Neurosci., 2004, 27(10), 589-594. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 2011, 135(1-3), 56-65. http://dx.doi.org/10.1016/j.jad.2011.03.010 [62] Pérez-Edgar, K.; Bar-Haim, Y.; McDermott, J.M.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2007, 12(9), 799-814. http://dx.doi.org/10.1038/sj.mp.4001992 [64] Kendler, K.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 2005, 62(5), 529-535. http://dx.doi.org/10.1001/archpsyc.62.5.529 [65] Oldehinkel, A.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 2003, 74(3), 237-246. http://dx.doi.org/10.1016/ S0165-0327(02)00014-9 [66] Kaufman, J.; Yang, B.Z.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychopharmacol., 2006, 20(3 suppl), 11-18. http://dx.doi.org/10.1177/1359786806064310 [69] Whyte, E.M.; Dew, M.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Drugs Aging, 2004, 21, 531-554. http://dx.doi.org/ 10.2165/00002512-200421080-00004 [70] Gildengers, A.G.; Houck, P.R.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry Neurol., 1988, 1, 49-52. http://dx.doi.org/10.1177/ 089198878800100109 [72] van Marwijk, H.W.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 1990, 20, 2 1 7-223. http://dx.doi.org/10.1016/0165-0327(90)90053-B [73] Zimmer, B.; Rosen, J.; Thornton, J.E.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychopharmacol., 1991, 11, 254-256. http://dx.doi.org/10.1097/00004714-199108000-00006 [74] Flint, A.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disord., 1996, 36(3-4), 95-105. http://dx.doi.org/10.1016/0165-0327(95)00063-1 [75] Whyte, E.M.; Basinski, J.; Farhi, P. Geriatric depression treatme nt in nonresponders to selective serotonin reuptake inhibitors.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2004, 65, 1634-1641. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2007, 164(6), 892-899. http://dx.doi.org/10.1176/ajp.2007.164.6.892 [77] Karp, J.F.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2008, 69(3), 457-463. http://dx.doi.org/10.4088/JCP.v69n0317 [78] Rutherford, B.; Sneed, J.; Miyazaki, M. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2007, 2 2(10), 986-991. http://dx.doi.org/10.1002/gps.1775 [79] Sheffrin, M.; Driscoll, H.C.; Lenze, E.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2009, 70(2), 20813. http://dx.doi.org/10.4088/JCP.07m03805 [80] Cuijpers, P.; Karyotaki, E.; Pot, A.M.; Park, M.; Reynolds,  C.F.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Maturitas, 2014, 79, 1 6 0-9. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"North Am., 2013, 36(4), 561-575. http://dx.doi.org/10.1016/j.psc.2013.08.005 [82] Reynolds, C.F.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Med., 2006, 354(11), 1130-1138. http://dx.doi.org/10.1056/NEJMoa052619 [83] Reynolds, C.F.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2006, 14(9), 777-786. http://dx.doi.org/ 10.1097/01.JGP.0000199341.25431.4b [85] Hollon, S.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Anxiety, 2010, 27(10), 891-932. http://dx.doi.org/10.1002/da.20741 [86] Bell, A.C.; D'Zurilla, T.J. Problem-solving therapy for depression: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Rev., 2009, 29(4), 348-353. http://dx.doi.org/10.1016/j.cpr.2009.02.003 [87] Malouff, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Rev., 2007, 27(1), 46-57. http://dx.doi.org/10.1016/j.cpr.2005.12.005 [88] Arean, P.A.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychol., 1993, 61(6), 1003-1010. http://dx.doi.org/10.1037/0022-006X.61.6.1003 [89] Arean, P.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2010, 167(11), 1391-1398. http://dx.doi.org/10.1176/appi.ajp.2010.09091327 [90] Arean, P.; Hegel, M.; Vannoy, S.; Fan, M.Y.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gerontologist, 2008, 48(3), 311-323. http://dx.doi.org/10.1093/ geront/48.3.311 [91] Haber, D. Life review: implementation, theory, research, and therapy.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2003, 18(12), 1088-1094. http://dx.doi.org/10.1002/ gps.1018 [93] Pinquart, M.; Forstmeier, S. Effects of reminiscence interventions on psychosocial outcomes: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Health, 2012, 16(5), 541-558. http://dx.doi.org/10.1080/13607863.2011.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neuron, 2005, 45(5), 651-660. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2010, 67(2), 110-116. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Funct., 2008, 213(1-2), 93-118. http://dx.doi.org/10.1007/s00429-008-0189-x [97] Greicius, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2007, 62(5), 429-437. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2011, 168(5), 502-510. http://dx.doi.org/10.1176/appi.ajp.2010.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neuropsychopharmacology, 2008, 33(2), 368-377. http://dx.doi.org/10.1038/sj.npp.1301408 [101] Malone, D.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2009, 65(4), 267-275. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neurosurgery, 2005, 57(3), 585-593. http://dx.doi.org/10.1227/01.NEU.0000170434.44335.19 [103] Sartorius, A.; Kiening, K.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"http://dx.doi.org/10.1212/ WNL.59.6_suppl_4.S3 [107] Elger, G.; Hoppe, C.; Falkai, P.; Rush, A.J.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Epilepsy Res., 2000, 42(2-3), 203-210. http://dx.doi.org/10.1016/S0920-1211(00)00181-9 [108] Harden, C.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Epilepsy Behav., 2000, 1(2), 93-99. http://dx.doi.org/10.1006/ebeh.2000.0046 [109] Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2000, 47(4), 276-286. http://dx.doi.org/10.1016/S0006-3223(99)00304-2 [110] Schlaepfer, T.E.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Med., 2008, 38(5), 651-661. http://dx.doi.org/10.1017/ S0033291707001924 [111] Lisanby, S.H.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Med., 2007, 357(19), 1939-1945. http://dx.doi.org/10.1056/ NEJMct075234 [112] Sackeim, H.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 2000, 57(5), 425-434. http://dx.doi.org/10.1001/archpsyc.57.5.425 [113] American Psychiatric Association Weiner, A.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"http://dx.doi.org/ 10.1038/sj.npp.1300135 [115] Mervaala, E.; Kononen, M.; Föhr, J.; Husso-Saastamoinen, M.; Valkonen-Korhonen, M.; Kuikka, J.T.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Disorder, 2001, 66(1), 47-58. http://dx.doi.org/10.1016/ S0165-0327(00)00288-3 [116] Merkl, A.; Schubert, F.; Quante, A. Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"http://dx.doi.org/10.1038/tp.2014.21 [118] Bilgen, A.E.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Bull., 2014, 104, 82-87. http://dx.doi.org/10.1016/j.brainresbull.2014.04.005 [119] Connolly, K.R.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"http://dx.doi.org/10.4088/JCP.11m07413 [120] Baeken, C.; De Raedt, R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neuro circuitry in unipolar depression.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neurosci., 2001, 14(8), 1405-1411. http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neuroreport, 1998, 9(5), 943-948. http://dx.doi.org/10.1097/ 00001756-199803300-00033 [123] Hayward, G.; Mehta, M.A.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neurosci., 2007, 25(7), 2224-2233. http://dx.doi.org/10.1111/j.1460-9568.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry Res., 2007, 156(3), 251-255. http://dx.doi.org/10.1016/j.pscychresns.2007.05.002 [125] Toyoda, H.; Zhao, M.G.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neurosci., 2 0 0 6, 17(4), 403-413. http://dx.doi.org/10.1515/ revneuro.2006.17.4.403 [126] Janicak, P.G.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Brain Stimulat., 2010, 3(4), 187-199. http://dx.doi.org/10.1016/j.brs.2010.07.003 [127] Lisanby, S.H.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Gen. Psychiatry, 2001, 58(3), 303-305. http://dx.doi.org/10.1001/archpsyc.58.3.303 [128] Kayser, S.; Bewernick, B.H.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Res., 2011, 4 5(5), 569-576. http://dx.doi.org/10.1016/j.jpsychires.2010.09.008 [129] Kayser, S.; Bewernick, B.; Axmacher, N.; Schlaepfer, T.E.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. ECT, 2009, 25(2), 137-140. http://dx.doi.org/10.1097/YCT.0b013e31817dc45a [130] Kosel, M.; Frick, C.; Lisanby, S.H.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neuropsychopharmacology, 2003, 28(11), 2045-2048. http://dx.doi.org/10.1038/sj.npp.1300293 [131] Lisanby, S.H.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Neuropsychopharmacology,2003, 28(10), 1852-1865. http://dx.doi.org/10.1038/sj.npp.1300229 [132] Bridle, C.; Spanjers, K.; Patel, S.; Atherton, N.M.; Lamb, S.E.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2012, 2 0 1, 180-185. http://dx.doi.org/ 10.1192/bjp.bp.111.095174 [133] Arent, S.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Rehabilitation, 2009, 23, 873-887. http://dx.doi.org/10.1177/0269215509337449 [135] Mura, G.; Carta, M.G.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Health, 2013, 9, 125-135. http://dx.doi.org/10.2174/1745017901309010125 [136] Sjösten, N.; Kivelä, S.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2006, 21, 410-418. http://dx.doi.org/ 10.1002/gps.1494 [137] Matthews, M.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Soc., 2011, 59, 495-500. http://dx.doi.org/ 10.1111/j.1532-5415.2011.03319.x [138] Sims, J.; Hill, K.; Davidson, S.; Gunn, J.; Huang, N. Exploring the feasibility of a community-based strength training program for older people with depressive symptoms and its impact on depressive symptoms.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Soc., 2011, 59, 1188-1196. http://dx.doi.org/10.1111/j.1532-5415.2011.03454.x [140] Blumenthal, J.A.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Med., 1999, 159, 2349-2356. http://dx.doi.org/10.1001/ archinte.159.19.2349 [141] Mather, A.S.; Rodriguez, C.; Guthire, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"J. Psychiatry, 2002, 180, 411-415. http://dx.doi.org/10.1192/bjp.180.5.411 [142] Singh, N.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"http://dx.doi.org/10.1093/gerona/56.8.M497 [143] McNeil, J.K.; LeBlanc, E.M.; Joyner, M. The effect of exercise on depressive symptoms in the moderately depressed elderly.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Aging, 2006, 6, 487-488. http://dx.doi.org/10.1037/0882-7974.6.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Sci., 2005, 60, 768-776. http://dx.doi.org/10.1093/gerona/ 60.6.768 [145] Kerse, N.; Hayman, K.J.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Med., 2010, 8, 214-223. http://dx.doi.org/10.1370/afm.1093 [146] Chou, K.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2004, 19, 1105-1107. http://dx.doi.org/10.1002/gps.1178 [147] Singh, N.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"http://dx.doi.org/10.1093/gerona/52A.1.M27 [148] Lavretsky, H.; Alstein, L.L.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2011, 19, 839-580. http://dx.doi.org/10.1097/JGP.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Skills, 2005, 100, 707-715. http://dx.doi.org/10.2466/PMS.100.3.707-715 [150] Netz, Y.; Wu, M.J.; Becker, B.J.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Ageing, 2005, 20, 272-284. http://dx.doi.org/10.1037/0882-7974.20.2.272 [151] Penninx, B.W.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Social Sci., 2002, 57, 124-132. http://dx.doi.org/10.1093/geronb/57.2.P124 [152] Kritz-Silverstein, D.; Barrett-Connor, E.; Corbeau, C. Cross-sectional and Prospective Study of Exercise and Depressed Mood in the Elderly.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Epidemiol., 2001, 153, 596-603. http://dx.doi.org/10.1093/aje/153.6.596 [153] Churchill, J.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Aging, 2002, 23, 941-955. http://dx.doi.org/10.1016/ S0197-4580(02)00028-3 [154] Colcombe, S.; Kramer, A.F.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Sci.,2003, 14(2), 125-130. http://dx.doi.org/10.1111/1467-9280.t01-1-01430 [155] Rosenberg, D.; Depp, C.A.",OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Psychiatry, 2010, 18, 221-226. http://dx.doi.org/10.1097/JGP.0b013e3181c534b5 [156] Steffens, D.C.",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
"Lancet, 2013, 382, 4-5. http://dx.doi.org/10.1016/S0140-6736(13)60860-0   Received: January 15, 2015 Revised: February 25, 2015 Accepted: February 27, 2015",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/CN-13-577.PMC4761630.pdf
METHODS  We searched the digitized medical research literature for reports related to pharmacological treatments of treatment-resistance in bipolar disorder patients using the MedLine/ PubMed database of the U.S. National Center for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Gen. Psychiatry, 2007, 64, 543-552. http://dx.doi.org/10.1001/archpsyc.64.5.543 [3] Baldessarini, R.J., Salvatore, P.; Khalsa, H.M.; G e b r e-Medhin, P. Morbidity in 303 first-episode bipolar I disorder patients.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 2010, 12, 264-270. http://dx.doi.org/10.1111/j.1399-5618.2010.00812.x [4] Baldessarini, R.J.; Vieta, E.; Calabrese, J.R.; Tohen, M.; Bowden, C.L.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2010, 18, 143-157. http://dx.doi.org/10.3109/ 10673221003747955 [5] Baldessarini, R.J.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Springer Press, New York, 2013. http://dx.doi.org/10.1007/978-1-4614-3710-9 [6] Baldessarini, R.J.; Pérez, J.; Salvatore, P.; Trede, K.; Maggini, C. History of bipolar manic-depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Anxiety, 2014, 31, 196-206. http://dx.doi.org/10.1002/ da.22248 [9] Tondo, L.; Vázquez, G.H.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry Rep., 2014, 16, 431. http://dx.doi.org/10.1007/s11920-013-0431-y [10] NICE (UK National Institute for Health and Clinical Excellence).",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
", 2013, 15, 1-44. http://dx.doi.org/10.1111/bdi.12025 [12] Baldessarini, R.J.; Henk, H.J.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry Serv., 2008, 59, 1175-1183. http://dx.doi.org/10.1176/ps.2008.59.10.1175 [13] Centorrino, F.; Ventriglio, A.; Vincenti, A.; Talamo, A.; Baldessarini, R.J. Changes in medication practices for hospitalized psychiatric patients: 2009 vs. 2004.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychopharmacol., 2010, 25, 179-186. http://dx.doi.org/10.1002/hup.1095 [14] Parikh, S.V.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 2009, 11, 76-81. http://dx.doi.org/10.1111/j.1399-5618.2008.00651.x [16] Erfurth, A.; Michael, N.; Stadtand, C.; Arolt, V. Bupropion as Add-on strategy in difficult to treat bipolar depressive patients.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neuropsychobiology, 2002, 45(Suppl 1), 33-36. http://dx.doi.org/ 10.1159/000049259 [17] González-Isasi, A.; Echeburúa, E.; Mosquera, F.; Ibáñez, B.; Aizpuru, F.; González-Pinto, A.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry Res., 2010, 176, 161-165. http://dx.doi.org/ 10.1016/j.psychres.2008.06.047 [18] Pacchiarotti, I.; Mazzarini, L.; Colom, F. Treatment-resistant bipolar depression: towards a new definition.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Scand., 2009, 120, 429-440. http://dx.doi.org/10.1111/j.1600-0447.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 2012, 14, 573-584. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 1996, 153, 759-764. http://dx.doi.org/10.1176/ajp.153.6.759 [23] Suppes, T.; Webb, A.; Paul, B.; Carmody, T.; Kraemer, H.; Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2003, 64, 451-458. http://dx.doi.org/10.4088/JCP.v64n0416 [25] Chang, J.; Ha, K.; Young, L.; Sik, K.; Min, A.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2006, 67, 461-467. http://dx.doi.org/10.4088/JCP.v67n0318 [26] Meltzer, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Gen. Psychiatry, 2003, 60, 82-91. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Schizophrenia Res., 2005, 73, 139-145. http://dx.doi.org/10.1016/j.schres.2004.05.015 [28] Zhornitsky, S.; Rizkallah, E.; Pampoulova, T.; Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychopharmacol., 2010, 30, 417-424. http://dx.doi.org/10.1097/JCP.0b013e3181e7810a [29] Keck, P.; Marcus, R.; Tourkodimitris, S. Placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 2003, 160, 1651-1658. http://dx.doi.org/10.1176/appi.ajp.160.9.1651 [30] Sachs, G.; Sanchez, R.; Marcus, R. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: 3-week placebo-controlled study.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychopharmacol., 2006, 20, 536-546. http://dx.doi.org/10.1177/0269881106059693 [31] Ketter, T.; Wang, P.; Chandler, R.; Culver, J.; Alarcon, A. Adjunctive aripiprazole in treatment-resistant bipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2006, 18, 169-172. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2007, 31, 574-577. http://dx.doi.org/10.1016/j.pnpbp.2006.12.009 [33] Benedetti, A.; Di Paolo, A.; Lastella, M. Augmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Health, 2010, 6, 30-35. http://dx.doi.org/10.2174/1745017901006010030 [34] Chen, J.; Muzina, D.; Kemp, D. Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: 12-week open-label study.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychopharmacol., 2001, 21, 469-473. http://dx.doi.org/10.1097/ 00004714-200110000-00002 [36] Ahn, Y.; Nam, J.; Culver, J.; Marsh, W.; Bonner, J.; Ketter, T. Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"1999, 42, 2582-2587. http://dx.doi.org/10.1021/jm980627g [38] Nath, K.; Bhattacharya, A.; Praharaj, S. Eslicarbazepine acetate in the management of refractory bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"2012, 35, 295. http://dx.doi.org/10.1097/WNF.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Pharmacol., 2 0 0 6, 70, 467-476. http://dx.doi.org/10.1124/mol.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Des., 2013, 19, 6367-6374. http://dx.doi.org/10.2174/ 13816128113199990425 [41] Oulis, P.; Florakis, A.A.; Tzanoulinos, G.; Papadimitriou, G.N.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neuropharmacol., 2009, 32, 174. http://dx.doi.org/10.1097/ WNF.0b013e31818a651a [42] Stein, D.J.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neuro- psychopharmacol., 2008, 18, 422-430. http://dx.doi.org/10.1016/ j.euroneuro.2008.01.004 [43] Conesa, M.; Rojo, L.; Plumed, J.; Livianos, L. Pregabalin in the treatment of refractory bipolar disorders.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Ther., 2012, 18, 269-270. http://dx.doi.org/10.1111/j.1755-5949.2011.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Disord., 2013, 147, 407-410. http://dx.doi.org/ 10.1016/j.jad.2012.09.005 [45] Martinotti, G.; Di Nicola, M.; Tedeschi, D.; Mazza, M.; Janiri, L.; Bria, P. Efficacy and safety of pregabalin in alcohol dependence.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Ther., 2008, 25, 608-618. http://dx.doi.org/10.1007/s12325-008-0066-2 [46] Oulis, P.; Konstantakopoulos, G. Pregabalin in the treatment of alcohol and benzodiazepines dependence.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Ther., 2010, 16, 45-50. http://dx.doi.org/10.1111/j.1755-5949.2009.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Epilepsia, 1994, 35, 450-460. http://dx.doi.org/10.1111/j.1528-1157.1994.tb02459.x [48] Gabriel, A. Adjunctive topiramate treatment in refractory obese bipolar patients: descriptive open label study.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Eating Weight Disord., 2007, 12, 48-53. http://dx.doi.org/10.1007/BF03327772 [49] Levy, N.; Janicak, P. Calcium channel antagonists for the treatment of bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"http://dx.doi.org/10.1002/14651858.cd003384.pub2 [51] Vieta, E.; Torrent, C.; Garcia-Ribas, G. Use of topiramate in treatment-resistant bipolar spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychopharmacol., 2002, 22, 431-435. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 2013, 170, 1249-1262. http://dx.doi.org/10.1176/appi.ajp.2013.13020185 [53] Tondo, L.; Baldessarini, R.J.; Vázquez, G.; Lepri, B.; Visioli, C. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neuropsychopharmacol., 2013, 16, 1673-1685. http://dx.doi.org/10.1017/S1461145713000023 [55] Vázquez, G.H.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Treat., 2014, 20, 193-201. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Scand., 2010, 121, 404-414. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Disord., 2012, 139, 89-93. http://dx.doi.org/10.1016/j.jad.2012.01.027 [59] Eastwood, S.L.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neurobiol., 2014, 23, 28-35. http://dx.doi.org/10.5607/en.2014.23.1.28 [61] Kohrs, R.; Durieux, M.E.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Analg., 1998, 87, 1186-1193. http://dx.doi.org/10.1111/aas.12377 [62] McNicol, E.D.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Scand., 2014, 58, 1199-213. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Gen. Psychiatry, 2010, 67, 793-802. http://dx.doi.org/10.1001/archgenpsychiatry.2010.90 [66] Cusin, C.; Hilton, G.; Nierenberg, A.; Fava, M. Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 2 0 1 2, 169, 868-869. http://dx.doi.org/10.1176/appi.ajp.2012.12020219 [67] Lara, D.; Bisol, L.; Munari, L. Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Neuro- Psychopharmacol., 2013, 16, 2111-2117. http://dx.doi.org/10.1017/ S1461145713000485 [68] Agarwal, V.; Tripathi, A. Memantine in the management of a clinically challenging case of bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Indian J. Psychiatry, 2009, 51, 137-138. http://dx.doi.org/10.4103/0019-5545.49455 [69] Koukopoulos, A.; Reginaldi, D.; Serra, G.; Koukopoulos, A.; Sani, G.; Serra, G. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 201 0, 12(3), 348-349. http://dx.doi.org/10.1111/j.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Disord., 2012, 136(1), 163-166. http://dx.doi.org/10.1016/j.jad.2011.09.040 [71] Serra, G.; De Chiara, L.; Koukopoulos, A.E.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry Pract., 2014, 20, 232-236. http://dx.doi.org/10.1097/ 01.pra.0000450324.44661.12 [72] Anand, A.; Gunn, A.D.; Barkay, G. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: double-blind, randomized, placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 2012, 14, 64-70. http://dx.doi.org/ 10.1111/j.1399-5618.2011.00971.x [73] Burt, T.; Sachs, G.; Demopulos, C. Donepezil in treatment-resistant bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 2006, 8, 75-80. http://dx.doi.org/10.1111/j.1399-5618.2006.00243.x [75] Kelly, T. Is donepezil useful for improving cognitive dysfunction in bipolar disorder?",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Pharm., 2014, 29, 191-195. http://dx.doi.org/10.4140/TCP.n.2014.191 [77] Kvernmo, T.; Härtter, S.; Burger, E. Review of the receptor-binding and pharmacokinetic properties of dopamine agonists.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Ther., 2006, 28, 1065-1078. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"P s y c h i a t r y , 2013, 74, 1101-1107. http://dx.doi.org/ 10.4088/JCP.13r08560 [81] Cusin, C.; Iovieno, N.; Iosifescu, D.V.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"http://dx.doi.org/10.4088/JCP.12m08093 [82] Goldberg, J.F.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 2004, 1 6 1, 564-566. http://dx.doi.org/10.1176/ appi.ajp.161.3.564 [83] Sporn, J.; Ghaemi, S.N.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Pharmacopsychiatry, 2001, 34, 137-141. http://dx.doi.org/10.1055/s-2001-15872 [85] Cassano, P.; Lattanzi, L.; Soldani, F. Pramipexole in treatment-resistant depression: an extended follow-up.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Depress Anxiety, 2004, 20, 131-138. http://dx.doi.org/10.1002/da.20038 [86] Dell'Osso, B.; Ketter, T.A.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"2013, 28, 297-304. http://dx.doi.org/10.1097/YIC.0b013e3283639015 [87] Rabinak, C.A.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neurol., 2010, 67, 58-63. http://dx.doi.org/10.1001/archneurol.2009.294 [88] Abbasowa, L., Kessing, L.V., Vinberg, M. Psycho stimulants in moderate to severe affective disorder: systematic review of randomized controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 2013, 67, 369-382. http://dx.doi.org/10.3109/08039488.2012.752035 [89] Parker, G.; Brotchie, H. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Scand., 2010, 121, 308-314. http://dx.doi.org/10.1111/j.1600-0447.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Neuropsychopharmacol., 2008, 33, 1477-1502. http://dx.doi.org/10.1038/sj.npp.1301534 [91] Loland, C.; Mereu, M.; Okunola, O. R-modafinil (armodafinil): unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2010, 71, 1363-1370. http://dx.doi.org/10.4088/JCP.09m05900gry [93] Frye, M.; Grunze, H.; Suppes, T. Placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"J. Psychiatry, 2007, 164, 1242-1249. http://dx.doi.org/10.1176/appi.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Affect Disord., 2013, 150, 130-135. http://dx.doi.org/10.1016/j.jad.2012.11.030 [95] Nurnberger, J.I.",OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Des., 2009, 15, 1612-1622. http://dx.doi.org/10.2174/138161209788168100 [100] Schiffman, J.E.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2012, 73, 992. http://dx.doi.org/10.4088/JCP.11cr07565 [101] Lasser, R.A.; Baldessarini, R.J. Thyroid hormones in depressive disorders: reappraisal of clinical utility.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 1997, 4, 291-305. http://dx.doi.org/10.3109/10673229709030557 [102] Kelly, T.; Lieberman, D. Use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Disord., 2009, 116, 222-226. http://dx.doi.org/10.1016/j.jad.2008.12.010 [103] Bauer, M. Thyroid h o r m o n e  a u g m e n t a t i o n  w i t h  l e v o t h y r o x i n e  i n  bipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Bipolar Disord., 2 0 0 2, 4(Suppl 1), 109-110. http://dx.doi.org/10.1034/j.1399-5618.4.s1.59.x [104] Stamm, T.J.; Lewitzka, U.; Sauer, C. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: randomized, double-blind, placebo-controlled study.",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Psychiatry, 2014, 75, 162-168. http://dx.doi.org/10.4088/JCP.12m08305   Received: September 05, 2014 Revised: December 06, 2014 Accepted: December 06, 2014",Non-OADS,/arxiv_data1/oa_pdf/70/62/CN-13-592.PMC4761631.pdf
"Methodol., 2005, 5, 14. http://dx.doi.org/10.1186/1471-2288-5-14 [2] Patsopoulos, N.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"JAMA, 2005, 293, 2362-2366. http://dx.doi.org/10.1001/jama.293.19.2362 [3] Feinstein, A.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Epidemiol., 1995, 48, 71-79. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychopharmacol., 2014, 28, 106-117. http://dx.doi.org/10.1177/ 0269881113504014 [5] Maier, W.; Moller, H.J.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"5    613 Neurosci., 2009, 260, 17-23. http://dx.doi.org/10.1007/s00406-009-0068-3 [6] Pereira, T.V.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Epidemiol., 2011, 64, 1060-1069. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"http://dx.doi.org/10.1056/NEJMsa065779 [8] Turner, E.H.; Matthews, A.M.; Linardatos, E. Selective publication of antidepressant trials and its influence on apparent efficacy.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2008, 358, 252-260. http://dx.doi.org/10.1111/j.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Bipolar Disord., 2008, 10, 957-968. http://dx.doi.org/10.1111/j.1399-5618.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2000, 176, 421-428. http://dx.doi.org/10.1192/ bjp.176.5.421 [11] Moncrieff, J.; Wessely, S.; Hardy, R. Active placebos versus antidepressants for dep ression.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"http://dx.doi.org/10.1002/14651858.cd003012.pub2 [12] Kirsch, I.; Deacon, B.J.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"http://dx.doi.org/10.1371/journal.pmed.0050045 [13] Fournier, J.C.; DeRubeis, R.J.; Hollon, S.D.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"JAMA, 2010, 303, 47-53. http://dx.doi.org/10.1001/jama.2009.1943 [14] Barbui, C.; Furukawa, T.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"CMAJ, 2008, 178, 296-305. http://dx.doi.org/ 10.1097/00004714-200202000-00007 [15] Khan, A.; Leventhal, R.M.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychopharmacol., 2002, 22, 40-45. http://dx.doi.org/10.1038/npp.2011.306 [16] Undurraga, J.; Baldessarini, R.J. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Neuropsychopharmacology, 2012, 37, 851-864. http://dx.doi.org/10.1038/npp.2011.306 [17] Fountoulakis, K.N.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Gen. Psychiatry, 2013, 12, 26. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Affect Disord., 2014, 159, 118-126. http://dx.doi.org/10.1016/j.jad.2014.02.026 [20] Renner, F.; Cuijpers, P.; Huibers, M.J.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2014, 44, 2913-2926. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"http://dx.doi.org/10.1371/journal.pmed.1001454 [23] Cuijpers, P.; Turner, E.H.; Mohr D.C.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Disord., 2013, 149, 1-13. http://dx.doi.org/10.1016/j.jad.2013.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2011, 65, 354-364. http://dx.doi.org/10.3109/08039488.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Rev., 2011, 31, 353-360. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2011, 168, 581-592. http://dx.doi.org/10.1176/appi.ajp.2010.10101411 [29] Cuijpers, P.; van Straten, A.; van Oppen, P. Comparing psychotherapy and pharmacotherapy for adult depression: adjusting for differential dropout rates.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2010, 71, 1246. http://dx.doi.org/10.4088/JCP.09l05891blu [30] Cuijpers, P.; Smit, F.; Bohlmeijer, E. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2010, 196, 173-178. http://dx.doi.org/10.1192/bjp.bp.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2010, 40, 211-223. http://dx.doi.org/10.1037/a0013075 [32] Cuijpers, P.; van Straten, A.; Andersson, G. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychol., 2008, 76, 909-922. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Anxiety, 2009, 26, 279-288. http://dx.doi.org/10.1002/da.20519 [34] Ioannidis, J.P.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2008, 3, 14. http://dx.doi.org/10.1186/1747-5341-3-14 [35] Fountoulakis, K.N.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Gen. Psychiatry, 2013, 12, 11. http://dx.doi.org/10.1186/ 1744-859X-12-11 [36] Kobak, K.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 1997, 170, 264-267. http://dx.doi.org/10.1192/ bjp.170.3.264 [39] Talamo, A.; Baldessarini, R.J.; Centorrino, F. Comparison of mania patients suitable for treatment trials versus clinical treatment.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychopharmacol., 2008, 23, 447-454. http://dx.doi.org/10.1002/ hup.952 [40] Zetin, M.; Hoepner, C .",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psycho- pharmacol., 2007, 27, 295-301. http://dx.doi.org/10.1097/JCP.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2002, 159, 469-473. http://dx.doi.org/10.1176/appi.ajp.159.3.469 [42] Partonen, T.; Sihvo, S.; Lonnqvist, J.K.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 1996, 57, 572-575. http://dx.doi.org/10.4088/JCP.v57n1203 [43] Wisniewski, S.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2009, 166, 599-607. http://dx.doi.org/10.1176/appi.ajp.2008.08071027",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2010, 41, 1353-1363. http://dx.doi.org/10.1017/S0033291710002175 [45] Wolf, S.; Pinsky, R.H.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Assoc., 1954, 155, 339-341. http://dx.doi.org/10.1001/jama.1954.03690220013004 [46] Tomba, E. Nowhere patients.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychosom., 2012, 81, 69-72. http://dx.doi.org/10.1159/000334112 [47] Fava, G.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2010, 35, 1593-1602. http://dx.doi.org/10.1016/j.pnpbp.2010.07.026 [48] Fava, G.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2013, 40, 306-311. http://dx.doi.org/10.1016/j.pnpbp.2012.10.014 [49] Trikalinos, T.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Epidemiol., 2004, 57, 1124-1130. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Epidemiol., 2005, 58, 753-756. http://dx.doi.org/10.1016/j.jclinepi.2004.12.006 [51] Fava, G.A.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Pract., 2011, 66, 11-15. http://dx.doi.org/10.1111/j.1742-1241.2011.02825.x [52] Borm, G.F.; Lemmers, O.; Fransen, J.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Scand., 2011, 125, 342-348. http://dx.doi.org/10.1111/j.1600-0447.2011.01791.x [55] Bech, P.; Fava, M.; Trivedi, M.H.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Disord., 2011, 132, 396-400. http://dx.doi.org/ 10.1016/j.jad.2011.03.011 [56] Romera, I.; Perez, V.; Menchon, J.M.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry Res., 2010, 186, 133-137. http://dx.doi.org/10.1016/j.psychres.2010.06.023 [57] Goldstein, D.J.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2002, 63, 225-231. http://dx.doi.org/10.4088/JCP.v63n0309 [58] Tourian, K.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Ther., 2009, 31 Pt 1, 1405-1423. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Scand., 1985, 72, 239-245. http://dx.doi.org/10.1111/j.1600-0447.1985.tb02601.x [61] Bech, P. Is the antidepressive effect of second-generation anti- depressants a myth?",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Neuropsychopharmacol.,  2004, 7, 283-290. http://dx.doi.org/10.1017/S1461145704004365 [63] McIntyre, R.S.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Anxiety, 2013, 30, 515-527. http://dx.doi.org/10.1002/da.22063 [64] McIntyre, R.S.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry., 2013, 74 Suppl 2, 14-18. http://dx.doi.org/10.4088/JCP.12084su1c.03 [65] Walsh, B.T.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Jama 2002, 287, 1840-1847. http://dx.doi.org/10.1001/jama.287.14.1840 [66] Khan, A.; Khan, S.; Brown, W.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Neuro- psychopharmacol., 2002, 5, 193-197. http://dx.doi.org/10.1017/ S1461145702002912 [67] Rutherford, B.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2013, 170, 723-733. http://dx.doi.org/10.1176/appi.ajp.2012.12040474 [68] Jubb, J.; Bensing, J.M.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Rev., 2013, 37, 2709-2720. http://dx.doi.org/ 10.1016/j.neubiorev.2013.09.006 [69] Stewart-Williams, S.; Podd, J.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Bull., 2004, 130, 324-340. http://dx.doi.org/10.1037/0033-2909.130.2.324 [70] Khan, A.; Kolts, R.L.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2004, 161, 2045-2049. http://dx.doi.org/10.1176/appi.ajp.161.11.2045 [71] Rutherford, B.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychosom., 2009, 78, 172-181. http://dx.doi.org/10.1159/000209348 [72] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Neuropsychopharmacol., 2009, 19, 34-40. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2007, 190, 287-292. http://dx.doi.org/10.1192/bjp.bp.106.028555 [74] Rutherford, B.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2011, 50, 782-795. http://dx.doi.org/10.1016/j.jaac.2011.04.004 [75] Rutherford, B.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2013, 43, 975-982. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Neuropsychopharmacology, 1994, 11, 33-43. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychopharmacol., 2001, 21, 561-568. http://dx.doi.org/10.1097/00004714-200112000-00004 [78] Kobak, K.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychopharmacol., 2007, 27, 1-5. http://dx.doi.org/10.1097/JCP.0b013e31802eb4b7 [79] Khan, A.; Faucett, J.; Brown, W.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Res., 2014, 51, 88-92. http://dx.doi.org/10.1016/j.jpsychires.2014.01.005 [80] Rutherford, B.R.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Res., 2012, 46, 697-702. http://dx.doi.org/10.1016/j.jpsychires.2012.02.008 [81] Mitsikostas, D.D.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry Res., 2014, 215, 82-86. http://dx.doi.org/10.1016/j.psychres.2013.10.019 [82] Waring, D.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2008, 31, 453-462. http://dx.doi.org/10.1016/j.ijlp.2008.09.001 [83] Kirsch, I.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2000, 47, 733-735. http://dx.doi.org/10.1016/ S0006-3223(00)00832-5 [84] Beasley, C.M., Jr.; Nilsson, M.E.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry., 2000, 61, 722-728. http://dx.doi.org/10.4088/ JCP.v61n1003 [85] Pae, C.U.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Neuro- psychopharmacol., 2011, 14, 261-268. http://dx.doi.org/10.1017/ S146114571000115X [87] Thase, M.E.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2005, 66, 974-981. http://dx.doi.org/10.4088/JCP.v66n0803 [88] Cipriani, A.; Furukawa, T.A.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Lancet, 2013, 382, 951-962. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"http://dx.doi.org/10.1371/journal.pone.0099682 [93] Lu, G.; Ades, A.E.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2004, 23, 3105-3124. http://dx.doi.org/10.1002/sim.1875 [94] Guyatt, G.H.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Epidemiol., 2011, 64, 1283-1293. http://dx.doi.org/10.1016/j.jclinepi.2011.01.012 [95] Thorlund, K.; Mills, E.J.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Rev., 2012, 1, 41. http://dx.doi.org/ 10.1186/2046-4053-1-41 [96] Mills, E.J.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Neuropsychopharmacol., 2011, 14, 405-412. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Pharmacopsychiatry, 1984, 17, 22-28. http://dx.doi.org/10.1055/s-2007-1017402 [101] Bech, P. Rating scales in psychopharmacology.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Suppl., 1988, 345, 45-55. http://dx.doi.org/10.1111/j.1600-0447.1988.tb08567.x [103] Bech, P. Psychometric developments of the Hamilton scales: the spectrum of depression, dysthymia, and anxiety.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Ser., 1990, 9, 72-79. http://dx.doi.org/10.1007/978-3-642-75373-2_9 [104] Bech, P. Modern psychometrics in clinimetrics: impact on clinical trials of antidepressants.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychosom., 2004, 73, 134-138. http://dx.doi.org/10.1159/000076448 [105] Bech, P. Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Scand., 2009, 120, 400-409. http://dx.doi.org/10.1111/j.1600-0447.2009.01445.x [106] Bech, P.; Allerup, P.; Gram, L.F.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Scand., 1981, 63, 290-299. http://dx.doi.org/10.1111/j.1600-0447.1981.tb00676.x [107] Bech, P.; Gram, L. F.; Dein, E. Quantitative rating of depressive states.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Scand., 1975, 51, 161-170. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"J. Psychiatry, 2004, 161, 2163-2177. http://dx.doi.org/ 10.1176/appi.ajp.161.12.2163 [109] Blomqvist, N. On the relation between change and initial value.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Bull., 1992, 111, 176-184. http://dx.doi.org/10.1037/ 0033-2909.111.1.176 [111] Fountoulakis, K.N.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Neuro- psychopharmacology, 2012, 37, 850. http://dx.doi.org/10.1038/npp.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Dis., 1962, 15, 969-977. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Dent., 2004, 32, 133-142. http://dx.doi.org/10.1016/j.jdent.2003.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 1999, 130, 995-1004. http://dx.doi.org/10.7326/0003-4819-130-12-199906150-00008 [116] Johnson, S.R.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Epidemiol., 2009, 63, 355-369. http://dx.doi.org/10.1016/j.jclinepi.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Gen. Psychiatry, 2012, 69, 572-579. http://dx.doi.org/10.1001/archgenpsychiatry.2011.2044 [118] Cameron, I.M.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Disord., 2014, 166, 48-58. http://dx.doi.org/10.1016/j.jad.2014.04.078 [119] Gartlehner, G.; Gaynes, B.N.",OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"BMC Med., 2013, 11, 230. http://dx.doi.org/10.1186/1741-7015-11-230 [124] Naudet, F.; Falissard, B.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"BMC Med., 2014, 12, 106. http://dx.doi.org/10.1186/1741-7015-12-106 [125] Deeks, J.J. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2002, 21, 1575-1600. http://dx.doi.org/10.1002/sim.1188 [126] Gartlehner, G.; Gaynes, B.N.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2008, 149, 734-750. http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00008 [127] Gartlehner, G.; Hansen, R.A.; Morgan, L.C.",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Med., 2011, 155, 772-785. http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00009   Received: September 05, 2014 Revised: December 06, 2014 Accepted: December 06, 2014",Non-OADS,/arxiv_data1/oa_pdf/66/1b/CN-13-605.PMC4761632.pdf
"Psychiatry, 2003, 64(12), 1465-1475. http://dx.doi.org/10.4088/JCP.v64n1211 [3] Kessler, R.C.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2006, 163(9), 1561-1568. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2006, 163(1), 28-40. http://dx.doi.org/10.1176/appi.ajp.163.1.28 [5] McIntyre, R.S.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2014, 156, 1-7. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2001, 62(2), 135-142; quiz 143. http://dx.doi.org/10.4088/JCP.v62n0212 [7] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2011, 31(4), 512-516. http://dx.doi.org/10.1097/JCP.0b013e3182228619 [9] Souery, D.; Serretti, A.; Calati, R.; Oswald, P.; Massat, I.; Konstantinidis, A.; Linotte, S.; Kasper, S.; Montgomery, S.; Zohar, J.; Mendlewicz, J. Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2011, 12(5), 364-375. http://dx.doi.org/10.3109/15622975.2011.590225 [10] Poirier, M.F.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 1999, 175, 12-16. http://dx.doi.org/10.1192/bjp.175.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"P s y c h o p h a r m a c o l ., 2008, 23(3), 113-119. http://dx.doi.org/10.1097/YIC.0b013e3282f424c2 [12] Baldomero, E.B.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Anxiety, 2005, 22(2), 68-76. http://dx.doi.org/10.1002/ da.20080 [13] Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Med., 2006, 354(12), 1231-1242. http://dx.doi.org/10.1056/NEJMoa052963 [14] Bauer, M.; Tharmanathan, P.; Volz, H.P.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neurosci., 2009, 259(3), 172-185. http://dx.doi.org/10.1007/s00406-008-0849-0 [15] Thase, M.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2001, 178, 234-241. http://dx.doi.org/ 10.1192/bjp.178.3.234 [16] Nemeroff, C.B.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neurosci., 2009, 259(6), 329-339. http://dx.doi.org/10.1007/s00406-009-0003-7 [18] de Silva, V.A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2012, 27(1), 8-16. http://dx.doi.org/10.1097/YIC.0b013e32834ce13f [19] Fava, M.; Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2006, 163(7), 1161-1172. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2003, 64(1), 35-39. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Gen. Psychiatry, 2002, 59(3), 233-239. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Scand., 1988, 78(6), 676-683. http://dx.doi.org/10.1111/j.1600-0447.1988.tb06403.x [25] Fang, Y.; Yuan, C.; Xu, Y.; Chen, J.; Wu, Z.; Cao, L.; Yi, Z.; Hong, W.; Wang, Y.; Jiang, K.; Cui, X.; Calabrese, J.R.; Gao, K.; Team, O.S.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2011, 31(5), 638-642. http://dx.doi.org/10.1097/jcp.0b013e31822bb1d9 [26] Seguí, J.; López-Muñoz, F.; Alamo, C.; Camarasa, X.; García-García, P.; Pardo, A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2010, 24(8), 1201-1207. http://dx.doi.org/ 10.1177/0269881109102641 [27] Carpenter, L.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2002, 51(2), 183-188. http://dx.doi.org/10.1016/ S0006-3223(01)01262-8 [28] Blier, P.; Gobbi, G.; Turcotte, J.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuropsychopharmacol., 2009, 19(7), 457-465. http://dx.doi.org/10.1016/j.euroneuro.2009.01.015 [29] Blier, P.; Ward, H.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2010, 167(3), 281-288. http://dx.doi.org/10.1176/appi.ajp.2009.09020186 [30] Rocha, F.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2012, 32(2), 278-281. http://dx.doi.org/10.1097/JCP.0b013e318248581b [31] Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2011, 168(7), 689-701. http://dx.doi.org/10.1176/appi.ajp.2011.10111645 [32] Nelson, J.C.; Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2009, 166(9), 980-991. http://dx.doi.org/10.1176/appi.ajp.2009.09030312 [33] Spielmans, G.I.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"http://dx.doi.org/10.1371/journal.pmed.1001403 [34] Shelton, R.C.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2001, 158(1), 131-134. http://dx.doi.org/10.1176/appi.ajp.158.1.131 [35] Thase, M.E.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2007, 68(2), 224-236. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2005, 66(10), 1289-1297. http://dx.doi.org/10.4088/ JCP.v66n1012 [37] Corya, S.A.; Williamson, D.; Sanger, T.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Anxiety, 2006, 23(6), 364-372. http://dx.doi.org/10.1002/da.20130 [38] Farooq, S.; Singh, S.P.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2009, 70(3), 387-396. http://dx.doi.org/10.4088/JCP.08m04064 [40] Brunner, E.; Tohen, M.; Osuntokun, O.; Landry, J.; Thase, M.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2009, 70(4), 540-549. http://dx.doi.org/10.4088/ JCP.08m04629 [42] Bauer, M.; Demyttenaere, K.; El-Khalili, N.; Thase, M.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2014, 29(1), 16-25. http://dx.doi.org/10.1097/YIC.0000000000000011 [43] Bauer, M.; Dell'osso, L.; Kasper, S.; Pitchot, W.; Dencker Vansvik, E.; Köhler, J.; Jørgensen, L.; Montgomery, S.A. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2013, 151(1), 209-219. http://dx.doi.org/10.1016/j.jad.2013.05.079 [44] Thase, M.E.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2013, 28(3), 113-120. http://dx.doi.org/10.1097/YIC.0b013e32835fb971 [45] Rapaport, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuropsychopharmacology, 2006, 31(11), 2505-2513. http://dx.doi.org/10.1038/sj.npp.1301113 [46] Mahmoud, R.A.; Pandina, G.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Med., 2007, 147(9), 593-602. http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00003 [47] Keitner, G.I.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Res., 2009, 43(3), 205-214. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2008, 69(8), 1228-1336. http://dx.doi.org/10.4088/ JCP.v69n0805 [49] Berman, R.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2007, 68(6), 843-853. http://dx.doi.org/ 10.4088/JCP.v68n0604 [51] Marcus, R.N.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2008, 28(2), 156-165. http://dx.doi.org/10.1097/JCP.0b013 e31816774f9 [52] Stewart, T.D.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2014, 162, 20-25. http://dx.doi.org/10.1016/j.jad.2014.03.017 [53] Nelson, J.C.; Thase, M.E.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2012, 27(3), 125-133. http://dx.doi.org/10.1097/YIC.0b013e3283502791 [54] Fava, M.; Mischoulon, D.; Iosifescu, D.; Witte, J.; Pencina, M.; Flynn, M.; Harper, L.; Levy, M.; Rickels, K.; Pollack, M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychosom., 2012, 81(2), 87-97. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2007, 68(7), 1071-1077. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2012, 73(12), 1541-1547. http://dx.doi.org/10.4088/JCP.12m07670 [57] Szegedi, A.; Zhao, J.; van Willigenburg, A.; Nations, K.R.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"BMC Psychiatry, 2011, 11, 101. http://dx.doi.org/ 10.1186/1471-244X-11-101 [58] Marston, H.M.; Martin, F.D.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2011, 25(10), 1388-1398. http://dx.doi.org/10.1177/0269881110376684 [59] Kato, M.; Chang, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"2, 92-109. http://dx.doi.org/10.1111/j.1399-5618.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Targets, 2014, 1-17. http://dx.doi.org/10.1517/14728222.2014.940893 [62] Bauer, M.; Dopfmer, S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 1999, 19(5), 427-434. http://dx.doi.org/ 10.1097/00004714-199910000-00006 [63] Nelson, J.C.; Baumann, P.; Delucchi, K.; Joffe, R.; Katona, C. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2014, 168C, 269-275. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2000, 20(5), 538-543. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Clin., 2014, 41(1), 9-14. http://dx.doi.org/10.1590/0101-60830000411914 [68] Bauer, M.; Bschor, T.; Kunz, D.; Berghöfer, A.; Ströhle, A.; Müller-Oerlinghausen, B. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2000, 157(9), 1429-1435. http://dx.doi.org/10.1176/ appi.ajp.157.9.1429 [69] Wilkinson, D.; Holmes, C.; Woolford, J.; Stammers, S.; North, J. Prophylactic therapy with lithium in elderly patients with unipolar major depression.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2002, 17(7), 619-622. http://dx.doi.org/10.1002/gps.671 [70] Cipriani, A.; Hawton, K.; Stockton, S.; Geddes, J.R. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"http://dx.doi.org/ 10.1136/bmj.f3646 [71] Aronson, R.; Offman, H.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Gen. Psychiatry, 1996, 53(9), 842-848. http://dx.doi.org/10.1001/archpsyc.1996.01830090090013 [72] Altshuler, L.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2001, 158(10), 1617-1622. http://dx.doi.org/10.1176/appi.ajp.158.10.1617 [73] Cooper-Kazaz, R.; Lerer, B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder  treated with specific serotonin reuptake inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Neuro- psychopharmacol., 2008, 11(5), 685-699. http://dx.doi.org/10.1017/ S1461145707008206 [74] Garlow, S.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Res., 2012, 46(11), 1406-1413. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuro- psychopharmacology, 1998, 18(6), 444-455. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Nervenarzt, 2004, 75(3), 242-248. http://dx.doi.org/ 10.1007/s00115-003-1550-1 [77] Łojko, D.; Rybakowski, J.K. L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Metab., 2004, 89(12), 6271-6276. http://dx.doi.org/10.1210/jc.2004-1147 [79] Patkar, A.A.; Masand, P.S.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2006, 26(6), 653-656. http://dx.doi.org/10.1097/01.jcp.0000246212.03530.fd [80] Ravindran, A.V.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2008, 69(1), 87-94. http://dx.doi.org/10.4088/JCP.v69n0112 [81] Goss, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2013, 74(11), 1101-1107. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2007, 19(3), 153-159. http://dx.doi.org/10.1080/10401230701464858 [83] Trivedi, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2013, 74(8), 802-809. http://dx.doi.org/10.4088/ JCP.13m08360 [84] Abbasowa, L.; Kessing, L.V.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2013, 67(6), 369-382. http://dx.doi.org/10.3109/08039488.2012.752035 [85] Corrigan, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Anxiety, 2000, 11(2), 58-65. http://dx.doi.org/10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H [86] Lattanzi, L.; Dell'Osso, L.; Cassano, P.; Pini, S.; Rucci, P.; Houck, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2013, 149(1-3), 319-325. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychopharmacol., 2003, 18(2), 93-96. http://dx.doi.org/10.1097/00004850-200303000-00005 [90] Appelberg, B.G.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2001, 62(6), 448-452. http://dx.doi.org/10.4088/JCP.v62n0608 [91] Landén, M.; Björling, G.; Agren, H.; Fahlén, T. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 1998, 59(12), 664-668. http://dx.doi.org/10.4088/ JCP.v59n1204 [92] Serafini, G.; Pompili, M.; Innamorati, M.; Dwivedi, Y.; Brahmachari, G.; Girardi, P. Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Des., 2013, 19(10), 1898-1922. http://dx.doi.org/10.2174/13816128113199990293 [93] Niciu, M.J.; Ionescu, D.F.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Transm., 2014, 121(8), 907-924. http://dx.doi.org/10.1007/s00702-013-1130-x [94] Maeng, S.; Zarate, C.A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2010, 71(12), 1605-1611. http://dx.doi.org/10.4088/JCP.09m05327blu [96] Sanacora, G.; Kendell, S.F.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2007, 61(6), 822-825. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2004, 161(1), 171-174. http://dx.doi.org/ 10.1176/appi.ajp.161.1.171 [98] Shin, I.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"http://dx.doi.org/10.1371/journal.pone.0088617 [99] Ballard, E.D.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Res., 2014, 58, 161-166. http://dx.doi.org/ 10.1016/j.jpsychires.2014.07.027 [100] Zarate, C.A.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Gen. Psychiatry, 2006, 63(8), 856-864. http://dx.doi.org/10.1001/archpsyc.63.8.856 [101] Murrough, J.W.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2013, 74(4), 250-256. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Pract., 2014, 27, 582-6.  http://dx.doi.org/10.1177/ 0897190014525754 [104] Drevets, W.C.; Furey, M.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2012, 73(11), 1428-1433. http://dx.doi.org/10.4088/ JCP.12m07706",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2014, 162, 39-42. http://dx.doi.org/10.1016/j.jad.2014.03.010 [107] Heresco-Levy, U.; Gelfin, G.; Bloch, B.; Levin, R.; Edelman, S.; Javitt, D.C.; Kremer, I.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Neuro- psychopharmacol., 2013, 16(3), 501-506. http://dx.doi.org/10.1017/ S1461145712000910 [108] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Genet., 2014, 165(1), 68-76. http://dx.doi.org/ 10.1002/ajmg.b.32209 [110] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2010, 167(8), 942-948. http://dx.doi.org/10.1176/ appi.ajp.2009.09081198 [111] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2012, 169(12), 1267-1274. http://dx.doi.org/10.1176/ appi.ajp.2012.11071114 [112] Miller, K.K.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2009, 65(9), 732-741. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuro- psychopharmacol., 2013, 23(12), 1672-1686. http://dx.doi.org/ 10.1016/j.euroneuro.2013.06.002 [115] Vogelzangs, N.; Beekman, A.T.; van Reedt Dortland, A.K.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuropsycho- pharmacology, 2014, 39(7), 1624-1634. http://dx.doi.org/10.1038/ npp.2014.9 [116] Na, K.S.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2014, 48, 79-85. http://dx.doi.org/10.1016/j.pnpbp.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2011, 72(5), 677-684. http://dx.doi.org/10.4088/JCP.10m06743 [119] Rethorst, C.D.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2013, 18(10), 1119-1124. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuropsychobiology, 2013, 67(2), 61-68. http://dx.doi.org/10.1159/000345160 [122] Krogh, J.; Nordentoft, M.; Sterne, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2011, 72(4), 529-538. http://dx.doi.org/10.4088/JCP.08r04913blu [123] Group, U.E.R.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Lancet, 2003, 361(9360), 799-808. http://dx.doi.org/10.1016/ S0140-6736(03)12705-5 [124] Ren, J.; Li, H.; Palaniyappan, L.; Liu, H.; Wang, J.; Li, C.; Rossini, P.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2014, 51, 181-189. http://dx.doi.org/10.1016/j.pnpbp.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neurological research, 2013, 35(10), 1084-1091. http://dx.doi.org/10.1179/ 1743132813Y.0000000245 [126] Moreines, J.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Brain Stimul, 2011, 4(1), 17-27. http://dx.doi.org/10.1016/j.brs.2010.01.005 [127] Association, A.P.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Anxiety, 2013, 30(2), 129-136. http://dx.doi.org/ 10.1002/da.22005 [129] Fregni, F.; Pascual-Leone, A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neurol., 2007, 3(7), 383-393. http://dx.doi.org/10.1038/ncpneuro0530 [130] Pascual-Leone, A.; Rubio, B.; Pallardo, F.; Catala, M.D.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Lancet, 1996, 348(9022), 233-237. http://dx.doi.org/10.1016/S0140-6736(96)01219-6 [131] Fitzgerald, P.B.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2006, 163(1), 88-94. http://dx.doi.org/10.1176/appi.ajp.163.1.88 [132] O'Reardon, J.P.; Solvason, H.B.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Gen. Psychiatry, 2010, 67(5), 507-516. http://dx.doi.org/ 10.1001/archgenpsychiatry.2010.46 [134] Lisanby, S.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"psychiatry, 2014, 75(5), 477-489. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Anxiety, 2007, 24(8), 537-544. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuropsychopharmacology, 2013, 38(4), 543-551. http://dx.doi.org/10.1038/npp.2012.237 [139] Rossi, S.; Hallett, M.; Rossini, P.M.; Pascual-Leone, A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neurophysiol., 2009, 120(12), 2008-2039. http://dx.doi.org/ 10.1016/j.clinph.2009.08.016 [140] Xia, G.; Gajwani, P.; Muzina, D.J.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"http://dx.doi.org/10.4088/JCP.11m07413 [142] Richieri, R.; Guedj, E.; Michel, P.; Loundou, A.; Auquier, P.; Lancon, C.; Boyer, L. Maintenance transcranial magnetic stimulation reduces depression relapse: A propensity-adjusted analysis.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2013, 151(1), 129-135. http://dx.doi.org/10.1016/ j.jad.2013.05.062 [143] Berlim, M.T.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2014, 15(7), 570-578. http://dx.doi.org/10.3109/15622975.2014.925141 [144] Müller, H.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"http://dx.doi.org/10.1097/YCT.0b013e318290f7ed [145] Aaronson, S.T.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Brain Stimul., 2013, 6(4), 631-640. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2000, 47(4), 276-286. http://dx.doi.org/10.1016/S0006-3223(99)00304-2 [147] Schlaepfer, T.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Med., 2008, 38(5), 651-661. http://dx.doi.org/10.1017/S0033291707001924 [148] Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2005, 58(5), 347-354. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Arquivos de Neuropsiquiatria, 2010, 68(3), 433-451. http://dx.doi.org/10.1590/S0004-282X2010000300021 [150] Cook, I.A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neuropsychiatr., 2014, 26, 382-4. http://dx.doi.org/10.1017/neu.2014.22 [153] Shiozawa, P.; Fregni, F.; Bensenor, I.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Disord., 2014, 28(4), 577-593. http://dx.doi.org/10.1521/ pedi_2013_27_070 [155] Newton-Howes, G.; Tyrer, P.; Johnson, T. Personality disorder and the outcome of depression: meta-analysis of published studies.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2006, 188, 13-20. http://dx.doi.org/10.1192/bjp.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2007, 68(7), 1062-1070. http://dx.doi.org/ 10.4088/JCP.v68n0713 [157] Rane, L.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Res., 2010, 44(15), 1082-1087. http://dx.doi.org/ 10.1016/j.jpsychires.2010.03.020 [158] Pompili, M.; Venturini, P.; Palermo, M.; Stefani, H.; Seretti, M.E.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Neurosci., 2014, 264(7), 567-575. http://dx.doi.org/10.1007/s00406-014-0495-7 [161] McGirr, A.; Van den Eynde, F.; Chachamovich, E.; Fleck, M.P.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Lett., 2014, 563, 144-148. http://dx.doi.org/ 10.1016/j.neulet.2014.01.037 [162] Keitner, G.I.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"North Am., 2012, 35(1), 249-265. http://dx.doi.org/10.1016/j.psc.2011.11.004 [163] Thase, M.E.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2007, 164(5), 739-752. http://dx.doi.org/10.1176/ ajp.2007.164.5.739 [164] Wiles, N.; Thomas, L.; Abel, A.; Ridgway, N.; Turner, N.; Campbell, J.; Garland, A.; Hollinghurst, S.; Jerrom, B.; Kessler, D.; Kuyken, W.; Morrison, J.; Turner, K.; Williams, C.; Peters, T.; Lewis, G. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Lancet, 2013, 381(9864), 375-384. http://dx.doi.org/10.1016/ S0140-6736(12)61552-9 [165] Hofmann, S.G.; Asnaani, A.; Vonk, I.J.",OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Res., 2012, 36(5), 427-440. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2011, 74(1), 58-71. http://dx.doi.org/10.1521/psyc.2011.74.1.58 [167] Leichsenring, F.; Rabung, S. Long-term psychodynamic psycho- therapy in complex mental disorders: update of a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2011, 199(1), 15-22. http://dx.doi.org/10.1192/bjp.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"Psychiatry, 2003, 53(8), 640-648. http://dx.doi.org/10.1016/S0006-3223(02)01670-0 [169] Macneil, C.A.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"BMC Med., 2012, 10, 111. http://dx.doi.org/ 10.1186/1741-7015-10-111   Received: September 30, 2014 Revised: December 15, 2014 Accepted: December 17, 2014",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CN-13-616.PMC4761633.pdf
"J. Psychiatry, 2006, 163(9), 1561-1568. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"(Washington, D.C.) 2009, 60(11), 1439-1445. http://dx.doi.org/10.1176/ps.2009.60.11.1439 [4] McIntyre, R.S.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Disord., 2014, 156, 1-7. http://dx.doi.org/10.1016/j.jad.2013.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychosom., 2014, 83(2), 70-88. http://dx.doi.org/10.1159/000357500 [6] Lopez-Munoz, F.; Alamo, C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Des., 2009, 15(14), 1563-1586. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"http://dx.doi.org/10.3399/ bjgp13X675430 [9] Rosenblat, J.D.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Brain Res., 2012, 235(2), 302-317. http://dx.doi.org/10.1016/j.bbr.2012.07.026 [11] McIntyre, R.S.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Brain Res., 2013, 237, 164-171. http://dx.doi.org/10.1016/j.bbr.2012.09.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Rev., 2009, 61(2), 105-123. http://dx.doi.org/10.1016/j.brainresrev.2009.05.005 [14] Machado-Vieira, R.; Manji, H.K.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Anxiety, 2011, 28(4), 267-281. http://dx.doi.org/10.1002/da.20800 [16] Leonard, B.E.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Ther., 2013, 138(2), 176-184. http://dx.doi.org/10.1016/j.pharmthera.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Lancet, 1998, 352(9141), 1714. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Immun., 2009, 23(2), 217-224. http://dx.doi.org/10.1016/j.bbi.2008.09.007 [22] Walker, J.R.; Graff, L.A.; Dutz, J.P.; Bernstein, C.N.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Suppl., 2011, 88, 31-35. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Immun., 2007, 21(7), 901-912. http://dx.doi.org/10.1016/j.bbi.2007.03.011 [24] McNamara, R.K.; Lotrich, F.E.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neurother., 2012, 12(9), 1143-1161. http://dx.doi.org/10.1586/ern.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Gen. Psychiatry, 2001, 58(5), 445-452. http://dx.doi.org/10.1001/archpsyc.58.5.445 [26] Wright, C.E.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Immun., 2005, 19(4), 345-350. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Immun., 2005, 19(1), 23-27. http://dx.doi.org/10.1016/ j.bbi.2004.05.001 [28] Dunn, A.J.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Rev., 2005, 29(4-5), 891-909. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Disord., 2013, 148(1), 136-140. http://dx.doi.org/10.1016/j.jad.2012.10.036 [30] Capuron, L.; Neurauter, G.; Musselman, D.L.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2003, 54(9), 906-914. http://dx.doi.org/10.1016/S0006-3223(03)00173-2 [31] Capuron, L.; Ravaud, A.; Neveu, P.J.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2002, 7(5), 468-473. http://dx.doi.org/10.1038/sj.mp.4000995 [32] Harry, G.J.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neurotoxicology, 2012, 33(2), 191-206. http://dx.doi.org/10.1016/j.neuro.2012.01.012 [33] Ekdahl, C.T.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Pharmacol., 2012, 3, 41. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Drug Targets, 2006, 7(2), 203-210. http://dx.doi.org/10.2174/138945006775515482 [35] Miller, A.H.; Haroon, E.; Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Anxiety, 2013, 30(4), 297-306. http://dx.doi.org/10.1002/ da.22084 [36] Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Immun., 2013, 31, 1-8. http://dx.doi.org/10.1016/j.bbi.2013.04.009",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2013, 26(1), 19-26. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neurosci., 2013, 263(5), 367-377. http://dx.doi.org/10.1007/s00406-013-0399-y [39] Sigalas, P.D.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 2012, 2(4), 139-149. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Med., 2010, 40(1), 1-4. http://dx.doi.org/10.1017/S0033291709005558 [41] Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Dis., 2014, 73(3), 529-535. http://dx.doi.org/10.1136/annrheumdis-2013-204575 [43] Vane, J.R.; Botting, R.M.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Res., 2003, 110(5-6), 255-258. http://dx.doi.org/10.1016/ S0049-3848(03)00379-7 [44] Berk, M.; Dean, O.; Drexhage, H.; McNeil, J.J.; Moylan, S.; O'Neil, A.; Davey, C.G.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"BMC Med., 2013, 11, 74. http://dx.doi.org/10.1186/1741-7015-11-74 [45] Goldstein, B.I.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2009, 70(8), 1078-1090. http://dx.doi.org/10.4088/JCP.08r04505 [46] Muller, N. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Disord., 2012, 141(2-3), 308-314. http://dx.doi.org/ 10.1016/j.jad.2012.03.033 [48] Faridhosseini, F.; Sadeghi, R.; Farid, L.; Pourgholami, M. Celecoxib: a new augmentation strategy for depressive mood episodes.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 2014, 29(3), 216-223. http://dx.doi.org/10.1002/hup.2401 [49] Na, K.S.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Cornerstone, 2001, 3(5), 50-60. http://dx.doi.org/10.1016/S1098-3597(01)90069-9 [51] Simopoulos, A.P.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Fatty Acids, 2008, 79(3-5), 101-108. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 2012, 32(1), 61-4. http://dx.doi.org/10.1097/JCP.0b013e31823f3b5f [54] Jazayeri, S.; Tehrani-Doost, M.; Keshavarz, S.A.; Hosseini, M.; Djazayery, A.; Amini, H.; Jalali, M.; Peet, M. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"N Z. J. Psychiatry, 2008, 42(3), 192-198. http://dx.doi.org/10.1080/00048670701827275 [55] Peet, M.; Horrobin, D.F.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Gen. Psychiatry, 2002, 59(10), 913-919. http://dx.doi.org/10.1001/ archpsyc.59.10.913 [56] Lopresti, A.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuropharmacol., 2013, 36(3), 73-77. http://dx.doi.org/10.1097/WNF.0b013e31828ef969 [58] Sanmukhani, J.; Satodia, V.; Trivedi, J.; Patel, T.; Tiwari, D.; Panchal, B.; Goel, A.; Tripathi, C.B.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Res.,2014, 28(4), 579-585. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Disord., 2014, 167, 368-375. http://dx.doi.org/10.1016/j.jad.2014.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 1996, 153(4), 582. http://dx.doi.org/10.1176/ajp.153.4.582b [61] Savitz, J.; Preskorn, S.; Teague, T.K.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Res., 2013, 47(10), 1521-1529. http://dx.doi.org/10.1016/j.jpsychires.2013.06.008 [63] Rawdin, B.J.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Immune., 2013, 31, 143-152. http://dx.doi.org/10.1016/ j.bbi.2012.11.011 [64] Gill, R.; Tsung, A.; Billiar, T. Linking oxidative stress to inflammation: Toll-like receptors.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Med., 2010, 48(9), 1121-1132. http://dx.doi.org/10.1016/j.freeradbiomed.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"CNS Drugs, 2014, 28(1), 1-10. http://dx.doi.org/10.1007/s40263-013-0119-1 [66] Pompella, A.; Visvikis, A.; Paolicchi, A.; De Tata, V.; Casini, A. F. The changing faces of glutathione, a cellular protagonist.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Pharmacol., 2003, 66 ( 8 ), 1499-1503. http://dx.doi.org/10.1016/ S0006-2952(03)00504-5 [67] Aboul-Fotouh, S. Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Behav., 2013, 104, 105-112. http://dx.doi.org/10.1016/j.pbb.2012.12.027 [68] Morris, G.; Anderson, G.; Berk, M.; Maes, M. Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neurobiol., 2013, 48 (3), 883-903. http://dx.doi.org/10.1007/s12035-013-8477-8 [69] Acuna-Castroviejo, D.; Martin, M.; Macias, M.; Escames, G.; Leon, J.; Khaldy, H.; Reiter, R.J. Melatonin, mitochondria, and cellular bioenergetics.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Pineal Res., 2001, 30(2), 65-74. http://dx.doi.org/10.1034/j.1600-079X.2001.300201.x",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Trans., 2003, 31(Pt 6), 1095-1105. http://dx.doi.org/ 10.1042/bst0311095 [71] Belanger, M.; Allaman, I.; Magistretti, P.J.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Cell Metab., 2011, 14(6), 724-738. http://dx.doi.org/10.1016/j.cmet.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2013, 18(5), 595-606. http://dx.doi.org/10.1038/mp.2012.33 [74] Zhou, L.; Zhu, D.Y.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Biochemistry, 2000, 39(5), 1040-1047. http://dx.doi.org/10.1021/bi992046e [76] Palta, P.; Samuel, L.J.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Med., 2014, 76(1), 12-19. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Sci., 2013, 34(3), 167-177. http://dx.doi.org/10.1016/j.tips.2013.01.001 [78] Das, P.; Tanious, M.; Fritz, K.; Dodd, S.; Dean, O.M.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 2013, 47(4), 347-354. http://dx.doi.org/10.1177/0004867412474074 [79] Berk, M.; Dean, O.M.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2014, 75(6), 628-636. http://dx.doi.org/10.4088/ JCP.13m08454 [80] Miller, G.E.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Bull., 2007, 133(1), 25-45. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Med., 1998, 28(3), 573-584. http://dx.doi.org/10.1017/S0033291798006680 [82] Murphy, B.E., Steroids and depression.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Boil., 1991, 38(5), 537-559. http://dx.doi.org/10.1016/0960-0760(91)90312-S [83] Sanacora, G.; Treccani, G.; Popoli, M., Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuropharmacology, 2012, 62(1), 63-77. http://dx.doi.org/10.1016/j.neuropharm.2011.07.036 [84] Jahn, H.; Schick, M.; Kiefer, F.; Kellner, M.; Yassouridis, A.; Wiedemann, K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Gen. Psychiatry, 2004, 61(12), 1235-1244. http://dx.doi.org/10.1001/ archpsyc.61.12.1235 [85] Cardoso, C.; Kingdon, D.; Ellenbogen, M.A.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychoneuroendocrinology, 2014, 49C, 161-170. http://dx.doi.org/10.1016/j.psyneuen.2014.07.014 [86] Keating, C.; Dawood, T.; Barton, D.A.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"BMC Psychiatry, 2013, 13, 124. http://dx.doi.org/10.1186/1471-244X-13-124 [87] Miller, A.H.; Maletic, V.; Raison, C.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2009, 65 ( 9 ) ,  7 32-741. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Diabetes Care, 2013, 36(2), 480-489. http://dx.doi.org/10.2337/dc12-1442 [91] McNay, E.C.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Memory, 2011, 96(3), 432-442. http://dx.doi.org/10.1016/j.nlm.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Diabetes Care, 2004, 27(4), 914-920. http://dx.doi.org/10.2337/diacare.27.4.914 [94] Mansur, R.B.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Med., 2014, 16, 6 5 8-68. http://dx.doi.org/10.1007/ s12017-014-8316-8 [95] Rotte, M.; Baerecke, C.; Pottag, G.; Klose, S.; Kanneberg, E.; Heinze, H.J.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuroendocrinology, 2005, 81(1), 49-55. http://dx.doi.org/10.1159/000084874 [96] Strachan, M.W.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Trans., 2005, 33(Pt 5), 1037-1040. http://dx.doi.org/10.1042/ BST0331037 [97] Benedict, C.; Hallschmid, M.; Schultes, B.; Born, J.; Kern, W. Intranasal insulin to improve memory function in humans.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuroendocrinology, 2007, 86(2), 136-142. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuroendocrinology, 2006, 83(1), 20-26. http://dx.doi.org/10.1159/000093338 [99] Shemesh, E.; Rudich, A.; Harman-Boehm, I.; Cukierman-Yaffe, T. Effect of intranasal insulin on cognitive function: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Metabol., 2012, 97(2), 366-376. http://dx.doi.org/10.1210/jc.2011-1802 [100] McIntyre, R.S.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Pharmacother., 2007, 8(11), 1615-1628. http://dx.doi.org/10.1517/ 14656566.8.11.1615 [101] Salehi-Sadaghiani, M.; Javadi-Paydar, M.; Gharedaghi, M.H.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacology (Berl), 2012, 223(3), 345-355. http://dx.doi.org/10.1007/s00213-012-2722-0 [102] Gold, P.W.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2013, 18(2), 154-165. http://dx.doi.org/10.1038/mp.2012.167 [103] Medzhitov, R. Origin and physiological roles of inflammation.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Nature, 2008, 454(7203), 428-435. http://dx.doi.org/10.1038/ nature07201 [104] Hotamisligil, G.S.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Cell, 2010, 140(6), 900-917. http://dx.doi.org/10.1016/j.cell.2010.02.034",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Dis., 2012, 136(3), 1164-1173. http://dx.doi.org/10.1016/j.jad.2011.06.033 [106] Sepanjnia, K.; Modabbernia, A.; Ashrafi, M.; Modabbernia, M.J.; Akhondzadeh, S. Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuropsychopharmacology, 2012, 37(9), 2093-2100. http://dx.doi.org/10.1038/npp.2012.58 [107] Kashani, L.; Omidvar, T.; Farazmand, B.; Modabbernia, A.; Ramzanzadeh, F.; Tehraninejad, E.S.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychoneuroendocrinology, 2013, 38(6), 767-776. http://dx.doi.org/10.1016/j.psyneuen.2012.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 2009, 166(5), 619. http://dx.doi.org/ 10.1176/appi.ajp.2008.08081195 [109] de Sousa, R.T.; Machado-Vieira, R.; Zarate, C.A., Jr.; Manji, H.K.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Targets,  2014, 18(10), 1131-1147. http://dx.doi.org/10.1517/14728222.2014.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Rev., 2012, 36(5), 1442-1462. http://dx.doi.org/10.1016/ j.neubiorev.2012.03.005 [111] Iosifescu, D.V.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2008, 63(12), 1127-1134. http://dx.doi.org/10.1016/ j.biopsych.2007.11.020 [112] Nierenberg, A.A.; Kansky, C.; Brennan, B.P.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Bipolar Dis., 2007, 9(7), 754-758. http://dx.doi.org/10.1111/j.1399-5618.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Disord., 2011, 135(1-3), 354-361. http://dx.doi.org/10.1016/j.jad.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry Rep., 2003, 5(6), 460-466. http://dx.doi.org/10.1007/ s11920-003-0085-2 [116] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 2004, 24(6), 661-664. http://dx.doi.org/10.1097/01.jcp.0000145339.45794.cd [119] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 2010, 167(8), 942-948. http://dx.doi.org/10.1176/appi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 2012, 169(12), 1267-1274. http://dx.doi.org/10.1176/ appi.ajp.2012.11071114 [121] Farah, A.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Drugs Today, 2013, 49(12), 791-798. http://dx.doi.org/10.1358/dot.2013.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2009, 70Suppl 5, 12-17. http://dx.doi.org/10.4088/JCP.8157su1c.03 [125] Reichardt, L.F. Neurotrophin-regulated signalling pathways.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Sci., 2006, 361(1473), 1545-1564. http://dx.doi.org/10.1098/rstb.2006.1894 [126] Duman, R.S.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Science, 2012, 338(6103), 68-72. http://dx.doi.org/10.1126/science.1222939 [127] Ota, K.T.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Dis., 2013, 57, 28-37. http://dx.doi.org/10.1016/j.nbd.2012.05.022 [128] Duman, R S.; Li, N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Boil., 2013, 982, 13-41. http://dx.doi.org/10.1007/978-1-62703-308-4_2 [130] Miskowiak, K.W.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psycho- pharmacology ( B e r l ) ,  2012, 219(3), 687-698. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuro- psychopharmacoloy, 2014, 39(6), 1399-1408. http://dx.doi.org/ 10.1038/npp.2013.335 [132] Abelaira, H.M.; Reus, G.Z.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Life Sci., 2014, 101(1-2), 10-14. http://dx.doi.org/10.1016/j.lfs.2014.02.014 [133] Niciu, M.J.; Henter, I.D.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Toxicol., 2014,  54, 119-139. http://dx.doi.org/10.1146/annurev-pharmtox-011613-135950 [134] Browne, C.A.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Pharmacol., 2013, 4, 161. http://dx.doi.org/10.3389/fphar.2013.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Gen. Psychiatry, 2006, 63(8), 856-864. http://dx.doi.org/10.1001/archpsyc.63.8.856 [137] Murrough, J.W.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 2013, 170(10), 1134-1142. http://dx.doi.org/10.1176/appi.ajp.2013.13030392 [138] Torjesen, I. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2013, 74(4), 250-256. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"(Oxford England), 2014, 28(6), 536-544. http://dx.doi.org/10.1177/ 0269881114527361 [141] Price, R.B.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Anxiety, 2014, 31(4), 335-343. http://dx.doi.org/10.1002/da.22253 [142] Ballard, E.D.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Res., 2014, 58, 161-166. http://dx.doi.org/ 10.1016/j.jpsychires.2014.07.027 [143] Lapidus, K.A.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"J. Psychiatry, 2004, 161(1), 171-174. http://dx.doi.org/ 10.1176/appi.ajp.161.1.171 [146] Sanacora, G.; Kendell, S.F.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2007, 61(6), 822-825. http://dx.doi.org/10.1016/ j.biopsych.2006.08.037 [147] Preskorn, S.H.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 2008, 28(6), 631-637. http://dx.doi.org/10.1097/JCP.0b013e31818 a6cea [148] Moghaddam, B.; Adams, B.; Verma, A.; Daly, D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Drugs R. D., 2012, 12(3), 127-139. http://dx.doi.org/10.2165/11634360-000000000-00000 [150] Tokita, K.; Yamaji, T.; Hashimoto, K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Behav., 2012, 100 ( 4 ) ,  6 8 8-704. http://dx.doi.org/ 10.1016/j.pbb.2011.04.016 [151] Bauer, M.; Adli, M.; Bschor, T.; Pilhatsch, M.; Pfennig, A.; Sasse, J.; Schmid, R.; Lewitzka, U. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neurosci., 2004, 24(29), 6578-6589. http://dx.doi.org/10.1523/JNEUROSCI.1258-04.2004 [153] Nonaka, S.; Chuang, D.M.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuroreport, 1998, 9(9), 2081-4. http://dx.doi.org/10.1097/00001756-199806220-00031 [154] Hashimoto, R.; Hough, C.; Nakazawa, T.; Yamamoto, T.; Chuang, D. M. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neurochem., 2002, 80(4), 589-597. http://dx.doi.org/10.1046/ j.0022-3042.2001.00728.x [155] Berrocoso, E.; Sanchez-Blazquez, P.; Garzon, J.; Mico, J.A.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Des., 2009, 15(14), 1612-1622. http://dx.doi.org/10.2174/138161209788168100 [156] Tenore, P. L. Psychotherapeutic benefits of opioid agonist therapy.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Dis., 2008, 27(3), 49-65. http://dx.doi.org/10.1080/ 10550880802122646 [157] Lutz, P. E.; Kieffer, B. L. Opioid receptors: distinct roles in mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Trends Neurosci., 2013, 36(3), 195-206. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuropsychopharmacology, 2004, 29(4), 649-659. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Pharmacol., 2007, 570(1-3), 89-96. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Drug Alcohol Depend., 2004, 75(1), 37-45. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 1995, 15(1), 49-57. http://dx.doi.org/10.1097/00004714-199502000-00008 [162] Janowsky, D.S.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Lancet 1972, 2(7778), 632-635. http://dx.doi.org/10.1016/S0140-6736(72) 93021-8 [163] Dilsaver, S.C. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 1986, 6(2), 65-74. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Pharmacopsychiatria, 1981, 14(6), 195-198. http://dx.doi.org/10.1055/s-2007-1019597 [165] Drevets, W.C.; Zarate, C.A., Jr.; Furey, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2013, 73(12), 1156-1163. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Brain Res., 1998, 788(1-2), 323-326. http://dx.doi.org/10.1016/ S0006-8993(98)00041-9 [167] Furey, M.L.",OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Gen. Psychiatry, 2006, 63(10), 1121-1129. http://dx.doi.org/10.1001/archpsyc.63.10.1121 [168] Drevets, W.C.; Furey, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2012, 73(11), 1428-1433. http://dx.doi.org/10.4088/ JCP.12m07706",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychopharmacol., 2008, 28(3), 340-344. http://dx.doi.org/10.1097/JCP.0b013e318172b49e [172] Philip, N.S.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2009, 70(7), 1026-1031. http://dx.doi.org/10.4088/JCP.08m04441 [173] Zarate, C.A., Jr.; Mathews, D.; Ibrahim, L.; Chaves, J.F.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Psychiatry, 2013, 74(4), 257-264. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/CN-13-636.PMC4761634.pdf
"Neuropsychopharmacol., 2014, 17(7), 1039-1052. http://dx.doi.org/10.1017/S1461145713000096 [3] Bowden, C.L.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Gen. Psychiatry, 2000, 57(5), 481-489. http://dx.doi.org/10.1001/archpsyc.57.5.481 [4] Wadee, A.A.; Kuschke, R.H.; Wood, L.A.; Berk, M.; Ichim, L.; Maes, M. Serological observations in patients suffering from acute manic episodes.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychopharmacol., 2002, 17(4), 175-179. http://dx.doi.org/10.1002/hup.390 [5] Moylan, S.; Berk, M.; Dean, O.M.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Res., 2011, 17(4), 211-216. http://dx.doi.org/10.1159/ 000327682 [7] Loebel, A.; Cucchiaro, J.; Silva, R.; Kroger, H.; Hsu, J.; Sarma, K.; Sachs, G. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"J. Psychiatry, 2014, 171(2), 160-168. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"J. Psychiatry, 2014, 171(2), 169-177. http://dx.doi.org/10.1176/appi.ajp.2013.13070985 [9] Berk, M.; Dodd, S. Efficacy of atypical antipsychotics in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Drugs, 2005, 65(2), 2 5 7-269. http://dx.doi.org/10.2165/ 00003495-200565020-00006 [10] Mallinger, A.G.; Thase, M.E.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Bipolar Disord., 2008, 10(8), 856-866. http://dx.doi.org/10.1111/j.1399-5618.2008.00636.x [11] Kulkarni, J.; Filia, S.; Berk, L.; Filia, K.; Dodd, S.; de Castella, A.; Brnabic, A.J.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"BMC Psychiatry, 2012, 12, 228. http://dx.doi.org/10.1186/1471-244X-12-228 [12] Fountoulakis, K.N.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Disord., 2012, 138(3), 222-238. http://dx.doi.org/10.1016/j.jad.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Suppl., 2007, (434), 41-49. http://dx.doi.org/ 10.1111/j.1600-0447.2007.01058.x [15] Mah, L.; Zarate, C.A., Jr.; Nugent, A.C.; Singh, J.B.; Manji, H.K.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neuropsychopharmacol., 2011, 14(4), 545-551. http://dx.doi.org/10.1017/S1461145710001203 [16] Veselinovic, T.; Paulzen, M.; Grunder, G. Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neurother., 2013, 13(11), 1141-1159. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychiatry, 2014. http://dx.doi.org/10.4088/JCP.13m08951 [18] Calabrese, J.R.; Ketter, T.A.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychiatry, 2010, 71(10), 1363-1370. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"J. Psychiatry, 2007, 164(8), 1242-1249. http://dx.doi.org/10.1176/ appi.ajp.2007.06060981 [20] Woo, T.U.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Gen. Psychiatry, 2004, 61(7), 649-657. http://dx.doi.org/10.1001/ archpsyc.61.7.649 [21] Martucci, L.; Wong, A.H.; De Luca, V.; Likhodi, O.; Wong, G.W.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Res., 2006, 84(2-3), 214-221. http://dx.doi.org/10.1016/j.schres.2006.02.001 [22] Mundo, E.; Tharmalingham, S.; Neves-Pereira, M.; Dalton, E.J.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychiatry, 2003, 8(2), 241-245. http://dx.doi.org/10.1038/sj.mp.4001218 [23] Zarate, C.A., Jr.; Brutsche, N.E.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"http://dx.doi.org/10.4088/JCP.13m08698 [25] Lee, B.H.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0035812 [26] Lucae, S.; Salyakina, D.; Barden, N.; Harvey, M.; Gagne, B.; Labbe, M.; Binder, E.B.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Genet., 2006, 15(16), 2438-2445. http://dx.doi.org/10.1093/hmg/ddl166 [27] Backlund, L.; Nikamo, P.; Hukic, D.S.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Bipolar Disord., 2011, 13(5-6), 500-508. http://dx.doi.org/10.1111/j.1399-5618.2011.00952.x [28] Akhondzadeh, S.; Milajerdi, M.R.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Bipolar Disord., 2006, 8(5 Pt 1), 485-489. http://dx.doi.org/10.1111/j.1399-5618.2006.00363.x [29] Machado-Vieira, R.; Soares, J.C.; Lara, D.R.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"P s y c h i a t r y ,  2008, 69(8), 1237-1245. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Gen. Psychiatry, 1978, 35(1), 119-122. http://dx.doi.org/10.1001/archpsyc.1978.01770250121012 [31] Furey, M.L.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Gen. Psychiatry, 2006, 63(10), 1121-1129. http://dx.doi.org/10.1001/archpsyc.63.10.1121 [32] Yehuda, R.; Brand, S.; Yang, R.K.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neuropsychopharmacol., 2012, 15(8), 1051-1061. http://dx.doi.org/ 10.1017/S1461145711001556 [35] Machado-Vieira, R.; Zarate, C.A., Jr.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Depress  Anxiety, 2011, 28(4), 267-281. http://dx.doi.org/10.1002/da.20800 [36] Gonzalez-Castro, T.B.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Bipolar Disord., 2014, 17, 27-38. http://dx.doi.org/10.1111/bdi.12227 [37] Cullen, S.P.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Cell Death Differ., 2009, 16(7), 935-938. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Chem., 2002, 277(33), 30128-30136. http://dx.doi.org/10.1074/jbc.M202931200 [40] Dean, O.M.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"CNS Drugs, 2012, 26(5), 391-401. http://dx.doi.org/10.2165/11632000-000000000-00000 [41] Dodd, S.; Dean, O.; Copolov, D.L.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Migr., 2009, 3(1), 129-137. http://dx.doi.org/10.4161/cam.3.1.7401 [44] Poo, M.M.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neurosci., 2001, 2(1), 24-32. http://dx.doi.org/10.1038/35049004 [45] Cohen-Cory, S.; Kidane, A.H.; Shirkey, N.J.; Marshak, S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neurobiol., 2010, 70(5), 271-288. http://dx.doi.org/10.1002/dneu.20774 [46] Frey, B.N.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"N. Z. J. Psychiatry, 2013, 47(4), 321-332. http://dx.doi.org/10.1177/0004867413478217 [47] Friedrich, M.J. Research on psychiatric disorders targets inflammation.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"JAMA, 2014, 312(5), 474-476. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Peptides, 2007, 28(7), 1447-1452. http://dx.doi.org/10.1016/j.peptides.2007.06.010 [50] Leonard, B.; Maes, M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Rev., 2012, 36(2), 764-785. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Immunol., 2008, 4(1), 2-11. http://dx.doi.org/10.1186/1710-1492-4-1-2 [52] Asnis, G.M.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychiatry, 2005, 29(5), 808-818. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychiatry Res., 2013, 210,880-6. http://dx.doi.org/ 10.1016/j.psychres.2013.08.007 [54] Lumeng, C.N.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Aspects Med., 2013, 34(1), 12-29. http://dx.doi.org/10.1016/j.mam.2012.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neurother., 2012, 12(9), 1143-1161. http://dx.doi.org/10.1586/ern.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychoses, 2012, 5(4), 208-216. http://dx.doi.org/ 10.3371/CSRP.5.4.5 [57] Schonbeck, U.; Libby, P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Physiol., 2011, 2, 94. http://dx.doi.org/10.3389/fphys.2011.00094 [60] Berk, M.; Copolov, D.L.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Gen. Psychiatry, 2010, 67(4), 360-368. http://dx.doi.org/10.1001/ archgenpsychiatry.2010.22 [62] Fattal, O.; Link, J.; Quinn, K.; Cohen, B.H.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Med., 2013, 45(1), 4-16. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Drug Targets, 2014, 13(5), 817-827. http://dx.doi.org/10.2174/ 1871527313666140711091400 [67] Soreca, I., Circadian rhythms and sleep in bipolar d i s o r d e r :  implications for pathophysiology and treatment.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Psychiatry, 2014, 27(6), 467-471. http://dx.doi.org/10.1097/YCO.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Cell Biol., 2002, 34(4), 348-357. http://dx.doi.org/10.1016/S1357-2725(01)00138-8 [69] Romo-Nava, F.; Alvarez-Icaza, G., D.; Fresan-Orellana, A.; Saracco, A. R.; Becerra-Palars, C.; Moreno, J.; Ontiveros, U., M.P.",OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Bipolar Disord., 2014, 16(4), 410-421. http://dx.doi.org/10.1111/bdi.12196 [70] Tosini, G.; Ye, K.; Iuvone, P.M. N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Neuroscientist, 2012, 18(6), 645-653. http://dx.doi.org/10.1177/1073858412446634 [71] Clarke, G.; O'Mahony, S.M.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Acta Paediatr., 2014, 103(8), 812-819. http://dx.doi.org/10.1111/apa.12674 [72] Bested, A.C.; Logan, A.C.; Selhub, E.M. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - c o n v e r g e n c e  t o w a r d  c l i n i c a l  t r i a l s .",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Pathog., 2014, 5(1), 4. http://dx.doi.org/10.1186/1757-4749-5-4 [73] Bested, A.C.; Logan, A.C.; Selhub, E.M. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research.",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"Pathog., 2013, 5(1), 3. http://dx.doi.org/10.1186/1757-4749-5-3   Received: September 05, 2014 Revised: October 10, 2014 Accepted: October 15, 2014",Non-OADS,/arxiv_data1/oa_pdf/23/b1/CN-13-656.PMC4761635.pdf
"http://dx.doi.org/10.1002/14651858.cd003727.pub3 [3] Iqbal, N.; Lambert, T.; Masand, P. Akathisia: problem of history or concern of today.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Res., 1995, 16, 33-45. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Care, 2011, 9, 209-212. http://dx.doi.org/10.1017/S1478951511000071 [7] Van Putten, T. Why do schizophrenic patients refuse to take their drugs?",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Gen. Psychiatry, 1974, 31, 67-72. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2009, 70, 627-643. http://dx.doi.org/10.4088/JCP.08r04210 [9] Seemüller, F.; Schennach, R.; Mayr, A.; Musil, R.; Jäger, M.; Maier, W.; Klingenberg, S.; Heuser, I.; Klosterkötter, J.; Gastpar, M.; Schmitt, A.; Schlösser, R.; Schneider, F.; Ohmann, C.; Lewitzka, U.; Gaebel, W.; Möller, H.J.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2012, 32, 694-698. http://dx.doi.org/10.1097/JCP.0b013e3182677958 [10] Jadad, A.R.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2002, 63, 763-771. http://dx.doi.org/10.4088/JCP.v63n0903 [13] Pigott, T.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2003, 64, 1048-1056. http://dx.doi.org/10.4088/JCP.v64n0910 [14] Chan, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2007, 68, 29-36. http://dx.doi.org/10.4088/JCP.v68n0104 [15] Potkin, S.G.; Saha, A.R.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Gen. Psychiatry, 2003, 60, 681-690. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Res., 2007, 41, 895-905. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2007, 22, 363-370. http://dx.doi.org/10.1097/YIC.0b013e32816f7779 [18] Fleischhacker, W.W.; McQuade, R.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2009, 65, 510-517. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2009, 70, 572-581. http://dx.doi.org/10.4088/JCP.08m04421 [20] McQuade, R.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2008, 69, 1046-1056. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Pract., 2013, 17, 21-29. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2011, 72, 349-355. http://dx.doi.org/ 10.4088/JCP.10m06306 [24] Kane, J.M.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2010, 30, 106-115. http://dx.doi.org/10.1097/ JCP.0b013e3181d35d6b [25] Buchanan, R.W.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2012, 32, 36-45. http://dx.doi.org/10.1097/JCP.0b013e31823f880a [26] Schoemaker, J.; Naber, D.; Vrijland, P.; Panagides, J.; Emsley, R. Long-term assessment of asenapine vs .",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Pharmacopsychiatry, 2010, 43, 138-146. http://dx.doi.org/10.1055/s-0030-1248313 [27] Potkin, S.G.; Cohen, M.; Panagides, J. Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- a n d  r i s p e r i d o n e-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2007, 68, 1492-1500. http://dx.doi.org/10.4088/JCP.v68n1004 [28] Ogasa, M.; Kimura, T.; Nakamura, M.; Guarino, J. Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"2013, 225, 519-530. http://dx.doi.org/ 10.1007/s00213-012-2838-2 [29] Loebel, A.; Cucchiaro, J.; Sarma, K.; X u ,  L .",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Res., 2013, 145, 101-109. http://dx.doi.org/10.1016/ j.schres.2013.01.009 [30] Meltzer, H.; Cucchiaro, J.; Silva, R.; Ogasa, M.; Phillips, D.; Xu, J.; Kalali, A.; Schweizer, E.; Pikalov, A.; Loebel, A. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"J. Psychiatry, 2011, 168, 957-967. http://dx.doi.org/10.1176/appi.ajp.2011.10060907 [31] Nasrallah, H.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Res., 2013, 47, 670-677. http://dx.doi.org/10.1016/j.jpsychires.2013.01.020 [32] Nakamura, M.; Ogasa, M.; Guarino, J.; Phillips, D.; Severs, J.; Cucchiaro, J.; Loebel, A. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.",OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychiatry, 2009, 70, 829-836. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Res., 2011, 132, 101-107. http://dx.doi.org/ 10.1016/j.schres.2011.04.008",OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2012, 27, 165-176. http://dx.doi.org/10.1097/YIC.0b013e32835281ef [35] Sunovion.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Neuro-psychopharmacol., 2013, 16, 1205-1218. http://dx.doi.org/10.1017/ S1461145712001277 [38] Poyurovsky, M.; Shardorodsky, M.; Fuchs, C.; Schneidman, M.; Weizman, A.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"J. Psychiatry, 1999, 174, 238-242. http://dx.doi.org/ 10.1192/bjp.174.3.238 [39] Abilify (aripiprazole) [package insert].",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2004, 18, 375-383. http://dx.doi.org/10.1177/026988110401800308 [41] Shapiro, D.A.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Neuropsychopharmacology, 2003, 28, 1400-1411. http://dx.doi.org/ 10.1038/sj.npp.1300203 [42] Fleischhacker, W. Aripiprazole.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Expert Opin Pharmacother 2005, 6, 2091-2101. http://dx.doi.org/10.1517/14656566.6.12.2091 [43] Burris, K.D.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Ther., 2002, 302, 381-389. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Ther., 2012, 34, 1023-1040. http://dx.doi.org/10.1016/j.clinthera.2012.03.002 [47] Shahid, M.; Walker, G.B.",OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacol., 2009, 23, 65-73. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psychopharmacology (Berl)., 2008, 198, 103-111. http://dx.doi.org/10.1007/s00213-008-1098-7 [49] Marin, C.; Parashos, S.; Kapitzoglou-Logothetis, V.; Peppe, A.; Chase, T. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Behav., 1993, 45, 195-200. http://dx.doi.org/10.1016/0091-3057(93)90104-2 [50] Zyprexa (olanzapine) [package insert].",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Drugs, 2009, 18, 1715-1726. http://dx.doi.org/10.1517/13543780903286388 [53] Ishibashi, T.; Horisawa, T.; Tokuda, K.; Ishiyama, T.; Ogasa, M.; Tagashira, R.; Matsumoto, K.; Nishikawa, H.; Ueda, Y.; Toma, S.; Oki, H.; Tanno, N.; Saji, I.; Ito, A.; Ohno, Y.; Nakamura, M. Pharmacological profile of lurasidone , a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Psycho- pharmacol., 2012, 28, 203-209. http://dx.doi.org/10.1097/JCP.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/CN-13-681.PMC4761637.pdf
"Med., 2010, 123, 711-718. http://dx.doi.org/10.1016/j.amjmed.2010.02.015 [2] Krog, N.H.; Engdahl, B.; Tambs, K. The association between tinnitus and mental health in a general population sample: results from the HUNT Study.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Res., 2010, 69, 289-298. http://dx.doi.org/10.1016/j.jpsychores.2010.03.008 [3] Davis, A.; El Rafaie, A.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"http://dx.doi.org/10.1371/journal.pone.0040544 [5] Schecklmann, M.; Landgrebe, M.; Poeppl, T. B.; Kreuzer, P.; Manner, P.; Marienhagen, J.; Wack, D.S.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Brain Mapp., 2013, 34, 233-240. http://dx.doi.org/10.1002/hbm.21426 [6] Vanneste, S.; Joos, K.; De Ridder, D. Prefrontal cortex based sex differences in tinnitus perception: same tinnitus intensity, same tinnitus distress, different mood.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"http://dx.doi.org/10.1371/journal.pone.0031182 [7] Golm, D.; Schmidt-Samoa, C.; Dechent, P.; Kroner-Herwig, B. Neural correlates of tinnitus related distress: an fMRI-study.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Res., 2013, 295, 87-99. http://dx.doi.org/10.1016/j.heares.2012.03.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Lancet Neurol., 2013, 12, 920-930. http://dx.doi.org/10.1016/S1474-4422(13)70160-1 [9] House, J.W.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Ciba Foundation Symposium., 1981, 85, 204-216. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Head Trauma Rehabil., 2014, 29, 432-442. http://dx.doi.org/10.1097/ HTR.0b013e31829d3129 [11] Moller, A.R.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"http://dx.doi.org/10.1016/S0030-6665(02)00170-6 [12] Moller, A.R.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Res., 1987, 28, 271-275. http://dx.doi.org/10.1016/0378-5955(87)90054-2 [15] De Ridder, D.; Elgoyhen, A.B.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"U. S. A., 2011, 108, 8075-8080. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurootol., 1999, 4, 258-268. http://dx.doi.org/10.1159/000013849 [18] LeDoux, J.E.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurobiol., 1992, 2, 191-197. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otol., 1978, 92, 115-121. http://dx.doi.org/10.1017/ S002221510008511X [20] De Ridder, D.; Vanneste, S.; Engineer, N.D.; Kilgard, M.P.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neuromodulation, 2014, 17, 170-179. http://dx.doi.org/10.1111/ner.12127 [21] Engineer, N.D.; Riley, J.R.; Seale, J.D.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Nature, 2011, 470, 101-104. http://dx.doi.org/10.1038/nature09656 [22] Zheng, Y.; McNamara, E.; Stiles, L.; Darlington, C.L.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurol., 2012, 3, 127. http://dx.doi.org/10.3389/fneur.2012.00127 [23] Figueiredo, R.R.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Surg., 2008, 138, 492-496. http://dx.doi.org/10.1016/ j.otohns.2007.11.027 [24] Zheng, Y.; Hooton, K.; Smith, P.F.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Acta Otolaryngol., 2008, 128, 48-52. http://dx.doi.org/10.1080/00016480701361939 [25] Hoekstra, C.E.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otol., 1997, 18, 268-269. http://dx.doi.org/10.1016/S0079-6123(07)66036-1 [27] De Ridder, D.; De Mulder, G.; Menovsky, T.; Sunaert, S.; Kovacs, S. Electrical stimulation of auditory and somatosensory cortices for treatment of tinnitus and pain.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neuro- surgery, 2004, 54, 381-8; discussion 388-90. http://dx.doi.org/ 10.1227/01.NEU.0000103420.53487.79 [31] Levine, R.A. Somatic (cranio cervical) tinnitus and the dorsal cochlear nucleus hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otolaryngol., 1999, 20, 351-362. http://dx.doi.org/10.1016/S0196-0709(99)90074-1 [32] Puel, J.L.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otorhinolaryngol., 2002, 59, 124-130. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Hear Res., 1996, 97, 46-53. http://dx.doi.org/10.1016/0378-5955(96) 00052-4 [35] Baldo, P.; Doree, C.; Lazzarini, R.; Molin, P.; McFerran, D.J.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
http://dx.doi.org/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Laryngol., 1989, 98, 867-872. http://dx.doi.org/10.1177/ 000348948909801107 [37] Sullivan, M.; Katon, W.; Russo, J.; Dobie, R.; Sakai, C. A randomized trial of nortriptyline for severe chronic tinnitus.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"1993, 153, 2251-2259. http://dx.doi.org/10.1001/archinte.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otolaryngol., 2001, 30, 300-303. http://dx.doi.org/10.2310/7070.2001.19597",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Psychopharmacol., 2008, 22, 574-575. http://dx.doi.org/10.1177/0269881107082126 [41] Tandon, R.; Grunhaus, L.; Greden, J.F.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Psychopharmacol., 2006, 26, 32-39. http://dx.doi.org/10.1097/01.jcp.0000195111.86650.19 [44] Robinson, S.K.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Med., 2005, 67, 981-988. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurotol., 2011, 32, 701-709. http://dx.doi.org/10.1097/ MAO.0b013e31820e737c [46] Sziklai, I.; Szilvassy, J.; Szilvassy, Z. Tinnitus control by dopamine agonist pramipexole in presbycusis patients: a randomized, placebo-controlled, double-blind study.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Laryngoscope, 2011, 121, 888-893. http://dx.doi.org/10.1002/lary.21461 [47] de Azevedo, A.A.; Langguth, B.; de Oliveira, P.M.; Rodrigues Figueiredo, R. Tinnitus treatment with piribedil guided by electro- cochleography a n d  a c o u s t i c  o t o e m i s s i o n s .",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurotol., 2009, 30, 676-680. http://dx.doi.org/10.1097/MAO.0b013e3181ab8fd5 [48] Salvi, R.; Lobarinas, E.; Sun, W. Pharmacological Treatments for Tinnitus: New and Old.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Surg., 1993, 119, 842-845. http://dx.doi.org/10.1001/ archotol.1993.01880200042006 [50] Jalali, M.M.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Psychiatry, 2012, 83, 821-827. http://dx.doi.org/10.1136/jnnp-2012-302273 [52] Bauer, C.A.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Laryngoscope, 2006, 116, 675-681. http://dx.doi.org/10.1097/01.MLG.0000216812.65206.CD [53] Witsell, D.L.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurotol., 2007, 28, 11-15. http://dx.doi.org/10.1097/01.mao.0000235967.53474.93 [54] Reed, H.T.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otolaryngol., 1985, 111, 803-805. http://dx.doi.org/10.1001/ archotol.1985.00800140047008 [55] Simpson, J.J.; Gilbert, A.M.; Weiner, G.M.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"1981, 95, 947-951. http://dx.doi.org/10.1017/ S0022215100091659 [57] Salembier, L.; De Ridder, D.; Van de Heyning, P.H.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Suppl., 2006, (556), 93-95. http://dx.doi.org/10.1080/03655230600895242 [58] Suckfull, M.; Althaus, M.; Ellers-Lenz, B.; Gebauer, A.; Gortelmeyer, R.; Jastreboff, P.J.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otorhinolaryngol., 2013, 270, 1999-2006. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Otolaryngol., 2011, 32, 19-23. http://dx.doi.org/10.1016/j.amjoto.2009.09.004 [61] Azevedo, A.A.; Figueiredo, R.R.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Brain Res., 2007, 166, 273-277. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Pharmacol., 2012, 44, 93-96. http://dx.doi.org/10.4103/0253-7613.91876 [63] Vanneste, S.; Azevedo, A.; De Ridder, D. The effect of naltrexone on the perception and distress in tinnitus: an open-label pilot study.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Ther., 2013, 51, 5-11. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurootol., 2012, 17, 179-188. http://dx.doi.org/10.1159/000335657 [65] Vanneste, S.; Figueiredo, R.; De Ridder, D. Treatment of tinnitus with cyclobenzaprine: an open-label study.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Ther., 2012, 50, 338-344. http://dx.doi.org/10.5414/CP201617 [66] Berkiten, G.; Yildirim, G.; Topaloglu, I.; Ugras, H. Vitamin B 1 2 levels in patients with tinnitus and effectiveness of vitamin B12 treatment on hearing threshold and tinnitus.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Neurotol., 2013, 34, 1146-1154. http://dx.doi.org/10.1097/MAO.0b013e31827e609e [68] Elgoyhen, A.B.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
http://dx.doi.org/10.1038/psp.2013.75 [69] Veterans Benefits Administration Annual Benefits Report.,Non-OADS,/arxiv_data1/oa_pdf/b1/e1/CN-13-692.PMC4761638.pdf
"Med., 1994, 121(12), 953-959. http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00009 [6] Carruthers, B.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Chronic Fatigue Syndrome, 2003, 11(1), 7-115. http://dx.doi.org/10.1300/ J092v11n01_02 [7] Carruthers, B.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2011, 270(4), 327-338. http://dx.doi.org/10.1111/j.1365-2796.2011.02428.x [8] Jason, L.A.; Sunnquist, M.; Brown, A.; Evans, M.; Newton,  J.L.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1177/ 1359105313520335 [9] Katon, W.; Russo, J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 1992, 152(8), 1604-1609. http://dx.doi.org/10.1001/archinte.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Fatigue, 2013, 1(3), 168-183. http://dx.doi.org/10.1080/21641846.2013.774556 [11] Institute of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immunol., 2014, 26(4), 233-242. http://dx.doi.org/10.1093/intimm/dxt068 [17] Morris, G.; Berk, M.; Galecki, P.; Maes, M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurobiol., 2014, 49(2), 741-756. http://dx.doi.org/10.1007/s12035-013-8553-0 [18] Morris, G.; Maes, M. Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropharmacol., 2014, 12(2), 168-185. http://dx.doi.org/10.2174/ 1570159X11666131120224653 [19] Morris, G.; Maes, M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Dis., 2014, 29(1), 19-36. http://dx.doi.org/10.1007/ s11011-013-9435-x [20] Broderick, G.; Ben-Hamo, R.; Vashishtha, S.; Efroni, S.; Nathanson, L.; Barnes, Z.; Fletcher, M.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2013, 28, 159-169. http://dx.doi.org/10.1016/j.bbi.2012.11.007 [21] Klimas, N.G.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Behav Immun, 2012, 26(8), 1202-1210. http://dx.doi.org/10.1016/j.bbi.2012.06.006 [22] Van Den Eede, F.; Moorkens, G. Neuroendocrine correlates of childhood trauma in CFS.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Endocrinol., 2012, 8(8), 502, author reply 502. http://dx.doi.org/10.1038/nrendo.2011.153-c1 [23] Ickmans, K.; Meeus, M.; De Kooning, M.; Lambrecht, L.; Pattyn, N.; Nijs, J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Ther., 2014, 94(4), 511-522. http://dx.doi.org/10.2522/ptj.20130367 [24] Nakatomi, Y.; Mizuno, K.; Ishii, R.; Wada, Y.; Tanaka, M.; Tazawa, S.; Onoe, K.; Fukuda, S.; Kawabe, J.; Takahashi, K.; Kataoka, Y.; Shiomi, S.; Yamkaguti, K.; Inaba, M.; Kuratsune, H.; Watanabe, Y. Neuroinflammation in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET study.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2014, 55(6), 945-950. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2014, 275(4), 409-417. http://dx.doi.org/10.1111/joim.12161 [26] Van Cauwenbergh, D.; Nijs, J.; Kos, D.; Van Weijnen, L.; Struyf, F.; Meeus, M. Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: A systematic literature review.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Invest., 2014, 44(5), 516-526. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Glia, 2014. http://dx.doi.org/10.1002/ glia.22687 [28] Nijs, J.; Van Oosterwijck, J.; Meeus, M.; Lambrecht, L.; Metzger, K.; Fremont, M.; Paul, L. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: The role of elastase, complement C4a and interleukin-1beta.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2010, 267(4), 418-435. http://dx.doi.org/10.1111/ j.1365-2796.2009.02178.x [29] Nijs, J.; van Eupen, I.; Vandecauter, J.; Augustinus, E.; Bleyen,  G.; Moorkens, G.; Meeus, M. Can pacing self-management  alter physical behavior and symptom severity in chronic  fatigue syndrome?",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Dev., 2009, 46(7), 985-996. http://dx.doi.org/10.1682/JRRD.2009.01.0007 [30] VanNess, J.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J. Womens Health (Larchmt), 2010, 19(2), 239-244. http://dx.doi.org/ 10.1089/jwh.2009.1507 [31] Jason, L.A.; Damrongvachiraphan, D.; Hunnell, J.; Bartgis, L.; Brown, A. Myalgic Encephalomyelitis: Case definitions.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/ 10.1016/S0002-9343(98)00171-5 [33] Light, A.R.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2009, 10(10), 1099-1112. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2012, 271(1), 64-81. http://dx.doi.org/10.1111/j.1365-2796.2011.02405.x [35] Vanness, J.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2005, 257, 299-310. http://dx.doi.org/ 10.1111/j.1365-2796.2005.01452.x [37] VanNess, M.; Snell, C.R.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Chronic Fatigue Syndrome, 2007, 14(2), 77-85. http://dx.doi.org/10.1300/ J092v14n02_07 [38] He, J.; Hollingsworth, K.G.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage Clin., 2013, 2, 168-173. http://dx.doi.org/ 10.1016/j.nicl.2012.12.006 [39] Hyde, B.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://www.hfme.org/Other/DefinitionBooklet_Sept_2011.pdf [Accessed on: 07/07/2014].,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Fatty Acids, 2004, 70(4), 403-407. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J., 1990, 66(777), 526-530. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry Res., 2012, 200(2-3), 754-760. http://dx.doi.org/10.1016/j.psychres.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Physiol., 2010, 588(Pt 11), 1823-1827. http://dx.doi.org/10.1113/ jphysiol.2010.190652 [51] Cannon, S.C. Voltage-sensor mutations in channelopathies of skeletal muscle.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1016/S0035-3787(13)70060-2 [53] Chaudhuri, A.; Behan, P.O.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Lancet, 2004, 363(9413), 978-988. http://dx.doi.org/10.1016/ S0140-6736(04)15794-2 [54] Chaudhuri, A.; Condon, B.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroreport, 2003, 14(2), 225-228. http://dx.doi.org/10.1097/00001756-200302100-00013 [55] Whitside, A.; Hansen, S.; Chaudhuri, A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2004, 109, 497-499. http://dx.doi.org/10.1016/j.pain.2004.02.029 [56] Kullmann, D.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"293-302. http://dx.doi.org/10.1016/ B978-012738903-5/50018-7 [57] Buzsaki, G. Rhythms of the Brain.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Oxford University Press, 2006. http://dx.doi.org/10.1093/acprof:oso/9780195301069.001.0001 [58] Snell, C.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Chronic Fatigue Syndrome, 2003, 11(1), 117-133. http://dx.doi.org/10.1300/ J092v11n01_03 [60] Jason, L.A.; Sorenson, M.; Porter, N.; Belkairous, N. An Etiological Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2011, 2(1), 14-27. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Dis., 2014, 63, 194-200. http://dx.doi.org/10.1016/j.nbd.2013.11.020 [62] Goddard, G.V.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Nature, 1967, 214(5092), 1020-1021. http://dx.doi.org/10.1038/2141020a0 [63] Jones, N.C.; Lee, H.E.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychoneuroendocrinology, 2013, 38(2), 263-270. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rev., 2007, 31(6), 858-873. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Epilepsy Behav., 2007, 10(3), 377-383. http://dx.doi.org/ 10.1016/j.yebeh.2007.02.001 [66] Loscher, W.; Ebert, U.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurobiol., 1996, 50(5-6), 427-481. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J. Neuroimmune Pharmacol., 2013, 8(3), 452-469. http://dx.doi.org/ 10.1007/s11481-012-9392-x [68] Sorrells, S.F.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuron, 2009, 64(1), 33-39. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Hypotheses,, 2011, 77(1), 77-83. http://dx.doi.org/10.1016/j.mehy.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Couns., 2009, 77, 237-241. http://dx.doi.org/10.1016/j.pec.2009.02.015 [71] Jason, L.A.; Brown, M.; Brown, A.; Evans, M.; Flores, S.; Grant-Holler, E.; Sunnquist, M. Energy Conservation/Envelope Theory Interventions to Help Patients with Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Health Behav., 2013, 1(1-2), 27-42. http://dx.doi.org/10.1080/21641846.2012.733602 [72] Johnson, C. Light on ME/CFS I: Bad reception: A key to ME uncovered?",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1300/J092v05n03_02 [74] Meeus, M.; Roussel, N.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2010, 42, 884-890. http://dx.doi.org/10.2340/16501977-0595 [75] Neu, D.; Mairesse, O.; Verbanck, P.; Linkowski, P.; Le Bon, O. Non-REM sleep EEG power distribution in fatigue and sleepiness.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2014, 76(4), 286-291. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Physical Therapy, 2013, 93(11), 1484-1492. http://dx.doi.org/10.2522/ptj.20110368 [78] Siemionow, V.; Fang, Y.; Calabrese, L.; Sahgal, V.; Yue, G.H.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurophysiol., 2004, 115(10), 2372-2381. http://dx.doi.org/10.1016/j.clinph.2004.05.012 [79] Neary, P.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Imaging, 2008, 28(6), 364-372. http://dx.doi.org/10.1111/j.1475-097X.2008.00822.x [80] Nijs, J.; Almond, F.; De Becker, P.; Truijen, S.; Paul, L. Can exercise limits prevent post-exertional malaise in chronic fatigue syndrome?",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rehabil., 2008, 22(5), 426-435. http://dx.doi.org/10.1177/0269215507084410 [81] White, A .",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychophysiology, 2010, 47(4), 615-624. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2010, 268(3), 265-278. http://dx.doi.org/10.1111/j.1365-2796.2010.02228.x [83] Vermeulen, R.C.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1186/1479-5876-12-20 [84] Lengert, N.; Drossel, B.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Chem., 2015, 202, 21-31. http://dx.doi.org/10.1016/j.bpc.2015.03.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 1996, 101(3), 281-290. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Biotechnol., 2010, 6(2), 120-135. http://dx.doi.org/10.3844/ ajbbsp.2010.120.135 [88] Michiels, V.; Cluydts, R. Neuropsychological functioning in chronic fatigue syndrome: A review.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Scand., 2001, 103(2), 84-93. http://dx.doi.org/10.1034/j.1600-0447.2001.00017.x [89] Cockshell, S.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2010, 40(8), 1253-1267. http://dx.doi.org/10.1017/S0033291709992054 [90] Cockshell, S.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychol., 2012, 34(7), 679-687. http://dx.doi.org/10.1080/13803395.2012.668176 [91] Cockshell, S.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychology, 2014, 28(3), 394-405. http://dx.doi.org/10.1037/neu0000025 [92] DeLuca, J.; Johnson, S.K.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurol., 1993, 50(3), 301-304. http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 1997, 59(1), 58-66. http://dx.doi.org/10.1097/00006842-199701000-00008 [94] Zinn, M.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychology, 2007, 21(4), 507-513. http://dx.doi.org/10.1037/ 0894-4105.21.4.507 [97] Deluca, J.; Johnson, S.K.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J., 2009, 3, 13-23. http://dx.doi.org/10.2174/1874205X00903010013 [99] Majer, M.; Welberg, L.A.; Capuron, L.; Miller, A.H.; Pagnoni, G.; Reeves, W.C. Neuropsychological performance in persons with chronic fatigue s yndr ome: Results from a po pulation-based study.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2008, 70(7), 829-836. http://dx.doi.org/10.1097/ PSY.0b013e31817b9793 [100] Colby, J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pathol., 2007, 60(2), 125-128. http://dx.doi.org/10.1136/jcp.2006.042606 [101] Haywood, K.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Child Care Health Dev., 2014, 40(6), 806-824. http://dx.doi.org/10.1111/ cch.12135 [102] Care, N.C.C.f.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurobiol., 2002, 67(1), 53-83. http://dx.doi.org/ 10.1016/S0301-0082(02)00011-4 [104] Hopkins, R.O.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Care, 2013, 17, 116. http://dx.doi.org/10.1186/cc11913 [105] Hopkins, R.O.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Chest, 2006, 130(3), 869-878. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2012, 26(4), 552-558. http://dx.doi.org/10.1016/j.bbi.2011.12.009 [108] Pizzagalli, D.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry, 2004, 9(4), 325, 393-405. http://dx.doi.org/10.1038/sj.mp.4001501 [109] Kuratsune, H.; Nakatomi, Y.; Mizuno, K.; Watanabe, Y. Neuroinflammation in patients with ME: A positron emission topography study.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurol., 2011, 70(3), 418-426. http://dx.doi.org/10.1002/ana.22362 [113] Kuratsune, H.; Watanabe, Y.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immunol., 2005, 12(1), 52-55. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rep., 2000, 5(2-3), 146-147. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"824. http://dx.doi.org/10.1007/978-3-319-07320-0 [119] de Lange, F.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage, 2005, 26, 777-781. http://dx.doi.org/10.1016/j.neuroimage.2005.02.037 [120] Clark, I.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Ther., 2010, 128, 519-548. http://dx.doi.org/10.1016/j.pharmthera.2010.08.007 [121] Kennedy, G.; Spence, V.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2005, 39, 584-589. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sports, 2009, 13, 1-9. http://dx.doi.org/10.1177/ 0363546508322885 [123] Meeus, M.; Nijs, J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rheumatol., 2007, 26(4), 465-473. http://dx.doi.org/10.1007/s10067-006-0433-9 [124] Pall, M.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 1992, 116(2), 103-113. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0058493 [130] Puri, B.K.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1259/bjr/93889091 [131] Lange, G.; DeLuca, J.; Maldjian, J.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 1999, 171(1), 3-7. http://dx.doi.org/10.1016/S0022-510X(99)00243-9 [132] Zeineh, M .",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Radiology, 2015, 274(2), 517-526. http://dx.doi.org/10.1148/radiol.14141079 [133] Ichise, M.; Salit, I.E.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Commun., 1992, 13(10), 767-772. http://dx.doi.org/10.1097/ 00006231-199213100-00011 [134] Natelson, B.H.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 1993, 120(2), 213-217. http://dx.doi.org/10.1016/0022-510X(93)90276-5 [135] Schwartz, R.B.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Roentgenol., 1994, 162(4), 935-941. http://dx.doi.org/10.2214/ajr.162.4.8141020 [136] Cope, H.; Pernet, A.; Kendall, B.; David, A. Cognitive functioning and magnetic resonance imaging in chronic fatigue.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J. Psychiatry, 1995, 167(1), 86-94. http://dx.doi.org/10.1192/bjp.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1016/S0002-9343(98) 00179-X [140] Brooks, J.C.; Roberts, N.; Whitehouse, G.; Majeed, T. Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Radiol., 2000, 73(875), 1206-1208. http://dx.doi.org/10.1259/bjr.73.875.11144799 [141] Lange, G.; Holodny, A.I.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychol., 2001, 8(1), 23-30. http://dx.doi.org/10.1207/ S15324826AN0801_4 [142] Lewis, D.H.; Mayberg, H.S.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Radiology, 2001, 219(3), 766-773. http://dx.doi.org/10.1148/ radiology.219.3.r01jn18766 [143] Kuratsune, H.; Yamaguti, K.; Lindh, G.; Evengard, B.; Hagberg, G.; Matsumura, K.; Iwase, M.; Onoe, H.; Takahashi, M.; Machii, T.; Kanakura, Y.; Kitani, T.; Langstrom, B.; Watanabe, Y.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage, 2002, 17(3), 1256-1265. http://dx.doi.org/10.1006/nimg.2002.1260 [144] Schmaling, K.B.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2003, 65(1), 129-136. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry, 2003, 74(7), 922-928. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain, 2004, 127(Pt 9), 1948-1957. http://dx.doi.org/10.1093/brain/awh225 [147] Okada, T.; Tanaka, M.; Kuratsune, H.; Watanabe, Y.; Sadato, N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"BMC Neurol., 2004, 4(1), 14. http://dx.doi.org/10.1186/1471-2377-4-14 [148] Yamamoto, S.; Ouchi, Y.; Onoe, H.; Yoshikawa, E.; Tsukada, H.; Takahashi, H.; Iwase, M.; Yamaguti, K.; Kuratsune, H.; Watanabe, Y.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroreport, 2004, 15(17), 2571-2574. http://dx.doi.org/10.1097/00001756-200412030-00002 [149] Cleare, A.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Biol Psychiatry, 2005, 57(3), 239-246. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage, 2005, 26(3), 777-781. http://dx.doi.org/10.1016/j.neuroimage.2005.02.037 [151] Lange, G.; Steffener, J.; Cook, D.B.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage, 2005, 26(2), 513-524. http://dx.doi.org/10.1016/j.neuroimage.2005.02.011 [152] Caseras, X.; M ataix-Cols, D.; Giampietro, V.; Rimes, K.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2006, 68(6), 947-955. http://dx.doi.org/10.1097/ 01.psy.0000242770.50979.5f [153] Tanaka, M.; Sadato, N.; Okada, T.; Mizuno, K.; Sasabe, T.; Tanabe, H.C.; Saito, D.N.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"BMC Neurol., 2006, 6, 9. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Imaging, 2006, 26(2), 83-86. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage, 2007, 36(1), 108-122. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimage, 2007, 34(4), 1438-1442. http://dx.doi.org/10.1016/j.neuroimage.2006.11.007 [157] Caseras, X.; Mataix-Cols, D.; Rimes, K.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2008, 38(7), 941-951. http://dx.doi.org/10.1017/S0033291708003450 [158] de Lange, F.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain, 2008, 131(Pt 8), 2172-2180. http://dx.doi.org/10.1093/brain/awn140 [159] Mathew, S.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"NMR Biomed., 2009, 22(3), 251-258. http://dx.doi.org/10.1002/nbm.1315 [160] Flor-Henry, P.; Lind, J.C.; Koles, Z.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry Res., 2010, 181(2), 155-164. http://dx.doi.org/10.1016/j.pscychresns.2009.10.007 [161] Murrough, J.W.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"NMR Biomed., 2010, 23(6), 643-650. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"NMR Biomed., 2011, 24(10), 1302-1312. http://dx.doi.org/10.1002/nbm.1692 [163] Biswal, B.; Kunwar, P.; Natelson, B.H.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 2011, 301(1-2), 9-11. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"NMR Biomed., 2012, 25(9), 1073-1087. http://dx.doi.org/10.1002/ nbm.2772 [165] Yamamoto, S.; Ouchi, Y.; Nakatsuka, D.; Tahara, T.; Mizuno, K.; Tajima, S.; Onoe, H.; Yoshikawa, E.; Tsukada, H.; Iwase, M.; Yamaguti, K.; Kuratsune, H.; Watanabe, Y.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"NMR Biomed., 2015, 28(3), 404-413. http://dx.doi.org/10.1002/nbm.3261 [167] Tanaka, H.; Matsushima, R.; Tamai, H.; Kajimoto, Y.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pediatr., 2002, 140(4), 412-417. http://dx.doi.org/10.1067/mpd.2002.122725 [168] Fischler, B.; D'Haenen, H.; Cluydts, R.; Michiels, V.; Demets, K.; Bossuyt, A.; Kaufman, L.; De Meirleir, K. Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: An exploratory study of clinical correlates of regional cerebral blood flow.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychobiology, 1996, 34(4), 175-183. http://dx.doi.org/10.1159/000119307 [169] MacHale, S.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J. Psychiatry, 2000, 176, 550-556. http://dx.doi.org/10.1192/bjp.176.6.550 [170] Ocon, A.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Funct., 2009, 5, 10. http://dx.doi.org/10.1186/1744-9081-5-10 [172] Morriss, R.K.; Robson, M.J.; Deakin, J.F.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychopharmacology, (Berl), 2002, 163(2), 166-173. http://dx.doi.org/10.1007/s00213-002-1129-8 [173] Nijs, J.; Meeus, M.; Van Oosterwijck, J.; Roussel, N.; De Kooning, M.; Ickmans, K.; Matic, M. Treatment of central sensitization in patients with 'unexplained' chronic pain: what options do we have?",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pharmacother., 2011, 12(7), 1087-1098. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Mapp., 2011, 32(12), 2151-2160. http://dx.doi.org/10.1002/hbm.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2011, 34(12), 2035-2042. http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Physiol., 2011, 96(5), 505-517. http://dx.doi.org/10.1113/expphysiol.2010.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry Res., 2011, 189(1), 128-134. http://dx.doi.org/10.1016/j.psychres.2010.12.005 [179] Donati, F.; Fagioli, L.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroscience, 2006, 137(4), 1087-1106. http://dx.doi.org/10.1016/ j.neuroscience.2005.10.029 [181] Ropper AH, S.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"BMC Neurol., 2011, 11, 82. http://dx.doi.org/10.1186/1471-2377-11-82 [183] Grech, R.; Cassar, T.; Muscat, J.; Camilleri, K.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rehabil., 2008, 5, 25. http://dx.doi.org/10.1186/1743-0003-5-25 [184] Pascual-Marqui, R.; Kochi, K.; Lehmann, D.; Koukkou, M.; Kinoshita, T. Functional independent components: Revealing cortico-cortical, cross-frequency interactions.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2014, 8. http://dx.doi.org/10.3389/fnhum.2014.00448",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Eng., 2001, 48(7), 760-771. http://dx.doi.org/10.1109/10.930901 [189] Nickl-Jockschat, T.; Kleiman, A.; Schulz, J.B.; Schneider, F.; Laird, A.R.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Funct., 2012, 217(1), 115-125. http://dx.doi.org/10.1007/s00429-011-0333-x [190] Le Bon, O.; Neu, D.; Berquin, Y.; Lanquart, J.P.; H o f f m a n n ,  R .",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry Res., 2012, 200(2-3), 742-747. http://dx.doi.org/10.1016/j.psychres.2012.06.027 [191] Flor-Henry, P.; Lind, J.C.; Koles, Z.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry Res., 2004, 130(2), 191-207. http://dx.doi.org/10.1016/j.pscychresns.2003.08.006 [192] Fray, P.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1002/(SICI)1099-1166(199604) 11:4<329::AID-GPS453>3.0.CO;2-6 [193] Jason, L.A.; Sunnquist, M.; Brown, A.; Evans, M.; Vernon, S.D.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Fatigue, 2014, 2(1), 40-56. http://dx.doi.org/10.1080/21641846.2013.862993 [194] Landis, C.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurol., 2011, 98, 613-637. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 2007, 333(2), 78-84. http://dx.doi.org/10.1097/00000441-200702000-00003 [197] Kishi, A.; Togo, F.; Cook, D.B.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Funct., 2009, 5, 43. http://dx.doi.org/10.1186/1744-9081-5-43 [199] Thatcher, R.W.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Future Med., 2011, 1(5), 495-514. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain Pract., 2010, 10(4), 294-300. http://dx.doi.org/ 10.1111/j.1533-2500.2009.00352.x [202] Blanco, I.; Beritze, N.; Arguelles, M.; Carcaba, V.; Fernandez, F.; Janciauskiene, S.; Oikonomopoulou, K.; de Serres, F.J.; Fernandez-Bustillo, E.; Hollenberg, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rheumatol., 2010, 29(12), 1403-1412. http://dx.doi.org/10.1007/ s10067-010-1474-7 [203] Shaver, J.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2013, 176(1-2), 85-90. http://dx.doi.org/10.1016/ j.autneu.2013.02.015 [205] Buysse, D.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry Res., 1989, 28(2), 193-213. http://dx.doi.org/10.1016/0165-1781(89)90047-4 [206] Whelton, C.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"BMJ, 1993, 306(6886), 1161-1164. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 1993, 37(4), 325-331. http://dx.doi.org/10.1016/0022-3999(93)90134-2 [209] Fischler, B.; Le Bon, O.; Hoffmann, G.; Cluydts, R.; Kaufman, L.; De Meirleir, K. Sleep anomalies in the chronic fatigue syndrome: A comorbidity study.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychobiology, 1997, 35(3), 115-122. http://dx.doi.org/10.1159/000119331 [210] Neu, D.; Mairesse, O.; H o f f m a n n ,  G .",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychobiology, 2007, 56(1), 40-46. http://dx.doi.org/10.1159/000110727 [211] Armitage, R.; Landis, C.; Hoffmann, R.; Lentz, M.; Watson, N.F.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1186/ar2425 [214] Armitage, R.; Landis, C.; Hoffmann, R.; Lentz, M.; Watson, N.; Goldberg, J.; Buchwald, D. Power spectral analysis of sleep EEG in twins discordant for chronic fatigue syndrome.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2009, 66(1), 51-57. http://dx.doi.org/10.1016/j.jpsychores.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sleep, 2011, 34(11), 1551-1560. http://dx.doi.org/10.5665/sleep.1396 [216] Gotts, Z.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://nrl.northumbria.ac.uk/21605/.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1371/journal.pone.0085387 [218] Watt, T.; Oberfoell, S.; Balise, R.; Lunn, M.R.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Virol., 2012, 84(12), 1967-1974. http://dx.doi.org/10.1002/jmv.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychol., 1994, 49(12), 1004-1017. http://dx.doi.org/10.1037/0003-066X.49.12.1004",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Virol., 2011, 85(14), 6913-6922. http://dx.doi.org/10.1128/JVI.00458-11 [223] Gaab, J.; Rohleder, N.; Heitz, V.; Engert, V.; Schad, T.; Schurmeyer, T.H.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychoneuroendocrinology, 2005, 30(2), 188-198. http://dx.doi.org/10.1016/j.psyneuen.2004.06.008 [224] Vollmer-Conna, U.; Piraino, B.F.; Cameron, B.; Davenport, T.; Hickie, I.; Wakefield, D.; Lloyd, A.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Dis., 2008, 47(11), 1418-1425. http://dx.doi.org/10.1086/592967 [225] Plata-Salaman, C.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Res., 2000, 75(2), 248-258. http://dx.doi.org/10.1016/S0169-328X(99)00306-X [226] Shandra, A.A.; Godlevsky, L.S.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2002, 42(2), 147-153. http://dx.doi.org/10.1016/S0168-0102(01)00309-1 [227] Aalbers, M.W.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroimmunol., 2014, 271(1-2), 36-42. http://dx.doi.org/ 10.1016/j.jneuroim.2014.03.016 [228] Zhao, R.R.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Commun., 2014, 448(4), 414-417. http://dx.doi.org/10.1016/ j.bbrc.2014.04.130 [229] Morris, G.; Maes, M. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain D i s ., 2013, 28, 523-40. http://dx.doi.org/10.1007/s11011-012-9324-8 [230] Maes, M.; Mihaylova, I.; Kubera, M.; Leunis, J.C.; Twisk, F.N.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Dis., 2012, 27(4), 415-423. http://dx.doi.org/10.1007/ s11011-012-9316-8 [231] Maes, M.; Twisk, F.N.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Funct., 2010, 6, 76. http://dx.doi.org/10.1186/1744-9081-6-76 [233] Brenu, E.W.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2011, 9, 81. http://dx.doi.org/10.1186/1479-5876-9-81 [234] Gomariz, R.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 2006, 1070, 51-74. http://dx.doi.org/10.1196/annals.1317.031 [235] Fletcher, M.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1371/journal.pone.0010817 [236] Brenu, E.W.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2012, 10, 88. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Disord., 2012, 141(2-3), 261-269. http://dx.doi.org/10.1016/j.jad.2012.03.037 [238] Broderick, G.; Fuite, J.; Kreitz, A.; Vernon, S.D.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2010, 24(7), 1209-1217. http://dx.doi.org/10.1016/j.bbi.2010.04.012 [239] Broderick, G.; Klimas, N.; Fletcher, M.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2011, 25(2), 302-313. http://dx.doi.org/10.1016/j.bbi.2010.10.011 [241] Sorenson, M.; Furst, J.; Mathews, H.; Jason, L.A. Disruption of cytokine pathways in Chronic Fatigue Syndrome.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immunol., 2001, 8(3), 658-662. http://dx.doi.org/10.1128/cdli.8.3.658-662.2001 [243] Huang, L.C.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2009, 7, 81. http://dx.doi.org/10.1186/1479-5876-7-81 [244] Stringer, E.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2013, 11, 93. http://dx.doi.org/10.1186/1479-5876-11-93 [245] Lerner, A.M.; Beqaj, S.; Fitzgerald, J.T.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1371/ journal.pone.0047891 [247] Embers, M.E.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1371/ journal.pone.0029914 [248] Tzartos, J.S.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurology, 2012, 78(1), 15-23. http://dx.doi.org/10.1212/WNL.0b013e31823ed057 [249] Capuron, L.; Pagnoni, G.; Demetrashvili, M.F.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychopharmacology, 2007, 32(11), 2384-2392. http://dx.doi.org/10.1038/sj.npp.1301362 [250] Fluge, O.; Risa, K.; Lunde S.; Alme, K.; Rekeland, I.G.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
32. https://www.jstage.jst.go.jp/article/tmh/36/1/36_2007-55/_pdf [Accessed on: 07/08/2014].,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Genet Epigenet, 2013, 5, 1-9. http://dx.doi.org/10.4137/GEG.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Adv., 2015, 1, 1-10. http://dx.doi.org/10.1126/sciadv.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurol., 2013, 117, 1-11. http://dx.doi.org/10.1016/ B978-0-444-53491-0.00001-8 [257] O'Connor, T.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"QJM, 2000, 93(6), 323-333. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rev., 2010, 35(1), 2-16. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuron, 2013, 79(1), 16-29. http://dx.doi.org/10.1016/j.neuron.2013.06.028 [260] Sorrells, S.F.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2007, 21(3), 259-272. http://dx.doi.org/10.1016/j.bbi.2006.11.006 [261] McEwen, B.S.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Behav., 2010, 57(2), 105-111. http://dx.doi.org/10.1016/j.yhbeh.2009.09.011 [262] Chrousos, G.P.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2003, 28(11), 1735-1742. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rev., 2000, 21(1), 55-89. http://dx.doi.org/10.1210/er.21.1.55 [265] Maniam, J.; Antoniadis, C.; Morris, M.J. Early-Life Stress, HPA Axis Adaptation, and Mechanisms Contributing to Later Health Outcomes.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Front Endocrinol., 2014, 5, 73. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychoneuroendocrinology, 2013, 38(8), 1271-1280. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Care Med., 2010, 38(3), 973-975. http://dx.doi.org/10.1097/CCM.0b013e3181cdf6de [268] Brouwer, M.C.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1002/ 14651858.cd004405.pub4 [269] Kern, S.; Rohleder, N.; Eisenhofer, G.; Lange, J.; Ziemssen, T. Time matters - Acute stress response and glucocorticoid sensitivity in early multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2014, 39(4), 719-730. http://dx.doi.org/10.1007/s11064-014-1260-z [271] Sapolsky, R.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Gerontol., 1983, 18(1), 55-64. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Springer: New York; 2011. http://dx.doi.org/10.1007/978-3-642-17575-6 [275] Rodrigues, S.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2009, 32, 289-313. http://dx.doi.org/10.1146/annurev.neuro.051508.135620 [276] Pajand, P.; Elahdadi Salmani, M.; Shajiee, H.; Abiri, H.; Goudarzi, I.; Abrari, K. Stress during first pregnancy increases seizure threshold in adult male offspring.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Epilepsy Behav., 2014, 38c, 148-159. http://dx.doi.org/10.1016/j.yebeh.2013.10.020 [278] Kellett, J.; Kokkinidis, L. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: Implications for kindling-associated fear and anxiety.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2004, 127(2), 277-287. http://dx.doi.org/10.1016/j.neuroscience.2004.05.011 [279] Willner, P.; Scheel-Kruger, J.; Belzung, C. The neurobiology  of depression and antidepressant action.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Rev., 2013, 37(10 Pt 1), 2331-2371. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2009, 71(5), 549-556. http://dx.doi.org/10.1097/PSY.0b013e3181 a4fea8 [281] Cleare, A.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Metab., 2004, 15(2), 55-59. http://dx.doi.org/10.1016/j.tem.2003.12.002 [282] Grippo, A.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
20-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuropsychobiol., 2007, 55(2), 112-120. http://dx.doi.org/10.1159/000104468 [284] Naschitz, J.E.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Hypotheses, 2004, 62(2), 203-206. http://dx.doi.org/10.1016/S0306-9877(03) 00331-1 [285] Martinez-Martinez, L.A.; Mora, T.; Vargas, A.; Fuentes-Iniestra, M.; Martinez-Lavin, M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Eng., 1995, 42(3), 250-259. http://dx.doi.org/10.1109/10.364511",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Auton Res., 1996, 6(6), 329-333. http://dx.doi.org/10.1007/BF02556303 [291] Jackson, M.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sleep Med., 2012, 8(6), 719-728. http://dx.doi.org/10.5664/jcsm.2276 [292] Ohashi, K.; Yamamoto, Y.; Natelson, B.H.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Behav., 2002, 77(1), 39-44. http://dx.doi.org/10.1016/ S0031-9384(02)00808-9 [293] VanElzakker, M.B.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Hypotheses, 2013, 81(3), 414-423. http://dx.doi.org/10.1016/j.mehy.2013.05.034 [294] Hollingsworth, K.G.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2012, 271(3), 264-270. http://dx.doi.org/10.1111/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2007, 137(1-2), 94-101. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"QJM, 2012, 105(9), 831-838. http://dx.doi.org/10.1093/qjmed/hcs085 [298] Ocon, A.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Clin Sci (Lond), 2012, 122(5), 227-238. http://dx.doi.org/10.1042/CS20110241 [299] Ravindran, M.; Adewuyi, O.; Zheng, Y.; Rayhan, R.U.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Heart J., 1998, 136(4 Pt 1), 664-671. http://dx.doi.org/10.1016/S0002-8703(98)70014-6 [304] Scott, A.; Norton, M.; Mabillard, H.; Newton, J.L.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Ophthalmol., 2013, 251(12), 2769-2776. http://dx.doi.org/10.1007/s00417-013-2431-3 [307] Hutchinson, C.V.; Maltby, J.; Badham, S.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Ophthalmol., 2014, 98(1), 144-145. http://dx.doi.org/10.1136/bjophthalmol-2013-304439 [308] Newton, J.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2007, 100(8), 519-526. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2012, 26(3), 401-406. http://dx.doi.org/10.1016/j.bbi.2012.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Immun., 2004, 18(4), 314-325. http://dx.doi.org/10.1016/ j.bbi.2003.12.011 [311] Demitrack, M.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 1998, 840, 684-697. http://dx.doi.org/10.1111/j.1749-6632.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Disord., 2005, 87(2-3), 299-304. http://dx.doi.org/10.1016/j.jad.2005.03.013 [313] Nijhof, S.L.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychoneuroendocrinology, 2014, 42, 199-206. http://dx.doi.org/10.1016/j.psyneuen.2014.01.017 [314] Poteliakhoff, A. Adrenocortical activity and some clinical findings in acute and chronic fatigue.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 1981, 25(2), 91-95. http://dx.doi.org/10.1016/0022-3999(81)90095-7 [315] Roberts, A.D.; Wessely, S.; Chalder, T.; Papadopoulos, A.; Cleare, A.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"J. Psychiatry, 2004, 184, 136-141. http://dx.doi.org/ 10.1192/bjp.184.2.136 [316] Torres-Harding, S.; Sorenson, M.; Jason, L.A.; Maher, K.; Fletcher, M.A.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychoneuroendocrinology, 2013, 38(11), 2405-2422. http://dx.doi.org/10.1016/j.psyneuen.2013.07.004 [318] Sorrells, S.F.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2013, 33(18), 7877-7889. http://dx.doi.org/10.1523/ JNEUROSCI.4705-12.2013 [319] Woon, F.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Care Med., 2012, 186(4), 333-340. http://dx.doi.org/10.1164/rccm.201112-2261OC [320] Hopkins, R.O.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Care Med., 2012, 186(12), 1220-1228. http://dx.doi.org/10.1164/rccm.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2014, 370(2), 185-186. http://dx.doi.org/10.1097/sa.0000000000000071 [322] Pandharipande, P.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2013, 369(14), 1306-1316. http://dx.doi.org/10.1056/ NEJMoa1301372 [323] Dinkel, K.; MacPherson, A.; Sapolsky, R.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurochem.,  2003, 84(4), 705-716. http://dx.doi.org/10.1046/j.1471-4159.2003.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Trends Immunol., 2003, 24(8), 444-448. http://dx.doi.org/ 10.1016/S1471-4906(03)00173-X [325] Goosens, K.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Disord., 1995, 34(4), 283-289. http://dx.doi.org/10.1016/0165-0327(95) 00026-J [328] Rohleder, N.; Schommer, N.C.; Hellhammer, D.H.; Engel, R.; Kirschbaum, C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2001, 63(6), 966-972. http://dx.doi.org/10.1097/ 00006842-200111000-00016 [329] Smith, A.K.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pharmacogenomics, 2006, 7(3), 387-394. http://dx.doi.org/10.2217/14622416.7.3.387 [330] Kavelaars, A.; Kuis, W.; Knook, L.; Sinnema, G.; Heijnen, C.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Metab., 2000, 85(2), 692-696. http://dx.doi.org/10.1210/jc.85.2.692 [331] Jason, L.; Porter, N.; Shelleby, E.; Till, L.; Bell, D.S.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Health Med., 2010, 3(3), 186-195. http://dx.doi.org/10.1037/h0100551 [332] Meyer, J.D.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Health  Behav., 2013. http://dx.doi.org/10.1080/21641846.2013.838444 [333] Yuan, Z.; R.-Z.N., Zhang, X.; Seto E. Histone Deacetylase Activity Assay.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2002, 32(6), 1075-1089. http://dx.doi.org/10.1017/S0033291702006086 [335] Pall, M.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Hypotheses, 2007, 69(4), 821-825. http://dx.doi.org/10.1016/j.mehy.2007.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Sci., 2003, 326(2), 55-60. http://dx.doi.org/10.1097/ 00000441-200308000-00001 [337] Cho, H.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Psychiatry, 2006, 19(1), 67-73. http://dx.doi.org/10.1097/01.yco.0000194370.40062.b0 [338] Bakheit, A.M.; Behan, P.O.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Suppl., 2000, 113, 72-77. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2001, 31(4), 585-591. http://dx.doi.org/10.1017/ S0033291701003580 [341] Badawy, A.A.; Morgan, C.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2004, 57(4), 391-398. http://dx.doi.org/10.1016/S0022-3999(04)00080-7 [343] Baraniuk, J.N.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Allergy Asthma Proc., 2010, 31(3), 169-178. http://dx.doi.org/10.2500/aap.2010.31.3311 [344] Jason, L.A.; So, S.; Brown, A.; Sunnquist, M.; Evans, M. Test-retest reliability of the DePaul Symptom Questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Health Behav., 2015, 3(1), 16-32. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2007, 11(4), 377-386. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Nurs., 2012, 13(1), 60-65. http://dx.doi.org/10.1016/j.pmn.2010.03.001 [347] Mendell, L.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Nature, 1965, 206, 97-99. http://dx.doi.org/10.1038/206097a0 [348] Martinez-Lavin, M.; Solano, C. Dorsal root ganglia, sodium channels, and fibromyalgia sympathetic pain.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Hypotheses, 2009, 72(1), 64-66. http://dx.doi.org/10.1016/j.mehy.2008.07.055 [349] McEwen, B.S.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1016/j.metabol.2010.07.012 [350] Vargas-Alarcon, G.; Alvarez-Leon, E.; Fragoso, J.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Disord., 2012, 13, 23. http://dx.doi.org/10.1186/1471-2474-13-23 [351] Bennett, G.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1016/S0885-3924(99)00120-7 [352] Luo, Z.D.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2000, 4(6), 459-466. http://dx.doi.org/10.1007/ s11916-000-0070-y [353] Johnson, C. Fibromyalgia: A brain disorder?",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 1975, 1, 277-299. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"(Maywood), 2007, 232(8), 1041-1049. http://dx.doi.org/10.3181/0702-RM-44 [356] Booth, N.E.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 2013, 11, 243. http://dx.doi.org/10.1186/1479-5876-11-243 [358] Keller, D.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
[Online] 2012. http://www.medscape.com/ viewarticle/772864?src=smo_neuro [Accessed on: 10/28/2012].,Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2013, 154(11), 2310-2316. http://dx.doi.org/10.1016/j.pain.2013.06.001 [360] Serra, J.; Collado, A.; Sola, R.; Antonelli, F.; Torres, X.; Salgueiro, M.; Quiles, C.; Bostock, H. Hyperexcitable C nociceptors in fibromyalgia.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurol., 2014, 75(2), 196-208. http://dx.doi.org/ 10.1002/ana.24065 [361] Uceyler, N.; Zeller, D.; Kahn, A.K.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain, 2013, 136(Pt 6), 1857-1867. http://dx.doi.org/10.1093/brain/awt053 [362] Chalaye, P.; Lafrenaye, S.; Goffaux, P.; Marchand, S. The role of cardiovascular activity in fibromyalgia and conditioned pain modulation.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2014, 155(6), 1064-1069. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Arthritis Rheum., 2012, 64(7), 2398-2403. http://dx.doi.org/10.1002/art.34412 [364] Pujol, J.; Macia, D.; Garcia-Fontanals, A.; Blanco-Hinojo, L.; Lopez-Sola, M.; Garcia-Blanco, S.; Poca-Dias, V.; Harrison, B.J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Pain, 2014. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"EEG Neurosci., 2010, 41(3), 132-139. http://dx.doi.org/10.1177/155005941004100305 [366] Fuster, J.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Elsevier, 2 0 0 9. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Belg., 2014, 114(1), 47-53. http://dx.doi.org/10.1007/s13760-013-0243-1 [368] Tupal, S.; Faingold, C.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Epidemiol., 2013, 23(6), 371-376. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Fatigue, 2014, 2(2), 93-109. http://dx.doi.org/10.1080/ 21641846.2014.906066 [372] Johnston, S.; Brenu, E.W.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Epidemiol., 2013, 5, 105-110. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Med., 1988, 108(3), 387-389. http://dx.doi.org/10.7326/0003-4819-108-3-387 [374] Ali, I.; O'Brien, P.; Kumar, G.; Zheng, T.; Jones, N.C.; Pinault, D.; French, C.; Morris, M.J.; Salzberg, M.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1371/ journal.pone.0066962 [375] Xue, T.; Yuan, K.; Zhao, L.; Yu, D.; Zhao, L.; Dong, T.; Cheng, P.; von Deneen, K.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"http://dx.doi.org/10.1371/ journal.pone.0052927 [376] Xu, Z.; Wang, Y.; Jin, M.; Yue, J.; Xu, C.; Ying, X.; Wu, D.; Zhang, S.; Chen, Z. Polarity-dependent effect o f  l o w-frequency stimulation on amygdaloid kindling in rats.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Brain Stimul., 2013, 6(2), 190-197. http://dx.doi.org/10.1016/j.brs.2012.04.010 [377] Smith, M.A.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Cell Neurosci., 1991, 2(2), 103-116. http://dx.doi.org/ 10.1016/1044-7431(91)90002-6 [378] Botterill, J.J.; Fournier, N.M.; Guskjolen, A.J.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neuroscience, 2014, 265, 158-171. http://dx.doi.org/10.1016/j.neuroscience.2014.01.040 [379] Beheshti, N.S.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Seizure, 2013, 22(8), 670-674. http://dx.doi.org/10.1016/j.seizure.2013.05.005 [380] Ninomiya, S.; Esumi, S.; Ohta, K.; Fukuda, T.; Ito, T.; Imayoshi, I.; Kageyama, R.; Ikeda, T.; Itohara, S.; Tamamaki, N. Amygdala kindling induces nestin expression in the leptomeninges of the neocortex.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Res., 2013, 75(2), 121-129. http://dx.doi.org/ 10.1016/j.neures.2012.12.006 [381] Chiang, S.; Haneef, Z. Graph theory findings in the pathophysiology of temporal lobe epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurophysiol., 2014, 125(7), 1295-1305. http://dx.doi.org/10.1016/j.clinph.2014.04.004 [382] Lee, S.S.; Murata, R.; Matsuura, S. Developmental study of hippocampal kindling.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2009, 10(6), 410-422. http://dx.doi.org/10.1038/nrn2648 [385] Sapolsky, R.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Dis., 2000, 7(5), 540-542. http://dx.doi.org/10.1006/nbdi.2000.0350 [386] Sapolsky, R.M.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Gen. Psychiatry, 2000, 57(10), 925-935. http://dx.doi.org/10.1001/archpsyc.57.10.925 [387] LeDoux, J.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Hypotheses, 2002, 59(6), 727-735. http://dx.doi.org/10.1016/S0306-9877(02)00321-3 [389] Sulheim, D.; Fagermoen, E.; Winger, A.; Andersen, A. M.; Godang, K.; Muller, F.; Wyller, V. B.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"JAMA Pediatrics, 2014, 168(4), 351-360. http://dx.doi.org/10.1001/ jamapediatrics.2013.4647 [390] Walsh, K.B.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Cell Host Microb., 2012, 11(6), 643-653. http://dx.doi.org/10.1016/ j.chom.2012.04.016 [391] Hooper, P.L.",OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Cell Stress Chaperones, 2012, 17(6), 647-655. http://dx.doi.org/10.1007/s12192-012-0352-4 [392] Agliari, E.; Barra, A.; Vidal, K.G.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Dyn., 2012, 6(2), 740-762. http://dx.doi.org/10.1080/17513758.2012.704083 [393] Bachstetter, A.D.; Norris, C.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Neurosci., 2012, 32(30), 10201-10210. http://dx.doi.org/10.1523/JNEUROSCI.1496-12.2012 [394] Rajeevan, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"Diagnostics, 2015, 5, 272-286. http://dx.doi.org/10.3390/diagnostics5020272 [396] Jason, L.A.; Sunnquist, M.; Brown, A.; Newton, J. L.; Strand, E. B.; Vernon, S. D. Chronic fatigue syndrome versus Systemic Exertion Intolerance Disease.",Non-OADS,/arxiv_data1/oa_pdf/1c/37/CN-13-701.PMC4761639.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)BLU suppresses tumorigenesis through anti-angiogenic activities Y Cheng et al 4228 Oncogene (2015) 4219 –4228 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/29/26/onc2014353a.PMC4761643.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Role of DACT2 in colon cancer S Wang et al 2585 © 2015 Macmillan Publishers Limited Oncogene (2015) 2575 –2585",Non-OADS,/arxiv_data1/oa_pdf/00/b4/onc2014201a.PMC4761644.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Overexpression of CDCP1 in solid cancers C Leroy et al 5598 Oncogene (2015) 5593 –5598 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e4/75/onc201519a.PMC4761645.pdf
"It must be noted, however,that through our analysis of cBioportal for Cancer Genomics(www.cBioportal.org) 41,42and The Wellcome Trust Sanger Insti- tute’s COSMIC (http://cancer.sanger.ac.uk/cancergenome/projects/ cosmic/)43databases we observed that allelic loss of ADORA2B has been reported in tumours of lung, ovarian, breast and largeintestine among others (Supplementary Figure S7).",Non-OADS,/arxiv_data1/oa_pdf/49/0b/onc2014436a.PMC4761646.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)p73 induces chemotherapy-induced death through A2B JS Long et al 5162 Oncogene (2015) 5152 –5162 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/49/0b/onc2014436a.PMC4761646.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Dual REV-ERB/autophagy inhibition in cancer cells C De Mei et al 2608 Oncogene (2015) 2597 –2608 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/06/7c/onc2014203a.PMC4761647.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Fibromyalgia Cognitive dysfunction NeuroimagingCognitive testing 1.,Non-OADS,/arxiv_data1/oa_pdf/32/aa/main.PMC4761650.pdf
http://dx.doi.org/10.1016/j.nicl.2016.01.021 2213-1582/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/32/aa/main.PMC4761650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/aa/main.PMC4761650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Using this experimental system, we observed that ribose5P, aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.02.001 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AUC, area under the curve; FGT, female genital tract; GC –MS, gas chromatography-mass spectrometry; GSH, reduced glutathione; GSSG, oxidizedglutathione; LC –MS, liquid chromatography –mass spectrometry; NET, neutrophil extracellular trap; NO, nitric oxide; NOB-PPP, non-oxidative branch pentosephosphate pathway; OB-PPP, oxidative branch pentose phosphate pathway; Pi,inorganic phosphate; PAP, human prostate acid phosphatase; PNP, purine nucleo- side phosphorylase; PNCP, purine nucleotide catabolic pathway; TLS, tumor lysis syndrome; u, units; XOR, xanthine oxidoreductase nCorrespondence address: 5347 Cottonwood Lane, Salt Lake City, Utah 84117, USA.",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.02.001 .,OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Wishnok, Macrophage oxi- dation of L-arginine to nitrite and nitrate: Nitric oxide is and intermediate, Biochemistry 27 (1988) 8706 –8711, http://dx.doi.org/10.1021/bi00424a003 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"30 (2001) 1191 –1212, http://dx.doi.org/10.1016/S0891-5849(01)00480-4 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"7 (2009) 32, http://dx.doi.org/10.1186/ 1477-5956-7-32 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"22(2000) 305 –312, http://dx.doi.org/10.1023/A:1017585308255 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"77 (2005) 8086 –8094, http://dx.doi.org/10.1021/ ac051211v .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Rutter, Mitochondrial pyruvate carrier required for pyruvate uptake in yeast, drosophila and humans, Science 337 (2012) 96–100, http://dx.doi.org/10.1126/science.1218099 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"352 (1998) 97 –102, http://dx.doi.org/10.1006/ abbi.1998.0600 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Acta 1594 (2002) 127 –135, http://dx.doi.org/10.1016/ S0167-4838(01)00296-5 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"22 (1989) 3 –9, http://dx.doi.org/10.1016/S0009-9120(89)80062-1 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"30 (2001) 1365 –1373, http://dx.doi.org/10.1016/ S0891-5849(01)00532-9 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"25 (1972) 153 –155, http://dx.doi.org/10.1016/0014-5793(72)80474-5 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"17 (2003) 349 –368, http://dx.doi.org/10.1096/fj.02-0473rev .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"68 (2001) 1086 –1092, http://dx.doi.org/10.1086/320108 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"30 (2007)735 –742, http://dx.doi.org/10.1007/s10545-007-0590-2 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"119 (2009) 1546 –1557, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Acta 38 (1960) 45 –56,http://dx.doi.org/10.1016/0006-3002(60) 91194-X .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"20 (2006) 1–15,http://dx.doi.org/10.1101/gad.1376506 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Christofferson, A. Ng, J. Yao, A. Degterev, R.J. Xavier, J. Yuan, Identi ﬁcation of a molecular signaling network that regulates a cellular ne- crotic cell death pathway by a genome wide siRNA screen, Cell 135 (2008)1311 –1323, http://dx.doi.org/10.1016/j.cell.2008.10.044 .",OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Adema, C. G. Figdor, The heme-heme oxygenase system: a molecular switch in woundhealing, Blood 102 (2003) 521 –528, http://dx.doi.org/10.1182/ blood-2002-07-2248 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"77 (1986) 319 –321, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"13 (2006) 211 –220, http://dx.doi.org/ 10.1016/j.ymthe.2005.07.684 .",OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"58 (2008) 165 –171, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"176 (2007) 231 –241, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"280 (2005) 10419 –10426, http://dx.doi.org/10.1074/jbc.M409457200 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"174 (2006) 615 –623, http://dx.doi.org/10.1083/jcb.200605036 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"54 (2005) 1027 –1033, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"7 (2012) 1730 –1739, http://dx.doi.org/10.2215/CJN.03150312 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"33 (2002) 774 –797, http://dx.doi.org/10.1016/ S0891-5849(02)00956-5 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"10 (2014) 725, http://dx.doi.org/10.1002/msb.20145228 .",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
"Barabasi, The large-scale or- ganization of metabolic networks, Nature 407 (2000) 651 –654, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/main.PMC4761651.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Functional connectivity Network topologysLORETATinnitus 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/73/main.PMC4761655.pdf
URL: http://www.lab-clint.org (S. Vanneste).,Non-OADS,/arxiv_data1/oa_pdf/f3/73/main.PMC4761655.pdf
http://dx.doi.org/10.1016/j.nicl.2016.01.0222213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/73/main.PMC4761655.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/73/main.PMC4761655.pdf
The solution space used in this study and associated lead ﬁeld matrix are those implemented in the LORETA-Key software (freely available at http://www.uzh.ch/keyinst/ loreta.htm ).,OADS,/arxiv_data1/oa_pdf/f3/73/main.PMC4761655.pdf
"Rep. 6, 19683 http://www.nature.com/articles/ srep19683 .",Non-OADS,/arxiv_data1/oa_pdf/f3/73/main.PMC4761655.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 30978 - http://dx.doi.org/10.3402/iee.v6.30978 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/e5/IEE-6-30978.PMC4761681.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30978 - http://dx.doi.org/10.3402/iee.v6.30978",Non-OADS,/arxiv_data1/oa_pdf/0f/e5/IEE-6-30978.PMC4761681.pdf
"comparingOne Health and EcoHealth Citation: Infection Ecology and Epidemiology 2016, 6: 30978 - http://dx.doi.org/10.3402/iee.v6.30978 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/e5/IEE-6-30978.PMC4761681.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30978 - http://dx.doi.org/10.3402/iee.v6.30978",Non-OADS,/arxiv_data1/oa_pdf/0f/e5/IEE-6-30978.PMC4761681.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"Discussion Key results 18 Summarize key results with reference to study objectives.Foot care knowledge and foot self-care practice Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"Systematic review ﬂow diagram on diabetes-related foot care knowledge and foot care skills interventions in US studies.Foot care knowledge and foot self-care practice Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"Ostomy Wound Manage 2002; 48: 50 /C16.Foot care knowledge and foot self-care practice Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
"8 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2016, 7: 29758 - http://dx.doi.org/10.3402/dfa.v7.29758",Non-OADS,/arxiv_data1/oa_pdf/e8/b7/DFA-7-29758.PMC4761684.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EpilepsyLaser interstitial thermal therapyCorpus callosotomyEpilepsy surgeryMRI-guided laser interstitial thermal ablationStereotactic functional neurosurgery 1.,Non-OADS,/arxiv_data1/oa_pdf/a7/63/main.PMC4761694.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.12.0032213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/63/main.PMC4761694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/63/main.PMC4761694.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.02.002 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/b2/76/main.PMC4761695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/76/main.PMC4761695.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Corpus callosotomyVagus nerve stimulationDrop attacksEndoscopy-assisted anterior two-thirds corpus callosotomy 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/08/main.PMC4761696.pdf
"De- spite various antiepileptic drugs, a ketogenic diet, and VNS, her seizuresEpilepsy & Behavior Case Reports 5 (2016) 27 –30 http://dx.doi.org/10.1016/j.ebcr.2016.01.001 2213-3232/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e5/08/main.PMC4761696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/08/main.PMC4761696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/56/main.PMC4761698.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.01.082 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/56/main.PMC4761698.pdf
"BMJ Case Rep. 22 (2013) 2013, http://dx.doi.org/10.1136/bcr-2012- 006656 .",Non-OADS,/arxiv_data1/oa_pdf/35/56/main.PMC4761698.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Brain connectivityConnectomicsBrain networksHuman brain developmentExtreme prematurityIntrauterine growth restrictionSocial cognition 1.,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.001 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
The high-resolution T1w volume is ﬁrst regis- tered to the diffusion space using the bbregister tool from Freesurfer software ( http://surfer.nmr.mgh.harvard.edu /).,OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
"In this work, the optimal modular decomposition was determined using the Brain Connectivity Toolbox (BCT) https://sites.google.",OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
"(source: http://neurolex.org/wiki/ and Atlas of the human brain, J.Mai.AP 3rd Edition).",Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1093/cercor/bhr176 .,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1088/1742 –5468/2008/10/P10008 .,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1016/j.ijdevneu.2013.11.005 .,OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1111/dmcn.12198 .,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
Cortex http://dx.doi.org/10.1093/cercor/bhu073 .,OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1371/ journal.pone.0065219 .208 E. Fischi-Gomez et al.,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1203/PDR.0b013e318212faa0 .,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
"Cortex 2016, 1 –14.http://dx.doi.org/10.1093/cercor/bhv305 .",OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1007/s00429 –012-0496-0 (Epub 2012).,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1371/journal.pone.0008525 .,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1016/S1474-4422(09)70257-1 .,OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
Brain http://dx.doi.org/10.1093/brain/awv244 .,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/67/59/main.PMC4761723.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AlphaFunctional connectivitySpatial working memory Encoding ADHDEEG-fMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.nicl.2016.01.023 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
S2 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
S3 and Table S1 can be found online at http://dx.doi.org/10.1016/j.nicl.2016.01.023 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1037/a0032371 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1006/nimg.1998.0361 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.01.023 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1109/Tmi.2003.822821 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/ S1053-8119(03)00435-X .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.jaac.2014.05.011 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"PLoS One 9 (8), e104185.http://dx.doi.org/10.1371/journal.pone.0104185 .",OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2699-08.2008 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5580-10.2011 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"Skills 95 (3 Pt 1), 837 –84 2. http://dx.doi.org/ 10.2466/pms.2002.95.3.837 .",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.0113-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"35 (1), 278– 300. http://dx.doi.org/10.1038/npp.2009.120 (npp2009120 [pii]).",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1038/nrn3475 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1176/appi.ajp.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.01.022 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"Methods 134 (1), 9 –21.http://dx.doi.org/10.1016/J.Jneumeth.2003.10.009 .",OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1017/S0954579405050388 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.cogbrainres.2004.03.009 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"2, 154. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2008.05.020 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/J.Cognition.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1097/01.wnr.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"120 (1), 73 –79.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2005.09.062 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/S0272-7358(03)00073-4 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1037//0012-1649.38.3.363 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"Neuropsychology 20 (4), 420 –42 9. http://dx.doi.org/10.1037/0894 –4105.20.4.420 .Huang-Pollock, C.L., Karalunas, S.L., Tam, H., Moore, A.N., 2012.",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1037/a0027205 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1093/cercor/bhh170 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1007/ s00406-009-0089-y .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"5, 41. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.tics.2012.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"2, 118. http://dx.doi.org/10.3389/fpsyg.2011.00118 .",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.cpr.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3755-12.2013 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00286-6 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1765-13.2014 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
Cortex http://dx.doi.org/10.1093/cercor/bhu204 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1097/chi.0b013e3181575014 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.01.031 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1097/ 01.Chi.0000153228.72591.73 .222 A. Lenartowicz et al.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1111/j.1469-7610.2005.01428.x .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"2, 99. http://dx.doi.org/10.3389/fpsyg.2011.00099 .",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/J.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/ j.clinph.2007.07.023 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1371/ journal.pone.0010298 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroscience.2013.03.011 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5295-10.2011 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1002/mrm.22361 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/ 10.1111/epi.12197 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"165 (1), 1 –11.http://dx.doi.org/10.1016/J.Bbr.2005.06.041 .",OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.tins.2007.02.001 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"2, 204. http://dx.doi.org/10.3389/ fpsyg.2011.00204 .",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.10.018 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1111/j.1460-9568.2007.05278.x .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1093/ Cercor/Bhm229 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0160-10.2010 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1586/14737175.2014.907526 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.08.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1089/brain.2012.0088 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.05.049 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1093/brain/awq183 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/J.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1017/ S1355617712000033 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.0875-06.2006 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1002/hbm.20665 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1016/J.Neuroimage.2008.02.042 .,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1006/nimg.1995.1023 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0962-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
http://dx.doi.org/10.1111/J.1745 –6924.2009.01127.X .223 A. Lenartowicz et al.,OADS,/arxiv_data1/oa_pdf/1f/f1/main.PMC4761724.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/51/omw004.PMC4761794.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/38/ofw003.PMC4761796.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 25, Number 4, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2015.0162 285",Non-OADS,/arxiv_data1/oa_pdf/24/17/scd.2015.0162.PMC4761802.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 24, Number 6, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ars.2015.6380 299",Non-OADS,/arxiv_data1/oa_pdf/24/20/ars.2015.6380.PMC4761803.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 22, Number 2, 2016, pp.",Non-OADS,/arxiv_data1/oa_pdf/5c/ba/acm.2015.0184.PMC4761810.pdf
"Online document at: https://www.g-ba.de/downloads/ 40-268-71/2006-04-18_Akupunktur-TGr.pdf, accessed January 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5c/ba/acm.2015.0184.PMC4761810.pdf
"Online document at: http://www.the-rheumatologist.org/article/what-role-does- fascia-play-in-rheumatic-dis eases/, accessed January 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5c/ba/acm.2015.0184.PMC4761810.pdf
"Online document at: http://wyss.harvard .edu/viewpage/about-us/about, accessed January 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5c/ba/acm.2015.0184.PMC4761810.pdf
"Online document at: https://www.media .mit.edu/about, accessed January 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5c/ba/acm.2015.0184.PMC4761810.pdf
"#Thomas Wernicke and Karin Kalbantner-Werni cke, 2016; Published by Mary Ann Liebert, In c. This Open Access article is distributed under the terms of the Creative Comm ons Attribution Noncommercial Lice nse (http://creativecommons.org/lic enses/by-nc/4.0/) which permits any noncommercial use, distribution, and rep roduction in any medium, provided the original author(s) and the source are credited.MEDICAL ACUPUNCTURE Volume 28, Number 1, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/acu.2015.1147 33",Non-OADS,/arxiv_data1/oa_pdf/90/13/acu.2015.1147.PMC4761815.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BIOPRESERVATION AND BIOBANKING Volume 14, Number 1, 2016Mary Ann Liebert, Inc.DOI: 10.1089/bio.2015.0061 56",Non-OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
"The GGBN Data Portal (http://data.ggbn.org) is based on established systems: GBIF (Global Biodiversity InformationFacility), 22BioCASe (Biological Collection Access Ser- vice),23IPT (Integrated Publishing Toolkit),24and INSDC (International Nucleotide Sequence Data Base Collabora-tion).25Each GGBN partner is responsible for its data and samples, and deﬁnes conditions for access; scientists can order samples easily via the shared portal.",OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
Furthermore it can handle SPREC (http://terms.tdwg.org/wiki/ggbn:preparationProcess).,OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
Available from: URL:http://www.wma.net/en/ 30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
Global Genome Biodi-versity Network http://ggbn.org/docs/ABS_Guidance/GG BN MTA_June_2015-Final.pdf.,OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
2008;http://www.oecd.org/scie nce/sci-tech/42237442.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
1994; ftp://ftp.fao.org/docrep/ fao/meeting/015/aj680e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/b9/bio.2015.0061.PMC4761830.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT Volume 6, Number 1, 2016Mary Ann Liebert, Inc.DOI: 10.1089/ther.2015.0022 48",Non-OADS,/arxiv_data1/oa_pdf/55/eb/ther.2015.0022.PMC4761850.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.GENETIC TESTING AND MOLECULAR BIOMARKERS Volume 20, Number 2, 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/b6/80/gtmb.2015.0148.PMC4761852.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/45/53/bmjdrc-2015-000164.PMC4761984.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/f4/main.PMC4762054.pdf
http://dx.doi.org/10.1016/j.ijcha.2015.07.001 2352-9067/© 2015 Published by Elsevier Ireland Ltd.,Non-OADS,/arxiv_data1/oa_pdf/28/f4/main.PMC4762054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/f4/main.PMC4762054.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.e lsevier.com/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/28/f4/main.PMC4762054.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Stroke Direct costsAgincourt HDSSCost-of-illnessRuralSouth Africa 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/62/main.PMC4762059.pdf
http://dx.doi.org/10.1016/j.ensci.2016.01.001 2405-6502/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/62/main.PMC4762059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/62/main.PMC4762059.pdf
Contents lists available at ScienceDirect eNeurologicalSci journal homepage: http://ees.elsevier.com/ensci/,Non-OADS,/arxiv_data1/oa_pdf/7d/62/main.PMC4762059.pdf
"[17] South African Reserve Bank, Historical Exchange and Interest Rates, Retrieved 09/26, 2015, from https://www.resbank.co.za/Research/Rates/Pages/ SelectedHistoricalExchangeAndInterestRates.aspx 2015.",Non-OADS,/arxiv_data1/oa_pdf/7d/62/main.PMC4762059.pdf
"[26] South African Medicines Price Registry, Available http://www.mpr.gov.za/ 2015 (2015, 08/12).",Non-OADS,/arxiv_data1/oa_pdf/7d/62/main.PMC4762059.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sanﬁlippo Syndrome, Type B Behavior phenotypeLack of fear and autistic symptoms 1.",Non-OADS,/arxiv_data1/oa_pdf/de/a8/main.PMC4762067.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.01.003 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/a8/main.PMC4762067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/a8/main.PMC4762067.pdf
http://dx.doi.org/10.1007/8904_2013_269 .,Non-OADS,/arxiv_data1/oa_pdf/de/a8/main.PMC4762067.pdf
"[28] R Core Team, R: a language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria, 2014 (URL http://www.R-project.org /).",Non-OADS,/arxiv_data1/oa_pdf/de/a8/main.PMC4762067.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009686).,Non-OADS,/arxiv_data1/oa_pdf/66/aa/bmjopen-2015-009686.PMC4762072.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009023).,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
"The NSW-CDS (http://www.nsw-cds.com.au) adopts a life course epidemiological approach to examine associa-tions at a population level between various indices of biological and environmental exposures (eg, perinatal complications, child maltreatment, parental mentalillness or parental criminal history), and a range of indices of psychosocial adjustment in later childhood, adolescence and young adulthood.",Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
"Aggregated data are publicly avail- able, and microdata for use in record linkage studiescan be accessed at http://www.AEDCdata.com.au.",OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
"The record linkage was conducted by an independent agency, the Centre for Health Record Linkage(CHeReL: http://www.cherel.org.au/) using ChoiceMaker software (Choice Maker T echnologies Inc.) to facilitate probabilistic record linkage methodsthat ensure strict privacy protocols are adhered to.",Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
http://www.health.gov.au/internet/main/publishing.nsf/Content/mental-pubs-m-child2 2.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
http://www.healthmetricsandevaluation.org/gbd/visualizations/ gbd-arrow-diagram 3.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
PHE 82. http://www.aihw.gov.au/publication-detail/?id=6442467990 5.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
3101.0. http://www.abs.gov.au/ausstats/abs@.nsf/mf/3101.0 7.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
3218.0. http://www.abs.gov.au/ausstats/abs@.nsf/mf/3218.0/ 8.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
2033.0.55.001. http://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001/ 13.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
Occasional Papers: New series No.14.2001 (cited 2 Nov 2015) http://www.health.gov.au/internet/main/ publishing.nsf/Content/E2EE19FE831F26BFCA257BF0001F3DFA/$File/ocpanew14.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
http://www.rch.org.au/aedi/Researchers/Technical_papers/ 15.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e72_national_statement_may_2015_150514_a.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
IHW 66. http://www.aihw.gov.au/publication-detail/?id=10737420657 17.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
4102.0. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4102.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
2011 (cited 12 Sep 2014 Sep).http://soac.fbe.unsw.edu .au/2011/papers/SOAC2011_0116_final.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
1367.0. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/1367.0~2011~Main%20Features~Australia%20Home~1 21.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
http://www.oecd.org/ pisa/keyfindings/pisa2009keyfindings.htm 22.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
3302.0. http://www.abs.gov.au/ausstats/abs@.nsf/mf/3302.0 23.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/bmjopen-2015-009023.PMC4762073.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010293).,Non-OADS,/arxiv_data1/oa_pdf/b1/f0/bmjopen-2015-010293.PMC4762074.pdf
variants within the MLH1 and PMS2 genes were classi- ﬁed for pathogenicity based on the InSiGHT database classiﬁcations15(http://insight-group.org/variants/ classiﬁcations/).,OADS,/arxiv_data1/oa_pdf/b1/f0/bmjopen-2015-010293.PMC4762074.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/f0/bmjopen-2015-010293.PMC4762074.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010134).,Non-OADS,/arxiv_data1/oa_pdf/9c/f3/bmjopen-2015-010134.PMC4762075.pdf
doi:10.1136/bmjopen-2015- 009689 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009689).,Non-OADS,/arxiv_data1/oa_pdf/2e/77/bmjopen-2015-009689.PMC4762078.pdf
http://www.hcsp.fr/Explore.cgi/AvisRapports(accessed 3 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/2e/77/bmjopen-2015-009689.PMC4762078.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010873).,Non-OADS,/arxiv_data1/oa_pdf/a8/59/bmjopen-2015-010873.PMC4762079.pdf
"R V .3.1.3 (R-project, http://www.r-project.org) was used to build a parallel-coordinates plot and a box plot of the between-group difference for visua- lising the results of Friedman ’st e s t .G * P o w e r3 .",OADS,/arxiv_data1/oa_pdf/a8/59/bmjopen-2015-010873.PMC4762079.pdf
doi:10.1136/bmjopen-2015- 010298 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010298).,Non-OADS,/arxiv_data1/oa_pdf/58/8d/bmjopen-2015-010298.PMC4762082.pdf
http://www.mnh.or.tz/index.php/about-us 13.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/bmjopen-2015-010298.PMC4762082.pdf
http://www.emtct-iatt.org/wp- content/uploads/2012/11/Costed-eMTCT-Plan-Final-Nov-20121.pdf(accessed 19 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/58/8d/bmjopen-2015-010298.PMC4762082.pdf
http://kff.org/global-health-policy/fact-sheet/the-global-hivaids-epidemic/ 22.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/bmjopen-2015-010298.PMC4762082.pdf
http://apps.who.int/iris/bitstream/10665/44443/1/9789241500395_eng.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/58/8d/bmjopen-2015-010298.PMC4762082.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010028).,Non-OADS,/arxiv_data1/oa_pdf/a8/00/bmjopen-2015-010028.PMC4762083.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/00/bmjopen-2015-010028.PMC4762083.pdf
(http://www.Rproject.org).,Non-OADS,/arxiv_data1/oa_pdf/4e/3b/bmjopen-2015-010282.PMC4762084.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008558).,Non-OADS,/arxiv_data1/oa_pdf/9d/fc/bmjopen-2015-008558.PMC4762085.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006813).,Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
2014. http://www.parkinsons.,Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
London: The Stationary Office: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/247900/0941.pdf(accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
"Sheffield: Sheffield Hallam University, 2014. http://shura.shu.ac.uk/7965/ (accessed Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
http://www.parkinsons.org.uk/sites/default/files/publications/download/english/memberssurvey_fullreport.pdf (accessed Jun2015).,Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
http://www.england.nhs.uk/wp-content/uploads/2013/12/bcf-itf-sup-pck.pdf (accessedAug 2014).,Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
http://www.rcn.org.,Non-OADS,/arxiv_data1/oa_pdf/cd/61/bmjopen-2014-006813.PMC4762087.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010164).,Non-OADS,/arxiv_data1/oa_pdf/bc/b4/bmjopen-2015-010164.PMC4762089.pdf
For further information see http://www.hra.nhs.uk Provenance and peer review Not commissioned; externally peer reviewed.,Non-OADS,/arxiv_data1/oa_pdf/bc/b4/bmjopen-2015-010164.PMC4762089.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/b4/bmjopen-2015-010164.PMC4762089.pdf
http://www.medscape.com/viewarticle/844809?nlid=81403_1004&src=wnl_edit_medp_urol&uac=224577PK&spon=15 7.,Non-OADS,/arxiv_data1/oa_pdf/dc/0e/bmjopen-2015-010191.PMC4762090.pdf
http://leitlinienprogrammonkologie.de/Leitlinien7.0.html 17.,Non-OADS,/arxiv_data1/oa_pdf/dc/0e/bmjopen-2015-010191.PMC4762090.pdf
2010;11.01.2010 http://www.sprechzimmer.ch/sprechzimmer/Fokus/Prostatakrebs/Aktuell/Prostatakrebs_Jeder_achte_PSA_Test_ist_falsch_positiv.php.,Non-OADS,/arxiv_data1/oa_pdf/dc/0e/bmjopen-2015-010191.PMC4762090.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/27/9d/bmjopen-2015-010583.PMC4762092.pdf
"2011, Chapter 7. http://handbook.cochrane.org/ 28.",Non-OADS,/arxiv_data1/oa_pdf/fc/cb/bmjopen-2015-010487.PMC4762093.pdf
2016. http://apps.who.int/classifications/icd10/browse/ 2016/en#/T66-T78 7.,OADS,/arxiv_data1/oa_pdf/25/1e/bmjopen-2015-009818.PMC4762095.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009690).,Non-OADS,/arxiv_data1/oa_pdf/71/75/bmjopen-2015-009690.PMC4762096.pdf
"The survey was hosted on Survey Monkey, a third party website and online survey administration software (http://www.surveymonkey.com).",OADS,/arxiv_data1/oa_pdf/71/75/bmjopen-2015-009690.PMC4762096.pdf
2015. http://www.forensicnurses.org/?page=A517.,Non-OADS,/arxiv_data1/oa_pdf/71/75/bmjopen-2015-009690.PMC4762096.pdf
http://client.dlc-inc.com/WCH/SADVTC/login.php.,Non-OADS,/arxiv_data1/oa_pdf/71/75/bmjopen-2015-009690.PMC4762096.pdf
http://dveducation.ca/sexualassault/.,Non-OADS,/arxiv_data1/oa_pdf/71/75/bmjopen-2015-009690.PMC4762096.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010533).,Non-OADS,/arxiv_data1/oa_pdf/7c/8e/bmjopen-2015-010533.PMC4762098.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/8e/bmjopen-2015-010533.PMC4762098.pdf
"HSE Books, 2003. http://www.hse.gov.uk/research/rrpdf/rr079.pdf (assessed 21Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/7c/8e/bmjopen-2015-010533.PMC4762098.pdf
1989. http://www.cdph.ca.gov/programs/hesis/Documents/epoxy.pdf (assessed 21Dec 2015).,OADS,/arxiv_data1/oa_pdf/7c/8e/bmjopen-2015-010533.PMC4762098.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010307).,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmjopen-2015-010307.PMC4762099.pdf
https://www.socialstyrelsen.,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmjopen-2015-010307.PMC4762099.pdf
http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/10414/2004-123-3_20041233.pdf(accessed 1 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmjopen-2015-010307.PMC4762099.pdf
Scand J Trauma Resusc Emerg Med 2012;20:3. http://www.sjtrem.com/content/20/1/3 (accessed 4 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmjopen-2015-010307.PMC4762099.pdf
https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/12697/1997-3-15.pdf (accessed 01 Oct 2015) 50.,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmjopen-2015-010307.PMC4762099.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009670).,Non-OADS,/arxiv_data1/oa_pdf/b0/98/bmjopen-2015-009670.PMC4762102.pdf
"https://www.gov.uk/government/news/extending-the-street-triage-scheme-new-patrolswith-nurses-and-the-police Heslin M, et al.BMJ Open 2016; 6:e009670.",Non-OADS,/arxiv_data1/oa_pdf/b0/98/bmjopen-2015-009670.PMC4762102.pdf
2013. http://neighbourhood.statistics.gov.uk/dissemination/ viewFullDataset.do?instanceSelection=033488&productId=2491& $ph=60_61_62&datasetInstanceId=33488&startColumn=1&numberOfColumns=8&containerAreaId=6275000(accessed 12 Feb 2015).,OADS,/arxiv_data1/oa_pdf/b0/98/bmjopen-2015-009670.PMC4762102.pdf
2001. http://www.medicine.ox.ac.uk/ bandolier/painres/download/whatis/ImplementQALYs.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/b0/98/bmjopen-2015-009670.PMC4762102.pdf
2012. https://www.nice.org.uk/article/pmg6/chapter/7-assessing-cost-effectiveness 12.,Non-OADS,/arxiv_data1/oa_pdf/b0/98/bmjopen-2015-009670.PMC4762102.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009981).,Non-OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
New in Stata 11. http://www.stata.com/ stata11/ (accessed 8 Apr 2015)).,OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.g2t66.,OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
https://indicators.ic.nhs.uk/download/GP%20Practice%20data/Specification/SMR%20v1.pdf (accessed 8 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
http://www.apho.org.uk/resource/item.aspx?RID=97049 (accessed8 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
December 2011.https://indicators.ic.nhs.uk/webview/index/en/MyServer/ NHS-Information-Centre-indicators.c.MyServer/GP-Practice-data.d.,Non-OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
https://gp-patient.co.uk/ surveys-and-reports (accessed 8 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
2010. https://indicators.ic.nhs.uk/download/Infrastructure/Specification/GP%20numbers%20v2.pdf (accessed 8 Apr 2015).,OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
http://www.apho.org.uk/resource/view.aspx?QN=IND_SERIES (accessed 11Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
HMSO 2014. http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0009/117378/FLS-09-1801-1029.pdf (accessed 24 Apr 2015).,OADS,/arxiv_data1/oa_pdf/25/02/bmjopen-2015-009981.PMC4762103.pdf
OECD Obesity Update 2014. http://www.oecd.org/health/health- systems/theeconomicsofprevention.htm (accessed December 2015).,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/bmjopen-2015-010062.PMC4762105.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008878).,Non-OADS,/arxiv_data1/oa_pdf/d7/3d/bmjopen-2015-008878.PMC4762106.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009421).,Non-OADS,/arxiv_data1/oa_pdf/2c/60/bmjopen-2015-009421.PMC4762107.pdf
http://www.idf.org/diabetesatlas (accessed 21 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/2c/60/bmjopen-2015-009421.PMC4762107.pdf
http://www.who.int/ mediacentre/factsheets/fs312/en/ (accessed 1 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/2c/60/bmjopen-2015-009421.PMC4762107.pdf
http://www.nicedsu.org.uk/evidence-synthesis-tsd-series%282391675%29.htm (accessed 1May 2015).,Non-OADS,/arxiv_data1/oa_pdf/2c/60/bmjopen-2015-009421.PMC4762107.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009540).,Non-OADS,/arxiv_data1/oa_pdf/38/75/bmjopen-2015-009540.PMC4762109.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010098).,Non-OADS,/arxiv_data1/oa_pdf/01/13/bmjopen-2015-010098.PMC4762110.pdf
http://www.helse-sorost.no/omoss/ english/Sider/page.aspx.,Non-OADS,/arxiv_data1/oa_pdf/01/13/bmjopen-2015-010098.PMC4762110.pdf
2. http://www.en.wikipedia.org/wiki/Decision-making (accessed 6 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/01/13/bmjopen-2015-010098.PMC4762110.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009915).,Non-OADS,/arxiv_data1/oa_pdf/e6/c6/bmjopen-2015-009915.PMC4762111.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/c6/bmjopen-2015-009915.PMC4762111.pdf
http://webarchive.nationalarchives.gov.uk/20130107105354/https://www.wp.dh.gov.uk/immunisation/files/2012/03/120319_HPV_UptakeReport2010 – 11-revised_acc.pdf (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/e6/c6/bmjopen-2015-009915.PMC4762111.pdf
http://webarchive.nationalarchives.gov.uk/20130123170526/http://immunisation.dh.gov.uk/ann-hpv-vac-cover-england-201112/ (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/e6/c6/bmjopen-2015-009915.PMC4762111.pdf
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/266190/HPV_AnnualDataTable2012_13_SHA_acc2.pdf (accessed Apr 2015).,OADS,/arxiv_data1/oa_pdf/e6/c6/bmjopen-2015-009915.PMC4762111.pdf
https://www.gov.uk/government/publications/annual-hpv-vaccine-coverage-in-england-in-2009 –2010 (access Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/e6/c6/bmjopen-2015-009915.PMC4762111.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010450).,Non-OADS,/arxiv_data1/oa_pdf/2b/8b/bmjopen-2015-010450.PMC4762113.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/8b/bmjopen-2015-010450.PMC4762113.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008681).,Non-OADS,/arxiv_data1/oa_pdf/22/4f/bmjopen-2015-008681.PMC4762115.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009196).,Non-OADS,/arxiv_data1/oa_pdf/4a/a4/bmjopen-2015-009196.PMC4762116.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 24574504 http://dx.doi.org/10.1093/bja/aeu013 34.,Non-OADS,/arxiv_data1/oa_pdf/4a/a4/bmjopen-2015-009196.PMC4762116.pdf
https://hee.nhs.uk/our-work/hospitals-primary-community- care/learning-be-safer/better-training-better-care-btbc/broadening-foundation-programme 2.,Non-OADS,/arxiv_data1/oa_pdf/b1/84/bmjopen-2015-009931.PMC4762117.pdf
2013. http://www.rcgp.org.uk/policy/rcgp-policy-areas/~/media/Files/Policy/A-Z-policy/Medical-Generalism-Impact-Report-March-2013.ashx 3.,Non-OADS,/arxiv_data1/oa_pdf/b1/84/bmjopen-2015-009931.PMC4762117.pdf
2015. http://www.england.,Non-OADS,/arxiv_data1/oa_pdf/b1/84/bmjopen-2015-009931.PMC4762117.pdf
"GMC, 2012. http://www.gmc-uk.org/Summary___The_state_of_medical_education_and_practice_in_the_UK_2012___English_0912.pdf_49860320.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/b1/84/bmjopen-2015-009931.PMC4762117.pdf
"2015. https://heeoe.hee.nhs.uk/cpd_primary_care 8 Griffin A, et al.BMJ Open 2016; 6:e009931.",Non-OADS,/arxiv_data1/oa_pdf/b1/84/bmjopen-2015-009931.PMC4762117.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010329).,Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmjopen-2015-010329.PMC4762118.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmjopen-2015-010329.PMC4762118.pdf
2015. http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmjopen-2015-010329.PMC4762118.pdf
2015. http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmjopen-2015-010329.PMC4762118.pdf
Presented at the International Congress on Peer Review and Biomedical Publication ;1 6–18 September 2005. http://www.peerreviewcongress.org/abstracts.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmjopen-2015-010329.PMC4762118.pdf
The Guardian 2010 Sept 18. http://www.theguardian.com/commentisfree/2010/sep/18/bad-science-medical-ghostwriters (accessed 11 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmjopen-2015-010329.PMC4762118.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010530).,Non-OADS,/arxiv_data1/oa_pdf/28/09/bmjopen-2015-010530.PMC4762119.pdf
"12 METHODS AND ANALYSIS The trial is registered at http://www.clinicaltrials.gov (NCT02280759), and any important changes in theprotocol will be implemented there.",Non-OADS,/arxiv_data1/oa_pdf/28/09/bmjopen-2015-010530.PMC4762119.pdf
http://www.who.int/childgrowth/ en/ 14.,Non-OADS,/arxiv_data1/oa_pdf/28/09/bmjopen-2015-010530.PMC4762119.pdf
2013. http://aaa.screening.nhs.uk 3.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
http://www.cochranehandbook.org.,OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
2009. http://controlled-trials.com/mrct/trial/229677/ajax 40.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
2005. http://www.controlled-trials.com/ISRCTN66212637/ISRCTN66212637 41.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
Balm R. 2012. http://www.cxvascular.com/cx-latest-news/cx-latest- news/ajax-confirms-no-difference-between-evar-and-open-repair-for- ruptured-aneurysms 42.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
http://www.hta.ac.uk/protocols/200700370064.pdf 48.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
http://clinicaltrials.gov/ct2/show/NCT00577616?term=ECAR&rank=1 52.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
2008. http://clinicaltrials.gov/ct2/show/NCT00577616?,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjopen-2015-008391.PMC4762122.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009414).,Non-OADS,/arxiv_data1/oa_pdf/da/02/bmjopen-2015-009414.PMC4762123.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/da/02/bmjopen-2015-009414.PMC4762123.pdf
https://www.iqwig.de/ 12.,Non-OADS,/arxiv_data1/oa_pdf/da/02/bmjopen-2015-009414.PMC4762123.pdf
2011. http://handbook.cochrane.org/ 13.,OADS,/arxiv_data1/oa_pdf/da/02/bmjopen-2015-009414.PMC4762123.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009743).,Non-OADS,/arxiv_data1/oa_pdf/d0/e3/bmjopen-2015-009743.PMC4762131.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/e3/bmjopen-2015-009743.PMC4762131.pdf
2014. http://www.iiyi.com/ d-29-198697.html 11.,Non-OADS,/arxiv_data1/oa_pdf/d0/e3/bmjopen-2015-009743.PMC4762131.pdf
2014. http://www.sts.org/sts-national-database/ 46.,OADS,/arxiv_data1/oa_pdf/d0/e3/bmjopen-2015-009743.PMC4762131.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010460).,Non-OADS,/arxiv_data1/oa_pdf/8d/d5/bmjopen-2015-010460.PMC4762136.pdf
http://reliefweb.int/report/iraq/iraq-emergency-response-humanitarian-partners-march-july-2015(accessed 17 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/d5/bmjopen-2015-010460.PMC4762136.pdf
http://www.theguardian.com/ world/2006/mar/24/iraq.jonathansteele (accessed 16 Sep 2006).,Non-OADS,/arxiv_data1/oa_pdf/8d/d5/bmjopen-2015-010460.PMC4762136.pdf
"http://who.int/hac/crises/irq/iraq_phra_24october2014.pdf (accessed17th September, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/d5/bmjopen-2015-010460.PMC4762136.pdf
http://www.theguardian.com/world/2015/sep/06/refugee-crisis- un-agencies-broke-failing (accessed 17 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/d5/bmjopen-2015-010460.PMC4762136.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010592).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
Secondary Heath and Social Care Act 2012 c.7 2012. http://www.legislation.gov.uk/ukpga/2012/7/contents/enacted (accessed Oct 2015).8.,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
http://www.southdevonandtorbayccg.nhs.uk/ about-us/Documents/annual-report-and-accounts-2014 –2015.pdf (accessed Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
"North, East and West Devon Clinical Commissioning Group Prospectus 2015. http://www.newdevonccg.nhs.uk/about-us/100069(accessed Oct 2015).",Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
http://www.somersetccg.nhs.uk/publications/ annual-report/ (accessed Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
2013.https://www.gov.uk/government/news/seven-day-8am-8pm-gp-access-for-hard-working-people (accessed Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
http://www.somersetsafehouse.co.uk/ index.php (accessed Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
https://www.hee.nhs.uk/sites/default/files/documents/The%20Future%20of%20Primary%20Care%20report.pdf(accessed 11 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
http://bma.org.uk/support-at-work/ pensions (accessed Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/bmjopen-2015-010592.PMC4762139.pdf
"To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjresp-2015- 000110) Received 8 September 2015 Revised 8 December 2015 Accepted 11 December 2015 1Oxford Centre for Respiratory Medicine, NIHROxford Biomedical Research Centre, Oxford University Churchill Campus, and Oxford University Hospitals NHS Trust, Oxford, UK 2Lane Fox Clinical Respiratory Physiology Centre, St Thomas ’Hospital, Guy ’s&S t Thomas ’NHS Foundation Trust, London, UK Correspondence to Dr Ari R Manuel; ari.manuel@ouh.nhs.ukABSTRACT Introduction: Only a third of obese patients develop chronic ventilatory failure.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/bmjresp-2015-000110.PMC4762144.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/bmjresp-2015-000110.PMC4762144.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007949).,Non-OADS,/arxiv_data1/oa_pdf/62/57/bmjopen-2015-007949.PMC4762147.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010455).,Non-OADS,/arxiv_data1/oa_pdf/99/6c/bmjopen-2015-010455.PMC4762151.pdf
http://www.who.int/ageing/about/facts/en/index.html 23.,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/bmjopen-2015-008119.PMC4762152.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008802).,Non-OADS,/arxiv_data1/oa_pdf/cd/b6/bmjopen-2015-008802.PMC4762153.pdf
http://ideas.repec.org/a/aea/aecrev/ v80y1990i1p305-08.html 15.,Non-OADS,/arxiv_data1/oa_pdf/cd/b6/bmjopen-2015-008802.PMC4762153.pdf
"Geneva: World Health Organization, 2009.http://www.who.int/gho/en/ 28.",Non-OADS,/arxiv_data1/oa_pdf/cd/b6/bmjopen-2015-008802.PMC4762153.pdf
"METHODS Study population and setting All 93 210 citizens aged ≥20 years in Nord-Trøndelag County, Norway, received a postal invitation to partici- pate in the third wave of HUNT (HUNT3, 2006 –2008, http://www.ntnu.edu/hunt).",Non-OADS,/arxiv_data1/oa_pdf/20/96/openhrt-2015-000363.PMC4762188.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/20/96/openhrt-2015-000363.PMC4762188.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/vetreco-2015-000154).,Non-OADS,/arxiv_data1/oa_pdf/55/e7/vetreco-2015-000154.PMC4762206.pdf
To view please visit the journal (http://dx.doi.org/10.1136/rmdopen-2015- 000228).,Non-OADS,/arxiv_data1/oa_pdf/9d/35/rmdopen-2015-000228.PMC4762207.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/35/rmdopen-2015-000228.PMC4762207.pdf
http://www.medicines.org.uk/emc/medicine/19714/SPC/.,Non-OADS,/arxiv_data1/oa_pdf/9d/35/rmdopen-2015-000228.PMC4762207.pdf
http://www.bmscanada.ca/ static/products/en/pm_pdf/ORENCIA_EN_PM.pdf.,OADS,/arxiv_data1/oa_pdf/9d/35/rmdopen-2015-000228.PMC4762207.pdf
To view please visit the journal (http://dx.doi.org/10.1136/rmdopen-2015- 000172).,Non-OADS,/arxiv_data1/oa_pdf/34/85/rmdopen-2015-000172.PMC4762208.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/34/85/rmdopen-2015-000172.PMC4762208.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000189).,Non-OADS,/arxiv_data1/oa_pdf/83/5b/rmdopen-2015-000189.PMC4762209.pdf
Available online: http://www.itl.nist.gov/div898/ handbook (2006).,Non-OADS,/arxiv_data1/oa_pdf/6b/83/srep04763.PMC4762219.pdf
http://www.fil.ion.ucl.ac.uk/spm/doc/ (Date of access: 03/13/ 2014) 48.,Non-OADS,/arxiv_data1/oa_pdf/6b/83/srep04763.PMC4762219.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/83/srep04763.PMC4762219.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4763 | DOI: 10.1038/srep04763 7",Non-OADS,/arxiv_data1/oa_pdf/6b/83/srep04763.PMC4762219.pdf
"28 mm midline hypervascular partially-cystic and par-tially solid sellar mass causing a signiﬁcant brain com-pression with oedema, and extending into the suprasellarregion with cavernous sinus invasion and chiasmal Open AccessJ Bukowczan and others Reversal of severe cognitive impairmentID: 15-0111; February 2016 DOI: 10.1530/EDM-15-0111 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2016 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd.",Non-OADS,/arxiv_data1/oa_pdf/cc/ec/edmcr-2016-150111.PMC4762223.pdf
J Bukowczan and others Reversal of severe cognitive impairmentID: 15-0111; February 2016 DOI: 10.1530/EDM-15-0111 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/cc/ec/edmcr-2016-150111.PMC4762223.pdf
At presentation After 6 months of treatment Reference range T Score Percentile T Score Percentile T Score Percentile Figure immediate 43 25 66 94 O52 O60 Figure delayed 35 7 61 87 O50 O60 Design learning 42 20 60 85 O48 O60 Story immediate 33 4 57 76 O45 O60 Story delayed 32 4 59 82 O43 O60 List learning 39 14 71 98 O45 O60 J Bukowczan and others Reversal of severe cognitive impairmentID: 15-0111; February 2016 DOI: 10.1530/EDM-15-0111 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/cc/ec/edmcr-2016-150111.PMC4762223.pdf
Received in ﬁnal form 8 December 2015 Accepted 9 February 2016 J Bukowczan and others Reversal of severe cognitive impairmentID: 15-0111; February 2016 DOI: 10.1530/EDM-15-0111 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/cc/ec/edmcr-2016-150111.PMC4762223.pdf
"After surgery, a chest and an abdominal computed tomography (CT) scan was performed due to persistent Open AccessT Zornitzki and others pNET co-secreting GHRH and calcitoninID: 15-0134; February 2016 DOI: 10.1530/EDM-15-0134 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2016 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd.",Non-OADS,/arxiv_data1/oa_pdf/78/13/edmcr-2016-150134.PMC4762224.pdf
T Zornitzki and others pNET co-secreting GHRH and calcitoninID: 15-0134; February 2016 DOI: 10.1530/EDM-15-0134 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/78/13/edmcr-2016-150134.PMC4762224.pdf
Test PatientControl/normal range Blood GHRH (ng/l) 1273 !60 Calcitonin (pg/ml) 978 !5 In vitro Incubation of pNET with medium pNET-derived GHRH release (ng/l) 57 404 UndetectedpNET-derived calcitonin release (pg/ml)3798 Undetected Effect of pNET-derived medium on GH release from human pituitary culture Change in GH release 36% increaseNo change in the presenceof control medium T Zornitzki and others pNET co-secreting GHRH and calcitoninID: 15-0134; February 2016 DOI: 10.1530/EDM-15-0134 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/78/13/edmcr-2016-150134.PMC4762224.pdf
( doi:10.1530/EJE-15-0917 ) Received in ﬁnal form 26 January 2016 Accepted 5 February 2016 T Zornitzki and others pNET co-secreting GHRH and calcitoninID: 15-0134; February 2016 DOI: 10.1530/EDM-15-0134 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/78/13/edmcr-2016-150134.PMC4762224.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"Immunomagnetic separation of EVs EVs (25 mg NK cell EVs, 50 mg platelet EVs or a mixture of 12.5 mg NK cell EVs and 25 mg platelet EVs) wereDiversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"beads linked to an antibody which does not bind EVs.Diversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"To resolve the small size of EVs, we used a superresolution microscopy technique, calledDiversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"Scale bars represent 500 nm.Diversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"Monocyte EVs stained with a mixture of the sameanti-CD81 antibody coupled to either one of two dyesrevealed that most EVs were stained with only one of theDiversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2011;21:708 /C121.Diversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2014;3:24641,doi: http://dx.doi.org/10.3402/jev.v3.24641 31.",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"J Extracell Vesicles.2013;2:20389, doi: http://dx.doi.org/10.3402/jev.v2i0.20389 42. van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R. Innovation in detection of microparticles and exosomes.",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2013;2:20920, doi: http://dx.doi.org/10.3402/jev.v2i0.20920 44.",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975",OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2012;1:18374, doi: http://dx.doi.org/10.3402/jev.v1i0.18374 58.",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2014;3: 24692, doi: http://dx.doi.org/10.3402/jev.v3.24692 59.",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
"2015;4:26316, doi:http://dx.doi.org/10.3402/jev.v4.26316Diversity of extracellular vesicles Citation: Journal of Extracellular Vesicles 2016, 5: 29975 - http://dx.doi.org/10.3402/jev.v5.29975 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/JEV-5-29975.PMC4762227.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/15/12/JIPS-15-33.PMC4762285.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/15/12/JIPS-15-33.PMC4762285.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d8/52/JIPS-15-8.PMC4762290.pdf
Available from: http://www.gktoday.in/indias‑elderly‑ populationsome‑fundamentals/.,Non-OADS,/arxiv_data1/oa_pdf/5c/ab/JIPS-15-17.PMC4762292.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/9c/11/JIPS-15-2.PMC4762294.pdf
Available from: http://www.td.sirona.com/pdf/6359801.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/78/JIPS-15-173.PMC4762301.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b4/49/JIPS-15-91.PMC4762305.pdf
Available from: http://www.ohg.cochrane.org.,OADS,/arxiv_data1/oa_pdf/ab/3b/JIPS-15-179.PMC4762313.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/ab/3b/JIPS-15-179.PMC4762313.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/ab/3b/JIPS-15-179.PMC4762313.pdf
Available from: http://www.en.wikipedia.org/wiki/sodium.hypochlorite.,Non-OADS,/arxiv_data1/oa_pdf/36/5d/JIPS-15-131.PMC4762316.pdf
Supportin ginformation andORCID(s )from theauthor(s) forthis article areavailable ontheWWW under http://dx.doi.org/ 10.1002/ anie.201510 847.,Non-OADS,/arxiv_data1/oa_pdf/ed/36/ANIE-55-3224.PMC4762321.pdf
"3,Novosibir sk6300 90(Russ ia) and Novosibir skState Universi ty,Pirogo va2,Novosibir sk630090 (Russia) Supportin ginformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.10 02/chem.20 1504644.",Non-OADS,/arxiv_data1/oa_pdf/4a/c9/CHEM-22-2599.PMC4762322.pdf
Available from: http://www.ortstom.odmu.edu.ua/en/methodical‑  work/practical/2nd‑ year‑3rd‑term/54‑silikonovye‑ottisknye‑materialy  ‑fiziko‑himicheskie‑svojstva‑pokazanija‑k‑primeneniju‑   predstaviteli‑metody‑poluchenija‑kombinirovannyh‑ottiskov.,Non-OADS,/arxiv_data1/oa_pdf/db/8e/JIPS-15-263.PMC4762328.pdf
Available from: http://www.modental.org/docs/events/ce/ ceimpression.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/8e/JIPS-15-263.PMC4762328.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/99/63/JIPS-15-250.PMC4762336.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/99/63/JIPS-15-250.PMC4762336.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/69/0e/JIPS-15-200.PMC4762337.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/38/58/JIPS-15-367.PMC4762351.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/38/58/JIPS-15-367.PMC4762351.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/69/79/JIPS-15-292.PMC4762353.pdf
Available  from: http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/0e/b4/JIPS-15-381.PMC4762359.pdf
Available from: http://www.guidelinedevelopment.org.,Non-OADS,/arxiv_data1/oa_pdf/0e/b4/JIPS-15-381.PMC4762359.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/dvv003.PMC4762373.pdf
"Available: https://ideas.repec.org/c/boc/bocode/s457581.html (4 March 2015, date last accessed) .",Non-OADS,/arxiv_data1/oa_pdf/9d/48/dvv003.PMC4762373.pdf
"R package version 3.6-0. http://CRAN.R-project.org/package=rms Received for publication: 7.5.2015; Accepted in revised form: 29.9.2015 Nephrol Dial Transplant (2016) 31: 447 –454 doi: 10.1093/ndt/gfv272Advance Access publication 6 July 2015 Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: apost hoc analysis (ORIENT-blood pressure) Enyu Imai1,2, Sadayoshi Ito3, Masakazu Haneda4, Atsushi Harada5, Fumiaki Kobayashi5, Tetsu Yamasaki5, Hirofumi Makino6and Juliana C.N.",Non-OADS,/arxiv_data1/oa_pdf/24/6b/gfv272.PMC4762397.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/6b/gfv272.PMC4762397.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Guideline on the Clinical Investigation of Medicinal Products to Prevent Development/Slow Progression of Chronic Renal Insuf ﬁciency .https://www.google.nl/search?q=EMA%2FCHMP% 2F355988%2F2014&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:nl:ofﬁcial&client= ﬁrefox-a&channel=f ﬂb&gfe_rd=cr&ei=gXF4VqT2JYO – Qan84OADQ (10 November 2015, date last accessed) 18.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_ report/human/002788/WC500187923.pdf (10 November 2015, date last accessed) 19.Reference to FDA Complete Response Letter 2013 .http://www.businesswire.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Efﬁcacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease .https://clinicaltrials.gov/ ct2/show/NCT02160145 (10 November 2015, date last accessed) 22.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Final Appraisal Deter- mination: Tolvaptan for Treating Autosomal Dominant Polycystic Kidney Disease .http://www.nice.org.uk/guidance/TA358/documents/kidney- disease-autosomal-dominant-polycystic-tolvaptan-id652- ﬁnal-appraisal- determination-document2 (10 November 2015, date last accessed) 23.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Evidence-Based Clinical Practice Guidelines for Polycystic Kidney Disease 2014.Japan .http://www.jsn.or.jp/BCD1572E-0531-492B-BBDD-803B7BF77CE2/ FinalDownload/DownloadId-BA08C144CD972059AB5B1F6CCB4D1BE5/ BCD1572E-0531-492B-BBDD-803B7BF77CE2/guideline/pdf/PKD_eng.pdf (10 November 2015, date last accessed) 40.Mayo ADPKD Class Calculator .http://www.mayo.edu/research/documents/ pkd-center-adpkd-classi ﬁcation/doc-20094754 (10 November 2015, date last accessed) 41.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Summary of Medicinal Product Characteris- tics Jinarc .http://www.ema.europa.eu/d ocs/en_GB/document_library/ EPAR_-_Product_Information/human/002788/WC500187921.pdf (10 November 2015, date last accessed) 46.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Drug-Induced Liver Injury: Premarketing Clin- ical Evaluation, 2009 .http://www.fda.gov/downloads/Drugs/Guidance/ UCM174090.pdf (10 November 2015, date last accessed) 48.FDA Brie ﬁng Document NDA 204441.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Delaying Progression of Renal Complications of ADPKD by Tolvaptan Inhibition of Arginine Vasopressin, 2013 .http://www.fda.gov/downloads/AdvisoryCommittees/Committees MeetingMaterials/Drugs/Cardiovascu larandRenalDrugsAdvisoryCommittee/ UCM363345.pdf (10 November 2015, date last accessed) 49.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/gfv456.PMC4762400.pdf
"Most recently, thisthree-tier classification has been supplanted by a two-tier low-grade (PanIN-1 and PanIN-2) and high-grade(PanIN-3) classification, which recognizes that the [Keywords : KRAS; cancer metabolism; pancreatic cancer; tumor immune modulation]Corresponding authors: rdepinho@mdanderson.org, hying@mdanderson.orgArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.275776.115.© 2016 Ying et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/7b/355.PMC4762423.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ce/7b/355.PMC4762423.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ce/7b/355.PMC4762423.pdf
"Targeting the KRAS pathway The essential role of KRAS for tumor maintenance under- scores the importance of efforts targeting oncogenicKRAS to achieve major therapeutic advances for PDAC.The significant opportunity, coupled with the meager pro-gress so far in achieving this goal, prompted the launch ofthe National Cancer Institute (NCI) RAS initiative ( “Kill RAS ”) to stimulate novel strategies to attack oncogenic RAS and its signaling surrogates in cancer (http://www.cancer.gov/research/key-initiatives/ras).",Non-OADS,/arxiv_data1/oa_pdf/ce/7b/355.PMC4762423.pdf
Corresponding author: stavazoie@mail.rockefeller.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.270645.115.© 2016 Fish et al.,Non-OADS,/arxiv_data1/oa_pdf/08/f3/386.PMC4762424.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/08/f3/386.PMC4762424.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/08/f3/386.PMC4762424.pdf
eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.274134.115.© 2016 Santanam et al.,OADS,/arxiv_data1/oa_pdf/81/3b/399.PMC4762425.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/81/3b/399.PMC4762425.pdf
We reported thatcardiac overexpression of MED13 increases energy con-sumption and confers a lean phenotype in mice (Grueter Corresponding author: eric.olson@utsouthwestern.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.273128.115.© 2016 Amoasii et al.,Non-OADS,/arxiv_data1/oa_pdf/8d/a2/434.PMC4762428.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/8d/a2/434.PMC4762428.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.272153.115.© 2016 Elmore et al.,Non-OADS,/arxiv_data1/oa_pdf/f0/2d/447.PMC4762429.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f0/2d/447.PMC4762429.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f0/2d/447.PMC4762429.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.273722.115.© 2016 Estrella et al.,OADS,/arxiv_data1/oa_pdf/46/70/460.PMC4762430.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/46/70/460.PMC4762430.pdf
"2014), localcommunication between pericycle and adjacent endoder-mal cells emerges as an important control point in the re-cruitment of founder cells (FCs) for initiation of the lateral Present addresses:6Department of Plant Molecular Biology, Biophore, UNIL-Sorge, University of Lausanne, 1015 Lausanne, Switzerland; 7Department of Molecular Biology and Ecology of Plants, Tel Aviv Univer- sity, Tel Aviv 69978, Israel;8Université de Picardie Jules Verne, 80025 Amiens, France.Corresponding author: eva.benkova@ist.ac.atArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.276964.115.© 2016 Marhavý et al.",Non-OADS,/arxiv_data1/oa_pdf/99/cb/471.PMC4762431.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/99/cb/471.PMC4762431.pdf
"2010), J1103 ,J0121 (Nottingham Arabidopsis Stock Centre (http://nasc.nott.ac.uk/), 35S::MAP4-GFP (Marc et al.",Non-OADS,/arxiv_data1/oa_pdf/99/cb/471.PMC4762431.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3a/ac/tcrm-12-139.PMC4762432.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 139–146Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  139Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9505 2effect of a nonsurgical treatment program on  the gait pattern of idiopathic toe walking: a case  report andrzej szopa1 Małgorzata Domagalska- szopa2 Weronika Gallert-Kopyto1  Wojciech Kiebzak3 Ryszard Plinta4 1Department of Physiotherapy,   2Department of Medical  Rehabilitation, School of Health  Sciences, Medical University of Silesia,   Katowice, 3Faculty of Health Sciences,   Jan Kochanowski University, Kielce,   4Department of Adapted Physical  Activity and Sport, School of Health  Sciences, Medical University of Silesia,   Katowice, PolandBackground:  Recent studies have reported many possibilities for the treatment of idiopathic  toe walking (ITW); however, none of them have been sufficiently documented.",Non-OADS,/arxiv_data1/oa_pdf/3a/ac/tcrm-12-139.PMC4762432.pdf
"In a normal gait, the term “heel Correspondence: andrzej szopa Department of Physiotherapy, School of  Health Sciences, Medical University of  Silesia, Medyków 12, 40-752 Katowice,  poland Tel/fax +48 32 208 8712 email aszopa@sum.edu.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Szopa et al Running head recto: Nonsurgical treatment program for ITW DOI: http://dx.doi.org/10.2147/TCRM.S95052",Non-OADS,/arxiv_data1/oa_pdf/3a/ac/tcrm-12-139.PMC4762432.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3a/ac/tcrm-12-139.PMC4762432.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/ac/tcrm-12-139.PMC4762432.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/84/ott-9-781.PMC4762433.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 781–786OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  781Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9580 6comparative analyses of postoperative  complications and prognosis of different surgical  procedures in stage ii endometrial carcinoma  treatment hongmei Yin1 Ting gui2 1Department of Obstetrics and  gynecology, Binzhou Medical  University hospital, Binzhou Medical  University, Binzhou, shandong,   2Department of Obstetrics and  gynecology, Peking Union Medical  college hospital, Peking Union  Medical college, chinese academy  of Medical sciences, Beijing,   People’s  republic of chinaObjective:  To investigate the impact of surgical resection extent on the postoperative  complications and the prognosis in patients with stage II endometrial cancer.",Non-OADS,/arxiv_data1/oa_pdf/46/84/ott-9-781.PMC4762433.pdf
"Surgical procedures mainly include laparoscopic hysterectomy, correspondence: Ting gui Department of Obstetrics and  gynecology, Peking Union Medical  college hospital, Peking Union  Medical college, chinese academy of  Medical sciences, 1 shuaifuyuan road,  Dongcheng District, Beijing 100730,  People’s republic of china Tel/fax +86 10 6915 6675 email gt-greating@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yin and Gui Running head recto: Different surgical procedures in treating stage II endometrial carcinoma DOI: http://dx.doi.org/10.2147/OTT.S95806",Non-OADS,/arxiv_data1/oa_pdf/46/84/ott-9-781.PMC4762433.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/46/84/ott-9-781.PMC4762433.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/84/ott-9-781.PMC4762433.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 225–232Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  225Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7185 5New developments in the treatment of acute  bacterial skin and skin structure infections:  considerations for the effective use of dalbavancin Janelle J Juul Caitlin F Mullins william J Peppard Angela M Huang Department of Pharmacy, Froedtert &  the Medical College of wisconsin,   Milwaukee, wi, USAAbstract:  Dalbavancin, an intravenous glycopeptide, was approved by the US Food and  Drug Administration in May 2014 for use in adult patients with acute bacterial skin and skin  structure infections.",Non-OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
"In addition to the risk  of nephrotoxicity and the need for therapeutic drug monitoring, reduced vancomycin  susceptibility due to the development of vancomycin-intermediate S. aureus (VISA;  minimum inhibitory concentration [MIC] 4–8 μg/mL) and vancomycin-resistant S. aureus  (VRSA; MIC $16 μg/mL) and enterococci strains is further limiting its use.1,6–8 Though the overall prevalence of these isolates remains low in the US, infections  caused by vancomycin-resistant strains are concerning due to high rates of treatment  failure and poor clinical outcomes.6–10 Therefore, novel antimicrobial agents are needed  for the treatment of ABSSSIs.Correspondence: Janelle Juul Department of Pharmacy, Froedtert &   the Medical College of wisconsin,  9200 w wisconsin Avenue, Milwaukee,  wi 53226, USA email janelle.juul@froedtert.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Juul et al Running head recto: Use of dalbavancin for the treatment of ABSSSIs DOI: http://dx.doi.org/10.2147/TCRM.S71855",Non-OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
"Available  from: http://content.stockpr.com/duratatherapeutics/files/docs/ Dalvance +APPROVED +USPI.PD F. Accessed September 2, 2015.",OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
"Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm398724.ht m.  Accessed September 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/43/tcrm-12-225.PMC4762434.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/a9/ott-9-797.PMC4762435.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 797–805OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  797Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9461 3Using the geometric mean fluorescence intensity  index method to measure ZaP-70 expression  in patients with chronic lymphocytic leukemia Yu-Jie Wu hui Wang Jian-hua liang Yi Miao lu liu hai-rong Qiu chun Qiao rong Wang Jian-Y ong li Department of hematology, First  affiliated hospital of nanjing Medical  University, Jiangsu Province hospital,   nanjing, People’s republic of chinaAbstract:  Expression of ζ-chain-associated protein kinase 70 kDa (ZAP-70) in chronic lym - phocytic leukemia (CLL) is associated with more aggressive disease and can help differentiate  CLL from cases expressing mutated or unmutated immunoglobulin heavy chain variable region  (IgHV ) genes.",Non-OADS,/arxiv_data1/oa_pdf/3c/a9/ott-9-797.PMC4762435.pdf
"Subsequently, several studies have measured ζ-chain-associated  protein kinase 70  kDa (ZAP-70) protein expression in CLL using flow cytometry, and correspondence: Yu-Jie Wu;   Jian-Yong li Department of hematology, The First  Affiliated Hospital of Nanjing Medical  University, Jiangsu Province hospital,  guangzhou road 300#, nanjing, Jiangsu  Province, 210029, People’s republic of  china Tel +86 25 8378 1120 Fax +86 25 8378 1120 email wuyujie123456@163.co m;   lijianyonglm@medmail.com.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: Geometric mean fluorescence intensity index method DOI: http://dx.doi.org/10.2147/OTT.S94613",Non-OADS,/arxiv_data1/oa_pdf/3c/a9/ott-9-797.PMC4762435.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3c/a9/ott-9-797.PMC4762435.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/a9/ott-9-797.PMC4762435.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pvascular Health and Risk Management 2016:12 35–44submit your manuscript | www.dovepress.co m Dove press   http: //dx.doi.org/10.2147/VHRM.S8913 0Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
"Or use: http://youtu.be/q9YyRNlgNp oReversing anticoagulant effects of novel oral  anticoagulants: role of ciraparantag, andexanet   alfa, and idarucizumab Tiffany Y Hu1 vaibhav R vaidya2 Samuel J Asirvatham2,3 1Mayo Medical School, 2Division of  Cardiovascular Diseases, Department  of internal Medicine, 3Department of  Pediatrics and Adolescent Medicine,   Mayo Clinic, Rochester, MN, USA Correspondence: Samuel J Asirvatham   Department of Pediatrics and Adolescent  Medicine, Mayo Clinic, 200 First Street  Sw, Rochester, MN 55905, USA   Tel +1 507 293 3376   Fax +1 507 255 2550   email asirvatham.samuel@mayo.ed uAbstract:  Novel oral anticoagulants (NOACs) are increasingly used in clinical practice, but lack  of commercially available reversal agents is a major barrier for mainstream use of these therapies.",Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
Available from: https://www.nice.org.uk/guidance/ ta354.,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
Available from: http://www.ema.europa.eu/ema/ index.jsp?curl =pages/medicines/human/medicines/002629/human_ med_001874.jsp&mid =WC0b01ac058001d12 4.,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
"Available from: http://www.fda.gov/Drugs/Informa - tionOnDrugs/ApprovedDrugs/ucm467396.ht m. Accessed: November  2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
"Available from: http://us.boehringer-ingelheim.com/news_events/ press_releases/press_release_archive/2015/4-23-2015-fda-grants- priority-review-boehringer-ingelheims-biologics-license-application- idarucizumab.htm l. Accessed October 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
Available from: http://investors.portola.com/  phoenix.zhtml?c =198136&p =irol-newsArticle&ID =187966 6.,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
"Available from: http://perosphere.com/content/media/  documents/PerosphereandDaiichiSankyoEnterintoaClinicalTrialAgree - mentforPhase3.pd f. Accessed October 10, 2015.",OADS,/arxiv_data1/oa_pdf/d1/ab/vhrm-12-035.PMC4762436.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/33/ppa-10-183.PMC4762437.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence Patient Preference and Adherence 2016:10 183–193Dove press submit your manuscript | www.dovepress.co m Dove press  Reviewopen access to scientific and medical research Open Access Full T ext Article 183 http: //dx.doi.org/10.2147/PPA.S5365 3inhaled antibiotics for the treatment of chronic  Pseudomonas aeruginosa  infection in cystic fibrosis  patients: challenges to treatment adherence and  strategies to improve outcomes Réka Bodnár1,2 Ágnes Mészáros2 Máté Oláh2 Tamás Ágh3 1Department of Pediatric  Pulmonology, Heim Pál Children’s  Hospital, Budapest, Hungary;   2University Pharmacy Department of  Pharmacy Administration, Semmelweis  University, Budapest, Hungary; 3Syreon  Research institute, Budapest, HungaryBackground:  Inhaled antibiotics (ABs) are recommended for use in the therapy of chronic  Pseudomonas aeruginosa  infection in patients with cystic fibrosis (CF).",Non-OADS,/arxiv_data1/oa_pdf/15/33/ppa-10-183.PMC4762437.pdf
"PA is one of the most  common gram-negative bacteria causing acute exacerbation and progress of the lung  disease in CF.3 In the management of lung infection with PA, inhaled antibiotic (AB) Correspondence: Réka Bodnár Department of Pediatric Pulmonology,  Heim Pál Children’s Hospital, Üllői Street  86, 1089 Budapest, Hungary Tel +36 1 459 9100 Fax +36 1 459 9100 email rekabodnar@ymail.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Bodnár et al Running head recto: Adherence to inhaled ABs for treatment of P. aeruginosa  infection in CF DOI: http://dx.doi.org/10.2147/PPA.S53653",Non-OADS,/arxiv_data1/oa_pdf/15/33/ppa-10-183.PMC4762437.pdf
"Available  from: http://www.fda.gov/downloads/AdvisoryCommittees/Commit - teesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ UCM193023.pd f. Accessed June 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/15/33/ppa-10-183.PMC4762437.pdf
Avail - able from: http://www.cff.org/research/DrugDevelopmentPipeline /.,Non-OADS,/arxiv_data1/oa_pdf/15/33/ppa-10-183.PMC4762437.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/15/33/ppa-10-183.PMC4762437.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/7b/tcrm-12-233.PMC4762438.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 233–239Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  233ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9816 5Drug-related problems in a sample of outpatients  with chronic diseases: a cross-sectional study  from Jordan sayer i al-azzam1 Karem h alzoubi1 salah abuRuz2 Qais alefan1 1Department of Clinical Pharmacy,   Faculty of Pharmacy, Jordan University  of science and T echnology, irbid,   2Department of Biopharmaceutics  and Clinical Pharmacy, Faculty of  Pharmacy, University of Jordan,   amman, JordanAbstract:  Optimization of drug therapy and preventing drug-related problems (DRPs) are  major factors to improve health care, reduce expenditure, and potentially save lives.",Non-OADS,/arxiv_data1/oa_pdf/2f/7b/tcrm-12-233.PMC4762438.pdf
"Keywords:  drug-related problems, outpatient, hospital, Jordan Introduction For most diseases, drug therapy enhances health-related quality of life.1 However,  inappropriate use of drugs may be harmful and could evoke side effects.2 Drug therapy  is growing more complex, thus making appropriate patient management increasingly  challenging.3 A drug-related problem (DRP), defined as a drug therapy problem, is any  undesirable event experienced by a patient that involves, or is suspected to involve, drug  therapy and that interferes with achieving the desired goals of therapy.4 Accordingly,  in clinical medicine, a wide range of DRPs may arise.5 Optimization of drug therapy  and preventing DRPs may save some of the health care expenditure, potentially save  lives, and enhance patient’s quality of life.6–8 Previous studies have largely addressed  DRPs as a cause of hospitalization,6,9,10 and in elderly,7,11 ambulatory care,11–14 nursing  homes,15 and hospitalized patients.16 DRPs have been identified as contributing to negative clinical and economic out - comes in several international health care systems such as the Netherlands,17 Denmark,18 Correspondence: sayer i al-azzam Department of Clinical Pharmacy, Faculty  of Pharmacy, Jordan University of science  and Technology, irbid 22110, Jordan Tel +962 2 720 1000 Fax +962 2 720 1075 email salazzam@just.edu.j oJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Al-Azzam et al Running head recto: Drug-related problems in outpatient ward DOI: http://dx.doi.org/10.2147/TCRM.S98165",Non-OADS,/arxiv_data1/oa_pdf/2f/7b/tcrm-12-233.PMC4762438.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/2f/7b/tcrm-12-233.PMC4762438.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/7b/tcrm-12-233.PMC4762438.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/e9/opth-10-321.PMC4762439.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 321–330Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  321Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8346 7Fuchs endothelial corneal dystrophy: current  perspectives Gustavo vedana Guadalupe villarreal Jr Albert S Jun wilmer eye institute, Johns Hopkins  Medical institutions, Baltimore,   MD, USAAbstract:  Fuchs endothelial corneal dystrophy (FECD) is the most common corneal dystrophy  and frequently results in vision loss.",Non-OADS,/arxiv_data1/oa_pdf/68/e9/opth-10-321.PMC4762439.pdf
"Anatomic changes Descemet’s membrane and endothelium Descemet’s membrane Deposits of collagen type VIII (COL8) perpendicular to the plane of DM are found at  4 months of gestation and at 8 months form the anterior banded layer (ABL) of DM.4,5 Correspondence: Albert S Jun wilmer eye institute, Johns Hopkins  Hospital, 400 N Broadway, Smith 5011,  Baltimore, MD 21231, USA Tel +1 410 955 5494 Fax +1 410 502 3526 email aljun@jhmi.ed uJournal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Vedana et al Running head recto: Fuchs endothelial corneal dystrophy DOI: http://dx.doi.org/10.2147/OPTH.S83467",Non-OADS,/arxiv_data1/oa_pdf/68/e9/opth-10-321.PMC4762439.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/68/e9/opth-10-321.PMC4762439.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/e9/opth-10-321.PMC4762439.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/3d/opth-10-313.PMC4762441.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 313–319Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  313Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9777 5Three-year follow-up of ranibizumab treatment of  wet age-related macular degeneration: influence  of baseline visual acuity and injection frequency  on visual outcomes Faraz razi1 adnaan haq2 Prabhu T onne3 Maharatnam logendran3 1Department of Paediatrics,   Basingstoke and north hampshire  hospital, Basingstoke, UK;   2Department of Ophthalmology,   leicester general hospital, leicester,   UK; 3Department of Ophthalmology,   northampton general hospital,   northampton, UKPurpose:  To determine the effect of ranibizumab on visual acuity (VA) following a 3-year  treatment period for patients diagnosed with wet age-related macular degeneration.",Non-OADS,/arxiv_data1/oa_pdf/18/3d/opth-10-313.PMC4762441.pdf
"Pivotal clinical trials, such as the ANCHOR2 and MARINA3  studies, demonstrated that monthly injections of 0.5 mg ranibizumab provided a mean  improvement in visual acuity (VA) of 10.7 and 7.2 Early Treatment Diabetic Retino- pathy Study (ETDRS) letters after 2 years, respectively.Correspondence: Faraz razi Basingstoke and north hampshire  hospital, aldermaston road, Basingstoke,  hampshire, rg24 9na, United Kingdom Tel +44 7891 963 812 email farazr@doctors.org.u k Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Razi et al Running head recto: Ranibizumab frequency and baseline visual acuity influence visual outcomes DOI: http://dx.doi.org/10.2147/OPTH.S97775",Non-OADS,/arxiv_data1/oa_pdf/18/3d/opth-10-313.PMC4762441.pdf
"Available from: http://www.novartis.com.au/pi_pdf/ luc.pd f. Accessed January 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/18/3d/opth-10-313.PMC4762441.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/3d/opth-10-313.PMC4762441.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/3d/opth-10-313.PMC4762441.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/27/ppa-10-171.PMC4762442.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 171–181Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  171OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10020 3how effective is an in-hospital heart failure  self-care program in a Japanese setting?",Non-OADS,/arxiv_data1/oa_pdf/c6/27/ppa-10-171.PMC4762442.pdf
"Approximately half of the readmissions for HF are considered to be potentially  preventable with adequate self-care and appropriate support.2 Although the optimal  model of HF management programs is still under debate,3 a multidisciplinary HF  management program successfully reduces morbidity and mortality in HF patients.4  The effects of multidisciplinary HF programs have widely been reported in Western  countries,3,5 but there have been no such programs in Japan so far.correspondence: naoko P Kato Department of Therapeutic strategy for  heart Failure, The University of Tokyo  graduate school of Medicine, 7-3-1,  hongo, Bunkyo-ku, Tokyo 1138655,  Japan Tel +81 3 5800 9082 Fax +81 3 5800 9082 email naokat-tky@umin.ac.j p Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kato et al Running head recto: A randomized controlled pilot study of HF self-care program DOI: http://dx.doi.org/10.2147/PPA.S100203",Non-OADS,/arxiv_data1/oa_pdf/c6/27/ppa-10-171.PMC4762442.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c6/27/ppa-10-171.PMC4762442.pdf
"2010; Available from: http://www.j-circ.or.jp/ guideline/pdf/JCS2010_matsuzaki_h.pd f. Accessed May, 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c6/27/ppa-10-171.PMC4762442.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/df/tcrm-12-251.PMC4762443.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 251–260Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  251ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9983 1Bacterial profile of urinary tract infection and  antimicrobial susceptibility pattern among pregnant  women attending at antenatal Clinic in Dil Chora  Referral Hospital, Dire Dawa, Eastern Ethiopia Behailu Derese1 haji Kedir2 Zelalem T eklemariam3 Fitsum Weldegebreal3 senthilkumar Balakrishnan4 1Department of Medical Laboratory,   Dil Chora Referral Hospital, Dire  Dawa, 2Department of Public Health,   3Department of Medical Laboratory  Sciences, 4Department of Medical  Microbiology, College of Health  and Medical Sciences, Haramaya  University, Harar, EthiopiaPurpose:  The aim of this study was to determine the bacterial profile of urinary tract infection  (UTI) and antimicrobial susceptibility pattern among pregnant women attending at antenatal  clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia.",Non-OADS,/arxiv_data1/oa_pdf/34/df/tcrm-12-251.PMC4762443.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/34/df/tcrm-12-251.PMC4762443.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/df/tcrm-12-251.PMC4762443.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/cb/tcrm-12-241.PMC4762444.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 241–250Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  241ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9830 0effectiveness of the clinical pharmacist in reducing  mortality in hospitalized cardiac patients: a  propensity score-matched analysis Xiao-bo Zhai1 Zhi-chun gu2 Xiao-yan liu2 1Department of Pharmacy, shanghai  east hospital, affiliated to Tongji  University school of Medicine,   2Department of Pharmacy, Renji  hospital, shanghai Jiao T ong University  school of Medicine, shanghai, People’s  Republic of ChinaBackground:  Pharmacist-led medication review services have been assessed in the meta- analyses in hospital.",Non-OADS,/arxiv_data1/oa_pdf/b0/cb/tcrm-12-241.PMC4762444.pdf
"Keywords:  drug-related problems, cardiology ward, clinical pharmacists, intervention, pro - pensity score matchingCorrespondence: Xiao-yan liu Department of Pharmacy, Renji hospital,  shanghai Jiao Tong University school  of Medicine, Pujian Road 160, shanghai  200127, People’s Republic of China email xiaoyan5156@163.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zhai et al Running head recto: Clinical pharmacist interventions on mortality of cardiac patients DOI: http://dx.doi.org/10.2147/TCRM.S98300 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/b0/cb/tcrm-12-241.PMC4762444.pdf
Or use: http://youtu.be/qBmj60olVC IVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/b0/cb/tcrm-12-241.PMC4762444.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b0/cb/tcrm-12-241.PMC4762444.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/cb/tcrm-12-241.PMC4762444.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/23/ott-9-787.PMC4762445.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 787–795OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  787Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9268 2PBOV1 promotes prostate cancer proliferation  by promoting g1/s transition Tiejun Pan1,* rongpei Wu2,* Bo liu1 handong Wen1 Zhong T u1 Jun guo1 Jiarong Yang1 guoqiu shen1 1Department of Urology, Wuhan  general hospital of guangzhou  Military command, Wuhan, hubei,   2Department of Urology, The First  affiliated hospital, sun Yat-sen  University, guangzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Prostate cancer (PC) is one of the leading causes of cancer death in men, and thus,  finding new regulators is critical for PC therapy.",Non-OADS,/arxiv_data1/oa_pdf/02/23/ott-9-787.PMC4762445.pdf
"They also analyzed the relationship between PBOV1 expression and the outcome and correspondence: Tiejun Pan Department of Urology, Wuhan  general hospital of guangzhou Military  command, Wuhan, hubei 430070,  People’s republic of china email mnwkptj@aliyun.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Pan et al Running head recto: PBOV1 promotes prostate cancer proliferation DOI: http://dx.doi.org/10.2147/OTT.S92682",Non-OADS,/arxiv_data1/oa_pdf/02/23/ott-9-787.PMC4762445.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/02/23/ott-9-787.PMC4762445.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/23/ott-9-787.PMC4762445.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/52/main.PMC4762447.pdf
http://dx.doi.org/10.1016/j.hrcr.2015.02.016,OADS,/arxiv_data1/oa_pdf/99/52/main.PMC4762447.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/28/ndt-12-349.PMC4762461.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 349–355Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  349OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9916 0sexual dysfunction, mood, anxiety, and personality  disorders in female patients with fibromyalgia Fatih Kayhan1 adem Küçük2 Yılmaz Satan3 erdem İlgün4 Şevket Arslan5 Faik İlik6 1Department of Psychiatry, Faculty  of Medicine, selçuk University,   2Department of Rheumatology, Faculty  of Medicine, Necmettin Erbakan  University, 3Department of Psychiatry,   Konya Numune state hospital,   4Department of Physical Therapy and  Rehabilitation, Faculty of Medicine,   Mevlana University, 5Department of  internal Medicine, Faculty of Medicine,   Necmettin Erbakan University,   6Department of Neurology, Faculty  of Medicine, Başkent University,   Konya, T urkeyBackground:  We aimed to investigate the current prevalence of sexual dysfunction (SD),  mood, anxiety, and personality disorders in female patients with fibromyalgia (FM).",Non-OADS,/arxiv_data1/oa_pdf/c1/28/ndt-12-349.PMC4762461.pdf
"The lifetime correspondence: Fatih Kayhan Department of Psychiatry, Faculty of  Medicine, selçuk University, alaeddin  Keykubat Campus, 42131 Selçuklu,  Konya, Turkey Tel +90 332 241 2181 email drkayhan@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kayhan et al Running head recto: Sexual dysfunction and comorbid psychiatric disorder in FM DOI: http://dx.doi.org/10.2147/NDT.S99160",Non-OADS,/arxiv_data1/oa_pdf/c1/28/ndt-12-349.PMC4762461.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c1/28/ndt-12-349.PMC4762461.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/28/ndt-12-349.PMC4762461.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/57/amep-7-091.PMC4762462.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Advances in Medical Education and Practice 2016:7 91–97Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  91Short rEPortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S10050 9A new method for teaching physical examination  to junior medical students Meelad Sayma hywel rhys Williams Peninsula College of Medicine and  Dentistry, Plymouth, UK Correspondence: Meelad Sayma; hywel  rhys Williams   Peninsula College of Medicine and  Dentistry, John Bull Building, tamar  Science Park, Plymouth PL6 8BU, UK   Email meelad.sayma@students.pcmd.",Non-OADS,/arxiv_data1/oa_pdf/3c/57/amep-7-091.PMC4762462.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/3c/57/amep-7-091.PMC4762462.pdf
Visit http://www.dovepress.com/testimonials.php to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/amep-7-091.PMC4762462.pdf
Available from: http://en.wikipedia.org/wiki/ Zone_of_proximal_development-mediaviewer/File:Zone_of_proximal_   development.svg.,Non-OADS,/arxiv_data1/oa_pdf/3c/57/amep-7-091.PMC4762462.pdf
